<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.4.549">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">

<meta name="author" content="Gaelen Guzman">
<meta name="author" content="Fikadu G. Tafesse">

<title>TB &amp; The Sphinx - 2&nbsp; Introduction Part 2</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="../../site_libs/quarto-nav/quarto-nav.js"></script>
<script src="../../site_libs/quarto-nav/headroom.min.js"></script>
<script src="../../site_libs/clipboard/clipboard.min.js"></script>
<script src="../../site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="../../site_libs/quarto-search/fuse.min.js"></script>
<script src="../../site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="../../">
<link href="../../parts/results.html" rel="next">
<link href="../../parts/introduction/intro_Layperson.html" rel="prev">
<script src="../../site_libs/quarto-html/quarto.js"></script>
<script src="../../site_libs/quarto-html/popper.min.js"></script>
<script src="../../site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="../../site_libs/quarto-html/anchor.min.js"></script>
<link href="../../site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="../../site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-text-highlighting-styles">
<link href="../../site_libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-text-highlighting-styles">
<script src="../../site_libs/bootstrap/bootstrap.min.js"></script>
<link href="../../site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="../../site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-bootstrap" data-mode="light">
<link href="../../site_libs/bootstrap/bootstrap-dark.min.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-bootstrap" data-mode="dark">
<script src="../../site_libs/quarto-contrib/glightbox/glightbox.min.js"></script>
<link href="../../site_libs/quarto-contrib/glightbox/glightbox.min.css" rel="stylesheet">
<link href="../../site_libs/quarto-contrib/glightbox/lightbox.css" rel="stylesheet">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>


<link rel="stylesheet" href="../../styles.css">
</head>

<body class="nav-sidebar floating nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg " data-bs-theme="dark">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container mx-auto">
    <a class="navbar-brand" href="../../index.html">
    <span class="navbar-title">TB and the Sphinx</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Search"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll ms-auto">
  <li class="nav-item compact">
    <a class="nav-link" href="https://drive.google.com/file/d/1Cdb-DDU9dsD4KLxv5WlcxFEM6ViPRuXl/view?usp=share_link" target="_blank"> <i class="bi bi-file-pdf" role="img" aria-label="Download .pdf">
</i> 
<span class="menu-text"></span></a>
  </li>  
  <li class="nav-item compact">
    <a class="nav-link" href="https://docs.google.com/document/d/1L0fe7AC-k4hhSJYj_NG2i_aBLd4QHr9T/edit?usp=share_link&amp;ouid=107014449567027741510&amp;rtpof=true&amp;sd=true" target="_blank"> <i class="bi bi-file-word" role="img" aria-label="Download .docx">
</i> 
<span class="menu-text"></span></a>
  </li>  
</ul>
          </div> <!-- /navcollapse -->
          <div class="quarto-navbar-tools">
  <a href="" class="quarto-color-scheme-toggle quarto-navigation-tool  px-1" onclick="window.quartoToggleColorScheme(); return false;" title="Toggle dark mode"><i class="bi"></i></a>
</div>
      </div> <!-- /container-fluid -->
    </nav>
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
        <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="../../parts/introduction.html">Introduction: TB and the Sphinx</a></li><li class="breadcrumb-item"><a href="../../parts/introduction/intro_Scientific.html"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Introduction Part 2</span></a></li></ol></nav>
        <a class="flex-grow-1" role="button" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
        </a>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal quarto-sidebar-collapse-item sidebar-navigation floating overflow-auto">
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Certificate of Approval</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Acknowledgements.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Acknowledgements</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Glossary.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Glossary</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="../../parts/introduction.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Introduction: TB and the Sphinx</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/introduction/intro_Layperson.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Introduction Part 1</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/introduction/intro_Scientific.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Introduction Part 2</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="../../parts/results.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Main Results</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/results/results_Mtb_phagocytosis.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Breaking and Entering</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/results/results_Mtb_Membrane_Damage_V2.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Sealing the Gaps</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/results/results_Mtb_lipidomics_v2.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Living Off the Fat of the Cell</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/results/results_trifunctionalProteomics.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">An Affinity for Sphingolipids</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="../../parts/addenda.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Additional work</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Addenda/addenda_SLs_GeneticTools.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Genetic tools to study sphingolipids in disease</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Addenda/addenda_SLs_Fungus.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">The Squeaky Yeast Gets Greased</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Addenda/addenda_MethodsForVisualizingPhagocytosis.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Rapid visualization and quantification of phagocytosis in neutrophils</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Addenda/addenda_Celegans_SMS_family.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Systematic analysis of the sphingomyelin synthase family in <em>C. elegans</em></span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="../../parts/discussionInterstitial.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Final thoughts &amp; future directions</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/Discussion/discussion.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Discussion</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">References</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="../../parts/about.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">About</span></a>
  </div>
</li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" class="quarto-sidebar-collapse-item" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#abstract" id="toc-abstract" class="nav-link active" data-scroll-target="#abstract"><span class="header-section-number">2.1</span> Abstract</a></li>
  <li><a href="#introduction" id="toc-introduction" class="nav-link" data-scroll-target="#introduction"><span class="header-section-number">2.2</span> Introduction</a></li>
  <li><a href="#mtb-and-the-innate-immune-system-a-tug-of-war-in-the-lung" id="toc-mtb-and-the-innate-immune-system-a-tug-of-war-in-the-lung" class="nav-link" data-scroll-target="#mtb-and-the-innate-immune-system-a-tug-of-war-in-the-lung"><span class="header-section-number">2.3</span> <em>Mtb</em> and the innate immune system: a tug of war in the lung</a>
  <ul class="collapse">
  <li><a href="#infection-start-the-granuloma" id="toc-infection-start-the-granuloma" class="nav-link" data-scroll-target="#infection-start-the-granuloma"><span class="header-section-number">2.3.1</span> Infection start &amp; the granuloma</a></li>
  <li><a href="#a-trojan-horse-in-the-belly-of-the-beast" id="toc-a-trojan-horse-in-the-belly-of-the-beast" class="nav-link" data-scroll-target="#a-trojan-horse-in-the-belly-of-the-beast"><span class="header-section-number">2.3.2</span> A Trojan Horse in the belly of the beast</a></li>
  <li><a href="#arresting-development-the-blockade-of-lysosomal-maturation." id="toc-arresting-development-the-blockade-of-lysosomal-maturation." class="nav-link" data-scroll-target="#arresting-development-the-blockade-of-lysosomal-maturation."><span class="header-section-number">2.3.3</span> Arresting development: the blockade of lysosomal maturation.</a></li>
  <li><a href="#breaking-free-damaging-the-phagosomal-membrane" id="toc-breaking-free-damaging-the-phagosomal-membrane" class="nav-link" data-scroll-target="#breaking-free-damaging-the-phagosomal-membrane"><span class="header-section-number">2.3.4</span> Breaking free: damaging the phagosomal membrane</a></li>
  <li><a href="#lipid-droplet-formation-in-late-stage-infection" id="toc-lipid-droplet-formation-in-late-stage-infection" class="nav-link" data-scroll-target="#lipid-droplet-formation-in-late-stage-infection"><span class="header-section-number">2.3.5</span> Lipid droplet formation in late-stage infection</a></li>
  <li><a href="#cytokine-production-in-the-granuloma" id="toc-cytokine-production-in-the-granuloma" class="nav-link" data-scroll-target="#cytokine-production-in-the-granuloma"><span class="header-section-number">2.3.6</span> Cytokine production in the granuloma</a></li>
  </ul></li>
  <li><a href="#mtb-and-lipids-a-recipe-for-pathogenicity" id="toc-mtb-and-lipids-a-recipe-for-pathogenicity" class="nav-link" data-scroll-target="#mtb-and-lipids-a-recipe-for-pathogenicity"><span class="header-section-number">2.4</span> <em>Mtb</em> and Lipids: A recipe for pathogenicity</a></li>
  <li><a href="#sphingolipids-overview" id="toc-sphingolipids-overview" class="nav-link" data-scroll-target="#sphingolipids-overview"><span class="header-section-number">2.5</span> Sphingolipids overview</a>
  <ul class="collapse">
  <li><a href="#sphingolipid-synthesis-and-trafficking" id="toc-sphingolipid-synthesis-and-trafficking" class="nav-link" data-scroll-target="#sphingolipid-synthesis-and-trafficking"><span class="header-section-number">2.5.1</span> Sphingolipid synthesis and trafficking</a></li>
  <li><a href="#sphingolipid-breakdown-signaling-through-salvage" id="toc-sphingolipid-breakdown-signaling-through-salvage" class="nav-link" data-scroll-target="#sphingolipid-breakdown-signaling-through-salvage"><span class="header-section-number">2.5.2</span> Sphingolipid breakdown: signaling through salvage</a></li>
  <li><a href="#sphingolipids-and-disease" id="toc-sphingolipids-and-disease" class="nav-link" data-scroll-target="#sphingolipids-and-disease"><span class="header-section-number">2.5.3</span> Sphingolipids and disease</a></li>
  </ul></li>
  <li><a href="#open-questions-regarding-sphingolipids-in-mtb-infection" id="toc-open-questions-regarding-sphingolipids-in-mtb-infection" class="nav-link" data-scroll-target="#open-questions-regarding-sphingolipids-in-mtb-infection"><span class="header-section-number">2.6</span> Open questions regarding sphingolipids in <em>Mtb</em> infection</a></li>
  <li><a href="#challenges-and-breakthroughs-in-studying-lipids" id="toc-challenges-and-breakthroughs-in-studying-lipids" class="nav-link" data-scroll-target="#challenges-and-breakthroughs-in-studying-lipids"><span class="header-section-number">2.7</span> Challenges and breakthroughs in studying lipids</a></li>
  <li><a href="#conclusion" id="toc-conclusion" class="nav-link" data-scroll-target="#conclusion"><span class="header-section-number">2.8</span> Conclusion</a></li>
  <li><a href="#contributions" id="toc-contributions" class="nav-link" data-scroll-target="#contributions"><span class="header-section-number">2.9</span> Contributions</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default"><nav class="quarto-page-breadcrumbs quarto-title-breadcrumbs d-none d-lg-block" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="../../parts/introduction.html">Introduction: TB and the Sphinx</a></li><li class="breadcrumb-item"><a href="../../parts/introduction/intro_Scientific.html"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Introduction Part 2</span></a></li></ol></nav>
<div class="quarto-title">
<h1 class="title"><span id="sec-ScientificIntroduction" class="quarto-section-identifier"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Introduction Part 2</span></span></h1>
</div>


<div class="quarto-title-meta-author">
  <div class="quarto-title-meta-heading">Authors</div>
  <div class="quarto-title-meta-heading">Affiliation</div>
  
    <div class="quarto-title-meta-contents">
    <p class="author">Gaelen Guzman </p>
  </div>
  <div class="quarto-title-meta-contents">
        <p class="affiliation">
            Department of Molecular Microbiology and Immunology, Oregon Health &amp; Science University, Portland, Oregon, USA
          </p>
      </div>
    <div class="quarto-title-meta-contents">
    <p class="author">Fikadu G. Tafesse <a href="mailto:tafesse@ohsu.edu" class="quarto-title-author-email"><i class="bi bi-envelope"></i></a> </p>
  </div>
  <div class="quarto-title-meta-contents">
        <p class="affiliation">
            Department of Molecular Microbiology and Immunology, Oregon Health &amp; Science University, Portland, Oregon, USA
          </p>
      </div>
  </div>

<div class="quarto-title-meta">

      
  
    
  </div>
  


</header>


<section id="abstract" class="level2" data-number="2.1">
<h2 data-number="2.1" class="anchored" data-anchor-id="abstract"><span class="header-section-number">2.1</span> Abstract</h2>
<p>Mycobacterium tuberculosis (<em>Mtb</em>) is a significant cause of infectious death worldwide. This intracellular pathogen uses many mechanisms to subvert the host immune system and lie undetected before causing active disease. This subtle pathogen is uniquely dependent on host lipids for energy, production of host-damaging materiel, and immune subversion. In the face of antibiotic-resistant <em>Mtb</em> strains, researchers have turned toward lipid biology for potential avenues of novel antitubercular therapy. The sphingolipid family has gained attention for its profound roles in determining cell fate, immune signaling, and antimicrobial activity. We review the state of the field regarding sphingolipids as candidate targets of host-directed antitubercular intervention.</p>
</section>
<section id="introduction" class="level2" data-number="2.2">
<h2 data-number="2.2" class="anchored" data-anchor-id="introduction"><span class="header-section-number">2.2</span> Introduction</h2>
<p><em>Mtb</em> has co-evolved with humans for millennia and thus possesses an astounding capacity to subvert the host antimicrobial defenses, establishing a latent TB infection that can persist for years before progressing to active TB disease<span class="citation" data-cites="quevalMacrophageDisputedFortress2017"><sup><a href="../references.html#ref-quevalMacrophageDisputedFortress2017" role="doc-biblioref">1</a></sup></span>. Among its adaptations is a profound reliance on host lipids. This intracellular pathogen utilizes host lipids as a source of energy and carbon source and is highly sensitive to subtle changes in its host lipidome<span class="citation" data-cites="tobinHostDirectedTherapiesTuberculosis2015 duttaAdjunctiveHostDirectedTherapy2020a"><sup><a href="../references.html#ref-tobinHostDirectedTherapiesTuberculosis2015" role="doc-biblioref">2</a>,<a href="../references.html#ref-duttaAdjunctiveHostDirectedTherapy2020a" role="doc-biblioref">3</a></sup></span>. Thus, in recent years, researchers have turned toward lipid biology as a potential route of host-directed therapy. A particular lipid family of interest is the sphingolipids. Sphingolipids are dual cell death and inflammation regulators, and they play a crucial role in host defense against pathogenic infections. Thus, studying the host-pathogen interactions and sphingolipid biology may provide new insights into developing effective TB therapies.</p>
<p>In addition to its direct impact on human health, studying Mtb provides unique opportunities to explore and unravel typical human immune function. As a highly adapted pathogen, Mtb has evolved redundant pathways to subvert host immune defenses, making it an excellent teacher and model for understanding human immune function. This chapter will discuss how host sphingolipid biology intersects with <em>Mtb</em> biology and how this niche class of lipids may provide promising routes for new antitubercular drugs.</p>
</section>
<section id="mtb-and-the-innate-immune-system-a-tug-of-war-in-the-lung" class="level2" data-number="2.3">
<h2 data-number="2.3" class="anchored" data-anchor-id="mtb-and-the-innate-immune-system-a-tug-of-war-in-the-lung"><span class="header-section-number">2.3</span> <em>Mtb</em> and the innate immune system: a tug of war in the lung</h2>
<section id="infection-start-the-granuloma" class="level3" data-number="2.3.1">
<h3 data-number="2.3.1" class="anchored" data-anchor-id="infection-start-the-granuloma"><span class="header-section-number">2.3.1</span> Infection start &amp; the granuloma</h3>
<p>The primary TB infection route is inhaling cough aerosols an active TB patient produces. In daily life, humans constantly experience airborne microbes and particulates – every breath will contain fungal, bacterial, and viral particles that reach the lungs<span class="citation" data-cites="zhaoGlobalAirborneBacterial2022"><sup><a href="../references.html#ref-zhaoGlobalAirborneBacterial2022" role="doc-biblioref">4</a></sup></span>. Many of these particles are filtered out and destroyed in the sinus cavity<span class="citation" data-cites="noceraExosomeSwarmsEliminate2019"><sup><a href="../references.html#ref-noceraExosomeSwarmsEliminate2019" role="doc-biblioref">5</a></sup></span>, but many will make their way down to the alveolar sacs, the deepest regions of the deepest regions of the lung. The alveoli are surveilled by resident immune cells called alveolar macrophages<span class="citation" data-cites="flynnImmuneCellInteractions2022a"><sup><a href="../references.html#ref-flynnImmuneCellInteractions2022a" role="doc-biblioref">6</a></sup></span>. These resident macrophages use damage recognition receptors and pathogen recognition receptors to probe for cells, objects (like silica dust), or invaders decorated with damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (PAMPs)<span class="citation" data-cites="rosalesPhagocytosisFundamentalProcess2017"><sup><a href="../references.html#ref-rosalesPhagocytosisFundamentalProcess2017" role="doc-biblioref">7</a></sup></span>.</p>
<p>In most cases, a macrophage will uptake these foreign or effete particles through phagocytosis and destroy them in a specialized cellular organelle called the lysosome. The destruction of would-be pathogens in the lysosome is directly beneficial for clearing an infection. However, the macrophage will also present peptides from the destroyed pathogen to the adaptive immune system, enabling the host to mount a concerted and long-lived immune response. These processes protect most immunocompetent (non-immunocompromised) individuals from infection by environmental pathogens. However, <em>Mtb</em> is adept at avoiding and subverting these processes.</p>
<p><em>Mycobacterium tuberculosis</em> has spent millennia adapting to the human immune response. Few microbes are as well-suited for aerosol transmission as mycobacteria: recent work has shown that the waxy, hydrophobic composition of the <em>Mtb</em> cell wall confers a high capacity to remain airborne for long periods<span class="citation" data-cites="michaudTaxonspecificAerosolizationBacteria2018 pfrommerEnhancedTenacityMycobacterial2020"><sup><a href="../references.html#ref-michaudTaxonspecificAerosolizationBacteria2018" role="doc-biblioref">8</a>,<a href="../references.html#ref-pfrommerEnhancedTenacityMycobacterial2020" role="doc-biblioref">9</a></sup></span>. Others have shown repeatedly that many, if not most, TB infections are initiated by an individual <em>Mtb</em> bacillus (first shown in guinea pigs housed in TB wards and recently verified by infecting macaques with aerosolized, barcoded <em>Mtb</em> bacilli)<span class="citation" data-cites="o1963experimental rileyAERIALDISSEMINATIONOP1995 martinDigitallyBarcodingMycobacterium2017 linSterilizationGranulomasCommon2014"><sup><a href="../references.html#ref-o1963experimental" role="doc-biblioref">10</a>–<a href="../references.html#ref-linSterilizationGranulomasCommon2014" role="doc-biblioref">13</a></sup></span>.</p>
<p>Within the lung space, <em>Mtb</em> infects alveolar macrophages in a Trojan Horse-style infection: <em>Mtb</em> bacilli allow themselves to be internalized via phagocytosis, initiating a program of immune subversion that, in a successful infection, culminates in the recruitment of more alveolar macrophages as well as other immune cells including monocyte-derived (hematopoietic) macrophages, neutrophils, natural killer cells, T cells, and dendritic cells, and non-immune fibroblasts. As reviewed by Ehlers and Schaible in 2013, the cyclic recruitment of immune cells to the site of <em>Mtb</em> infection has two simultaneous, opposing effects: (1) encapsulating the infection in a fibrous net of fibroblasts and antimicrobial immune cells, which prevents the spread of <em>Mtb</em> bacilli throughout the lung and (2) serving the bacteria fresh macrophages, which serve as host cells and propagate the ongoing infection<span class="citation" data-cites="ehlersGranulomaTuberculosisDynamics2013 kellerGeneticallyDeterminedSusceptibility2006"><sup><a href="../references.html#ref-ehlersGranulomaTuberculosisDynamics2013" role="doc-biblioref">14</a>,<a href="../references.html#ref-kellerGeneticallyDeterminedSusceptibility2006" role="doc-biblioref">15</a></sup></span>.</p>
<p>These self-contradictory roles for the granuloma result in restricted bacterial spread <em>and</em> sustained infection – it is thus how a latent TB infection is maintained for potentially years before activation to active TB disease. In 2009, Cardona proposed a model in which the same individual is “reinfected” repeatedly as infected macrophages spontaneously escape from the granuloma and seed infection in a new site<span class="citation" data-cites="cardonaDynamicReinfectionHypothesis2009"><sup><a href="../references.html#ref-cardonaDynamicReinfectionHypothesis2009" role="doc-biblioref">16</a></sup></span>. In support of this, Lin et al.&nbsp;(2014) used longitudinal scanning to show that macaque granulomas are often sterilized and cleared<span class="citation" data-cites="linSterilizationGranulomasCommon2014"><sup><a href="../references.html#ref-linSterilizationGranulomasCommon2014" role="doc-biblioref">13</a></sup></span>. However, this is counteracted by the formation of new granulomas in new sites<span class="citation" data-cites="linSterilizationGranulomasCommon2014"><sup><a href="../references.html#ref-linSterilizationGranulomasCommon2014" role="doc-biblioref">13</a></sup></span>. In this now-widely accepted model of granuloma containment of <em>Mtb</em>, a patient with a latent TB infection can control infection for long periods but will proceed to active TB disease if the immune regulation within the granuloma fails.</p>
<p>The dissolution of the granuloma structure is marked by widespread necrotic cell death, caseation (tissue degradation with a “cheese-like” appearance<span class="citation" data-cites="kimCaseationHumanTuberculosis2010"><sup><a href="../references.html#ref-kimCaseationHumanTuberculosis2010" role="doc-biblioref">17</a></sup></span>), and eventual cavitation (total collapse, leaving a hole in the lung space) of the granuloma releases the contained bacteria from its restriction and allows them to replicate uncontrolled. At this point, bacteria and necrotic cellular detritus spill into the airway, and the patient’s coughing spreads the released bacteria.</p>
<p>Shortly, we will discuss how lipids influence the interactions between an infecting <em>Mtb</em> bacillus and an individual host cell. First, though, we must note that lipid dysregulation is a hallmark trait of uncontrolled TB disease, even at the organismal level. Histological studies by Hunter et al.&nbsp;in 2007 showed that activation of latent TB disease occurs in tandem with a spillage of lipidated material from ruptured granulomas into the airway<span class="citation" data-cites="hunterPathologyPostprimaryTuberculosis2007"><sup><a href="../references.html#ref-hunterPathologyPostprimaryTuberculosis2007" role="doc-biblioref">18</a></sup></span> – a form of lipidated pneumonia in which cholesterols and cholesteryl esters, triacylglycerols, and lactocylceramides accumulate in the caseum<span class="citation" data-cites="kimCaseationHumanTuberculosis2010"><sup><a href="../references.html#ref-kimCaseationHumanTuberculosis2010" role="doc-biblioref">17</a></sup></span>. In many ways, the moment-to-moment stability/integrity of the granuloma reflects the immunocompetence of the host: immunocompromising events such as HIV, chemotherapy, or malnutrition tip the balance in favor of the invading <em>Mycobacterium tuberculosis</em>. The granuloma’s structure is the product of many host-pathogen interactions, the sum of many individual battles between host and microbe. In the unique <em>Mtb</em> infection, many host-pathogen interactions occur via a lipid or membrane interface. We will now discuss the <em>Mtb</em> lifecycle within a host cell: how <em>Mtb</em> subverts the typical immunological processes of the macrophage.</p>
<!-- TODO: granuloma figure? -->
</section>
<section id="a-trojan-horse-in-the-belly-of-the-beast" class="level3" data-number="2.3.2">
<h3 data-number="2.3.2" class="anchored" data-anchor-id="a-trojan-horse-in-the-belly-of-the-beast"><span class="header-section-number">2.3.2</span> A Trojan Horse in the belly of the beast</h3>
<p>Alveolar macrophages surveil the lung space for would-be pathogens, foreign material, or dying cells. To accomplish this, they express an array of receptors that recognize pathogen-associated or damage-associated molecular patterns (PAMPs and DAMPs, respectively). These receptors, or pathogen-recognition receptors (PRRs), bind to a cognate antigen and initiate a signaling cascade that can trigger phagocytosis, cytokine secretion, and adaptive immune system activation.</p>
<p>As is the case with most bacterial pathogens, a variety of <em>Mtb</em> surface structures are recognized by phagocytic receptors such as Dectin-1, the Mannose Receptor, and DC-SIGN, as well as non-phagocytic receptors such as TLR2. Upon recognizing the <em>Mtb</em> pathogen-particle, the alveolar macrophage internalizes the bacterial cell via phagocytosis. However, unlike other pathogens, <em>Mtb</em> appears to selectively engage receptors that fail to initiate immune signaling. Van Kooyk and others have reported that <em>Mtb</em> selectively binds receptors that fail to initiate inflammatory signaling<span class="citation" data-cites="vankooykDCSIGNEscapeMechanism2003a hossainPatternRecognitionReceptors2013"><sup><a href="../references.html#ref-vankooykDCSIGNEscapeMechanism2003a" role="doc-biblioref">19</a>,<a href="../references.html#ref-hossainPatternRecognitionReceptors2013" role="doc-biblioref">20</a></sup></span>.</p>
<div class="border">
<div id="fig-ScientificIntro-Fig1" class="quarto-figure quarto-figure-center quarto-float anchored" data-group="intro-ScientificGallery">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-ScientificIntro-Fig1-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="../../parts/introduction/introduction_files/Figure 1-Mtbmanipulation.png" class="lightbox" data-gallery="intro-ScientificGallery" data-glightbox="description: .lightbox-desc-1"><img src="../../parts/introduction/introduction_files/Figure 1-Mtbmanipulation.png" class="img-fluid figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-ScientificIntro-Fig1-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;2.1: <strong>The balancing act of <em>Mtb</em> control.</strong> A highly simplified cartoon depicting the anti-/pro-<em>Mtb</em> features of infected macrophages. The terminal fate of internalized <em>Mtb</em> appears related to programming initiated with the sensing and internalization of the bacteria by PRRs. Inflammatory PRRs direct the bacteria toward a maturing endosome, resulting in ROS/RNS production, bacterial death, and secretion of inflammatory cytokines involved in overall infection control. Uptake by anti-inflammatory PRRs results in the bacteria residing in a non-maturing endosome, gaining cytosolic access via membrane disruption, the accumulation of lipid droplets, and finally, anti-inflammatory cytokine production — resulting in tuberculosis disease progression. (Abbreviations: PRR = pathogen recognition receptor; TLR2 = toll-like receptor 2; CR = complement receptor; FCγR = Fc-gamma receptor; MR = mannose receptor; SP-A = surfactant protein A; ROS/RNS = reactive oxygen/nitrogen species; IL-12/18/1β/10/4 = interleukins 12/18/1β/10/4; TGF-β = transformative growth factor-β; IFN-α/β = interferon-α/β).
</figcaption>
</figure>
</div>
</div>
<p>Therein lies the Trojan Horse infection: the macrophage internalizes the <em>Mtb</em> bacillus as a part of its typical antimicrobial program – but <em>Mtb</em> subverts this programming to hijack the cell and enable its survival therein. Much evidence has shown that the polarization of the infected macrophage has an immense impact on whether it will destroy the bacteria or succumb to its machinations<span class="citation" data-cites="kleinnijenhuisInnateImmuneRecognition2011"><sup><a href="../references.html#ref-kleinnijenhuisInnateImmuneRecognition2011" role="doc-biblioref">21</a></sup></span>. In 2022, Arish and Naz described that the plasticity of the macrophage might be a therapeutic target for TB therapy: inducing a so-called M1 inflammatory polarization enhances the cell’s capacity to mount an antimicrobial defense against <em>Mtb</em>, among which is the upregulated expression of inflammatory pathogen recognition receptors such as TLR2<span class="citation" data-cites="arishMacrophagePlasticityTherapeutic2022"><sup><a href="../references.html#ref-arishMacrophagePlasticityTherapeutic2022" role="doc-biblioref">22</a></sup></span>.</p>
</section>
<section id="arresting-development-the-blockade-of-lysosomal-maturation." class="level3" data-number="2.3.3">
<h3 data-number="2.3.3" class="anchored" data-anchor-id="arresting-development-the-blockade-of-lysosomal-maturation."><span class="header-section-number">2.3.3</span> Arresting development: the blockade of lysosomal maturation.</h3>
<p>For most phagocytosed particles, the lysosome is the end of the line. This organelle is responsible for destroying unwanted material in the cell. It thus contains hydrolases (which can cleave proteins, lipids, sugars, and nucleic acids), vATPases (which produce a highly acidic pH), and antimicrobial peptides (which are directly bactericidal)<span class="citation" data-cites="rosalesPhagocytosisFundamentalProcess2017 purdyTakingOutTB2011"><sup><a href="../references.html#ref-rosalesPhagocytosisFundamentalProcess2017" role="doc-biblioref">7</a>,<a href="../references.html#ref-purdyTakingOutTB2011" role="doc-biblioref">23</a></sup></span>.</p>
<p>The contents of the phagosome are delivered to the lysosomal compartment through a series of fusion/fission events with the endosomal compartment. As depicted in the left hand of <a href="#fig-ScientificIntro-Fig1" class="quarto-xref">Figure&nbsp;<span>2.1</span></a>, the phagosome will fuse with the early endosome, the late endosome, and then the lysosome. We and others have written extensively on the maturation of the phagosome, and we recommend further reading for an in-depth discussion on standard endosomal trafficking (<a href="../Addenda/addenda_SLs_Fungus.html" class="quarto-xref"><span>Chapter 8</span></a>)<span class="citation" data-cites="flannaganCellBiologyPhagocytosis2012 harrisonPhagosomesFuseLate2003 chernomordikProteinLipidInterplayFusion2003 guzmanSqueakyYeastGets2020"><sup><a href="../references.html#ref-flannaganCellBiologyPhagocytosis2012" role="doc-biblioref">24</a>–<a href="../references.html#ref-guzmanSqueakyYeastGets2020" role="doc-biblioref">27</a></sup></span>.</p>
<p>However, <em>Mtb</em> initiates a cascade of immune subversion once inside the host cell<span class="citation" data-cites="quevalMacrophageDisputedFortress2017"><sup><a href="../references.html#ref-quevalMacrophageDisputedFortress2017" role="doc-biblioref">1</a></sup></span>. Environmental cues such as reduced pH and increased sodium concentration trigger these pathogenic programs, which block the typical maturation of the phagosome and allow the bacteria to survive within an atypical endosomal compartment commonly called the mycobacteria-containing vacuole<span class="citation" data-cites="tanMycobacteriumTuberculosisResponds2013"><sup><a href="../references.html#ref-tanMycobacteriumTuberculosisResponds2013" role="doc-biblioref">28</a></sup></span>. We recommend the 2019 review by Carranza et al.&nbsp;for an in-depth description of the mechanisms that <em>Mtb</em> utilizes to halt phagosomal maturation<span class="citation" data-cites="carranzaSeveralRoutesSame2019"><sup><a href="../references.html#ref-carranzaSeveralRoutesSame2019" role="doc-biblioref">29</a></sup></span>.</p>
<p>Following phago/lysosomal blockade, the <em>Mtb</em>-containing vacuole retains many canonical features of the early phagosome<span class="citation" data-cites="poirierMycobacteriumTuberculosisModulators2012 upadhyayTuberculosisArtMacrophage2018"><sup><a href="../references.html#ref-poirierMycobacteriumTuberculosisModulators2012" role="doc-biblioref">30</a>,<a href="../references.html#ref-upadhyayTuberculosisArtMacrophage2018" role="doc-biblioref">31</a></sup></span>. This compartment has a nearly neutral pH, is decorated with early endosomal markers such as Rab5<span class="citation" data-cites="poirierMycobacteriumTuberculosisModulators2012"><sup><a href="../references.html#ref-poirierMycobacteriumTuberculosisModulators2012" role="doc-biblioref">30</a></sup></span>. Additionally, the <em>Mtb</em>-containing phagosome retains Rab14 and Rab22a. Unlike the early endosome, however, the <em>Mtb</em>-contaiing vacuole is largely devoid of Vps34, a class III phosphotidylinositol-3 kinase which produces phosphatidylinositol-3-phosphate (PI(3)P)<span class="citation" data-cites="upadhyayTuberculosisArtMacrophage2018"><sup><a href="../references.html#ref-upadhyayTuberculosisArtMacrophage2018" role="doc-biblioref">31</a></sup></span>. PI(3)P is an essential inducer of autophagy and lysosomal trafficking, and, accordingly, several crucial PI(3)P-binding proteins are not recruited to the <em>Mtb</em>-containing vacuole – including the hepatocyte growth factor-regulated tyrosine kinase substrate (HGS/HRS), which responsible for recruiting the ESCRT complex to initiate lysosomal degradation<span class="citation" data-cites="upadhyayTuberculosisArtMacrophage2018 jaberClassIIIPI3K2013"><sup><a href="../references.html#ref-upadhyayTuberculosisArtMacrophage2018" role="doc-biblioref">31</a>,<a href="../references.html#ref-jaberClassIIIPI3K2013" role="doc-biblioref">32</a></sup></span>. Intriguingly, in 2017, Schnettger et al.&nbsp;found that <em>Mtb</em> subverts the Rab20-dependent membrane trafficking pathway to reside in so-called “tight” phagosomes (as opposed to “spacious” phagosomes, which are associated with IFN-γ-induced immunoproteolysis)<span class="citation" data-cites="schnettgerRab20DependentMembraneTrafficking2017"><sup><a href="../references.html#ref-schnettgerRab20DependentMembraneTrafficking2017" role="doc-biblioref">33</a></sup></span>.</p>
<p>There are several <em>Mtb</em> pathogenicity factors critical for the subversion of lysosomal maturation. Perhaps the most significant is the <em>Mtb</em> ESX Type VII secretion system<span class="citation" data-cites="mendumLipidMetabolismType2015"><sup><a href="../references.html#ref-mendumLipidMetabolismType2015" role="doc-biblioref">34</a></sup></span>. This secretion system mediates the transfer of many <em>Mtb</em> factors into the lumen of the lysosome, including proteins, lipids, and small molecules<span class="citation" data-cites="quigleyCellWallLipid2017 osmanMycobacteriumMarinumPhthiocerol2020 bedardTerpeneNucleosideTuberculosis2023"><sup><a href="../references.html#ref-quigleyCellWallLipid2017" role="doc-biblioref">35</a>–<a href="../references.html#ref-bedardTerpeneNucleosideTuberculosis2023" role="doc-biblioref">37</a></sup></span>. Several of these factors appear to independently serve as membrane-damaging agents – these include the highly characterized ESAT-6/CFP-10 protein heterodimer and the glycolipid phthiocerol dimycocerosate<span class="citation" data-cites="pengMechanismESAT6Membrane2016 simeonePhagosomalRuptureMycobacterium2012"><sup><a href="../references.html#ref-pengMechanismESAT6Membrane2016" role="doc-biblioref">38</a>,<a href="../references.html#ref-simeonePhagosomalRuptureMycobacterium2012" role="doc-biblioref">39</a></sup></span>. Other factors directly remodel the phagosomal environment; for example, the terpene nucleoside 1-tuberculosinyladenosine is reported to act as an “antacid” that neutralizes the acid pH in the nascent phagosome<span class="citation" data-cites="buterMycobacteriumTuberculosisReleases2019"><sup><a href="../references.html#ref-buterMycobacteriumTuberculosisReleases2019" role="doc-biblioref">40</a></sup></span> and eventually induces the formation of lipid droplets<span class="citation" data-cites="bedardTerpeneNucleosideTuberculosis2023a"><sup><a href="../references.html#ref-bedardTerpeneNucleosideTuberculosis2023a" role="doc-biblioref">41</a></sup></span>. We will discuss lipid droplets further below.</p>
<p>As will be discussed below, however, this vacuole is dynamic and undergoes dramatic changes as the <em>Mtb</em> continues to overcome the macrophage’s defenses and wrests control over the cell. Prior to phagosomal escape, however, Russell proposed in 2016 a model in which intracellular <em>Mtb</em> will spend an outsize proportion of its time within the endosomal compartment, surreptitiously avoiding immune recognition by existing in a semi-quiescent state<span class="citation" data-cites="russellInsOutsMycobacterium2016"><sup><a href="../references.html#ref-russellInsOutsMycobacterium2016" role="doc-biblioref">42</a></sup></span>. Among many pieces of supporting evidence, the long-observed paucibacillary quality of the TB lung aligns well with Russell’s model – there are simply very few individual <em>Mtb</em> bacilli in a latent TB infection. Expanding on this model, Russell suggests that it is upon progression to active disease via immune suppression, malnutrition, or some other trigger that the <em>Mtb</em> bacillus will begin a program of phago/endosomal damage<span class="citation" data-cites="russellInsOutsMycobacterium2016"><sup><a href="../references.html#ref-russellInsOutsMycobacterium2016" role="doc-biblioref">42</a></sup></span> – a topic discussed further below.</p>
</section>
<section id="breaking-free-damaging-the-phagosomal-membrane" class="level3" data-number="2.3.4">
<h3 data-number="2.3.4" class="anchored" data-anchor-id="breaking-free-damaging-the-phagosomal-membrane"><span class="header-section-number">2.3.4</span> Breaking free: damaging the phagosomal membrane</h3>
<section id="mtb-and-other-intracellular-bacterial-pathogens-benefit-from-endolysosomal-membrane-damage" class="level4" data-number="2.3.4.1">
<h4 data-number="2.3.4.1" class="anchored" data-anchor-id="mtb-and-other-intracellular-bacterial-pathogens-benefit-from-endolysosomal-membrane-damage"><span class="header-section-number">2.3.4.1</span> <em>Mtb</em> and other intracellular bacterial pathogens benefit from endo/lysosomal membrane damage</h4>
<p>Many intracellular bacterial pathogens utilize phago/lysosomal membrane damage as a mechanism of immune escape; these include <em>Mtb</em>, <em>Salmonella enterica</em> serovar Typhimurium, <em>Lysteria monocytogenes</em> and many others<span class="citation" data-cites="utermohlenFusogenicityMembranesImpact2008 houbenESXMediatedTranslocation2012"><sup><a href="../references.html#ref-utermohlenFusogenicityMembranesImpact2008" role="doc-biblioref">43</a>,<a href="../references.html#ref-houbenESXMediatedTranslocation2012" role="doc-biblioref">44</a></sup></span>.</p>
<p>The reason for this convergent mechanism of pathogenicity is apparent: by permeabilizing the phagosomal membrane as it matures through the endosomal pathway, the pathogen can inhibit the acquisition of antimicrobial factors<span class="citation" data-cites="barischMembraneDamageRepair2023"><sup><a href="../references.html#ref-barischMembraneDamageRepair2023" role="doc-biblioref">45</a></sup></span>. Chief among these factors is the intraluminal pH of the maturing phagosome: the membrane-bound proton pump vATPase is delivered via fusion with the early endosome shortly after bacterial lumen, which accumulates on the maturing phagosome and acidifies the phagosomal interior<span class="citation" data-cites="purdyTakingOutTB2011"><sup><a href="../references.html#ref-purdyTakingOutTB2011" role="doc-biblioref">23</a></sup></span>. A variety of pH-regulated antimicrobial factors are simultaneously delivered to the maturing phagosome via fusion with the early endosome, then the late endosome, and finally the lysosome; these include hydrolases which cleave proteins, lipids, and glycans (proteases, lipases, and glycosidases, respectively), as well as pore-forming antimicrobial peptides, and reactive oxygen and nitrogen species<span class="citation" data-cites="sachdevaInterplayHostLysosomes2020"><sup><a href="../references.html#ref-sachdevaInterplayHostLysosomes2020" role="doc-biblioref">46</a></sup></span>. By perforating the phagosomal membrane, intracellular pathogens such as <em>Mtb</em> prevent the accumulation of these factors within the pathogen-containing vacuole, enabling escape from lysosomal degradation and the presentation of antigens to the adaptive immune system<span class="citation" data-cites="sachdevaInterplayHostLysosomes2020 santucciIntracellularPathogensMembrane2021"><sup><a href="../references.html#ref-sachdevaInterplayHostLysosomes2020" role="doc-biblioref">46</a>,<a href="../references.html#ref-santucciIntracellularPathogensMembrane2021" role="doc-biblioref">47</a></sup></span>.</p>
<p>To achieve phagosomal perforation, <em>Mtb</em> utilizes a cohort of Type VII secretion systems to transfer soluble pathogenicity factors into the phagosomal lumen – chiefly ESX-1 and ESX-5<span class="citation" data-cites="simeoneESXTypeVII2015"><sup><a href="../references.html#ref-simeoneESXTypeVII2015" role="doc-biblioref">48</a></sup></span>. Among the most well-characterized of these soluble effectors are EsxA and EsxB – more commonly referred to as early secreted antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10)<span class="citation" data-cites="simeoneESXTypeVII2015"><sup><a href="../references.html#ref-simeoneESXTypeVII2015" role="doc-biblioref">48</a></sup></span>. These proteins are the immunodominant antigens of an <em>Mtb</em> infection and are major determinants of <em>Mtb</em> virulence<span class="citation" data-cites="osmanTerminusMycobacteriumESX12022 houbenESXMediatedTranslocation2012"><sup><a href="../references.html#ref-houbenESXMediatedTranslocation2012" role="doc-biblioref">44</a>,<a href="../references.html#ref-osmanTerminusMycobacteriumESX12022" role="doc-biblioref">49</a></sup></span>. Many reports have shown that the loss of either ESAT-6 or CFP-10 results in the significant attenuation of pathogenic <em>Mtb</em> strains<span class="citation" data-cites="smithEvidencePoreFormation2008 dejongeESAT6MycobacteriumTuberculosis2007 osmanTerminusMycobacteriumESX12022"><sup><a href="../references.html#ref-osmanTerminusMycobacteriumESX12022" role="doc-biblioref">49</a>–<a href="../references.html#ref-dejongeESAT6MycobacteriumTuberculosis2007" role="doc-biblioref">51</a></sup></span>. Though not the first to show this, Smith et al.&nbsp;elegantly demonstrated in 2007 that ESAT-6 directly induces the formation of pores in the phago/lysosomal membrane<span class="citation" data-cites="smithEvidencePoreFormation2008"><sup><a href="../references.html#ref-smithEvidencePoreFormation2008" role="doc-biblioref">50</a></sup></span>. Consequently, the permeabilization of the phago/lysosome is a significant driver of <em>Mtb</em>-induced cell death and pathogenicity<span class="citation" data-cites="hsuPrimaryMechanismAttenuation2003"><sup><a href="../references.html#ref-hsuPrimaryMechanismAttenuation2003" role="doc-biblioref">52</a></sup></span>.</p>
<p>However, as with other stages of an <em>Mtb</em> infection, membrane damage represents a fulcrum of control for the host cell: the cell has several layers of redundant membrane repair mechanisms which seek to counteract the membranolytic activities of <em>Mtb</em> and regain control over the infection.</p>
</section>
<section id="an-arms-race-for-control-host-response-to-membrane-damage-mtbs-inhibition-of-membrane-repair" class="level4" data-number="2.3.4.2">
<h4 data-number="2.3.4.2" class="anchored" data-anchor-id="an-arms-race-for-control-host-response-to-membrane-damage-mtbs-inhibition-of-membrane-repair"><span class="header-section-number">2.3.4.2</span> An arms race for control: Host response to membrane damage <em>Mtb</em>’s inhibition of membrane repair</h4>
<p>As described above, the lysosome encloses a toxic milieu of acidic pH, antimicrobial peptides, proteases, lipases, glycosidases, and nucleases<span class="citation" data-cites="radulovicCholesterolTransferEndoplasmic2022"><sup><a href="../references.html#ref-radulovicCholesterolTransferEndoplasmic2022" role="doc-biblioref">53</a></sup></span>. Independent of pathogenic action, unmitigated lysosomal damage is a potent inducer of cell death<span class="citation" data-cites="papadopoulosDetectionClearanceDamaged2017"><sup><a href="../references.html#ref-papadopoulosDetectionClearanceDamaged2017" role="doc-biblioref">54</a></sup></span> – thus, the cell utilizes independent and redundant mechanisms of membrane repair. These repair mechanisms operate at different levels of damage and timespan: from the minor and acute to the major and chronic.</p>
<p>In the case of minor membrane damage resulting from an acute membranolytic injury, a suite of proteins called the Sequestosome-like receptors (SLRs), which includes Sequestosome, NDP52, and the galectins<span class="citation" data-cites="dereticAutophagyInnateImmunity2012"><sup><a href="../references.html#ref-dereticAutophagyInnateImmunity2012" role="doc-biblioref">55</a></sup></span>. These SLRs are also used to mark defunct organelles, depolarized mitochondria, protein aggregates, and cytosolic bacteria. These membrane sensors initiate membrane repair by directing the polymerization of components of the ESCRT-III complex. ESCRT-III is composed of a cohort of charged multivesicular body proteins: CHMP1, CHMP2A, -2B, -3, -4A, -4B, -4C and -6<span class="citation" data-cites="henneESCRTPathway2011"><sup><a href="../references.html#ref-henneESCRTPathway2011" role="doc-biblioref">56</a></sup></span>. These monomers insert into damaged membranes and polymerize into a spiral which induces membrane curvature around the site of membrane damage. ATP hydrolysis by VPS4 provides the requisite energy to constrict the polymerized ESCRT-III complex and pinch off the targeted membrane region<span class="citation" data-cites="henneESCRTPathway2011"><sup><a href="../references.html#ref-henneESCRTPathway2011" role="doc-biblioref">56</a></sup></span>. This membrane-repairing behavior of the ESCRT-III complex is somewhat ancillary to its primary role of producing multivesicular bodies (MVB) during secretory trafficking: the same complex assembles at the surface of these complex organelles and mediates the scission of microvesicles into the lumen of the MVB<span class="citation" data-cites="henneESCRTPathway2011"><sup><a href="../references.html#ref-henneESCRTPathway2011" role="doc-biblioref">56</a></sup></span>.</p>
<p>In circumstances of major or chronic damage – instances where, despite the efforts of the ESCRT-III complex, an organelle is beyond repair – the deposition of ubiquitin and Sequestosome-like receptors over time induces the recruitment of autophagy machinery<span class="citation" data-cites="henneESCRTPathway2011 maejimaAutophagySequestersDamaged2013"><sup><a href="../references.html#ref-henneESCRTPathway2011" role="doc-biblioref">56</a>,<a href="../references.html#ref-maejimaAutophagySequestersDamaged2013" role="doc-biblioref">57</a></sup></span>. Autophagy results in the destruction of damaged endosome; this is a process used by the cell to degrade defunct or unneeded organelles<span class="citation" data-cites="khandiaComprehensiveReviewAutophagy2019"><sup><a href="../references.html#ref-khandiaComprehensiveReviewAutophagy2019" role="doc-biblioref">58</a></sup></span>. Autophagy involves the construction of a double membrane around a targeted organelle and fusion with to pre-formed lysosomes in order to degrade targeted organelle<span class="citation" data-cites="khandiaComprehensiveReviewAutophagy2019"><sup><a href="../references.html#ref-khandiaComprehensiveReviewAutophagy2019" role="doc-biblioref">58</a></sup></span>. This process is highly dependent on the recruitment of the acyl-CoA synthetase Faa1<span class="citation" data-cites="schutterLocalFattyAcid2020"><sup><a href="../references.html#ref-schutterLocalFattyAcid2020" role="doc-biblioref">59</a></sup></span>. This enzyme enables the on-site assembly of phospholipids in the double membrane of the autophagosome, and is critical for the encapsulation of the targeted organelle<span class="citation" data-cites="schutterLocalFattyAcid2020"><sup><a href="../references.html#ref-schutterLocalFattyAcid2020" role="doc-biblioref">59</a></sup></span>.</p>
<p>Autophagy is a central mechanism for restricting <em>Mtb</em> infection<span class="citation" data-cites="golovkineAutophagyRestrictsMycobacterium2023 siregarAutophagyresistantMycobacteriumTuberculosis2022 typasAutophagyCounteractsMycobacterium2023"><sup><a href="../references.html#ref-golovkineAutophagyRestrictsMycobacterium2023" role="doc-biblioref">60</a>–<a href="../references.html#ref-typasAutophagyCounteractsMycobacterium2023" role="doc-biblioref">62</a></sup></span>. This process that enables the destruction of chronically damaged membranes further enables the proteasomal degradation of the bacterial contents within: the resulting microbe-derived peptides can thus be loaded onto the MHC-II complex and presented to the adaptive immune system via the cross-presentation pathway<span class="citation" data-cites="khandiaComprehensiveReviewAutophagy2019"><sup><a href="../references.html#ref-khandiaComprehensiveReviewAutophagy2019" role="doc-biblioref">58</a></sup></span>. Accordingly, as seen at many other points of the host-pathogen interface, <em>Mtb</em> proactively interferes with the autophagic membrane damage repair response of the host<span class="citation" data-cites="sainiSuppressionAutophagyAntigen2016"><sup><a href="../references.html#ref-sainiSuppressionAutophagyAntigen2016" role="doc-biblioref">63</a></sup></span>. In one notable example, Divangazi et al.&nbsp;showed in 2009 that <em>Mtb</em> infection induces membrane damage both at the plasma membrane and the in lysosome, and that the bacteria produces a molecule called lipoxin A<sub>4</sub> (LXA<sub>4</sub>), which blocks prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) synthesis<span class="citation" data-cites="divangahiMycobacteriumTuberculosisEvades2009"><sup><a href="../references.html#ref-divangahiMycobacteriumTuberculosisEvades2009" role="doc-biblioref">64</a></sup></span>. These authors show that PGE<sub>2</sub> is essential for the recruitment/activation of synaptotagmin, a cytosolic Ca<sup>2+</sup> sensor<span class="citation" data-cites="divangahiMycobacteriumTuberculosisEvades2009"><sup><a href="../references.html#ref-divangahiMycobacteriumTuberculosisEvades2009" role="doc-biblioref">64</a></sup></span>. Similarly, Mittal et al.&nbsp;showed in 2018 that the secreted <em>Mtb</em> effectors EsxG and EsxH<span class="citation" data-cites="mittalMycobacteriumTuberculosisType2018"><sup><a href="../references.html#ref-mittalMycobacteriumTuberculosisType2018" role="doc-biblioref">65</a></sup></span> directly interfere with the ESCRT response pathway. And as a final example (though this is not to say that these examples are exhaustive), authors such as Saini et al.&nbsp;(and many others) have shown that <em>Mtb</em> suppresses the autophagy response of the cell and directly benefits from the subsequent escape from the adaptive immune response<span class="citation" data-cites="sainiSuppressionAutophagyAntigen2016 duanMycobacteriumTuberculosisEIS2016 strongIdentificationAutophagyInhibitingFactors2020"><sup><a href="../references.html#ref-sainiSuppressionAutophagyAntigen2016" role="doc-biblioref">63</a>,<a href="../references.html#ref-duanMycobacteriumTuberculosisEIS2016" role="doc-biblioref">66</a>,<a href="../references.html#ref-strongIdentificationAutophagyInhibitingFactors2020" role="doc-biblioref">67</a></sup></span>.</p>
<p>These examples of the membrane damage response highlight the tit-for-tat manner of an <em>Mtb</em> infection – an arms race over the millennia. As alluded above and as will be discussed further below, the cell’s capacity to respond to and limit the damage caused by <em>Mtb</em> is highly influenced by the immunological priming of the cell prior to infection: a cell primed for antimicrobial effect via IFN-γ stimulation has a higher propensity for maintaining phago/lysosomal integrity and directing the bacterial to lysosomal degradation. It is in an inadequate immune environment that the bacteria is able to inflict major damage to the maturing phagosome and gain cytosolic access.</p>
</section>
</section>
<section id="lipid-droplet-formation-in-late-stage-infection" class="level3" data-number="2.3.5">
<h3 data-number="2.3.5" class="anchored" data-anchor-id="lipid-droplet-formation-in-late-stage-infection"><span class="header-section-number">2.3.5</span> Lipid droplet formation in late-stage infection</h3>
<p>Lipid droplets (LDs) are organelles consisting of a phospholipid monolayer encapsulating a hydrophobic core composed mainly of triacylglycerol species (TG) and sterol esters<span class="citation" data-cites="olzmannDynamicsFunctionsLipid2019"><sup><a href="../references.html#ref-olzmannDynamicsFunctionsLipid2019" role="doc-biblioref">68</a></sup></span>. Research suggests that LDs are a central feature of mycobacterial infection, where mature granulomas are replete with “foamy” macrophages<span class="citation" data-cites="barischBreakingFatHow2017"><sup><a href="../references.html#ref-barischBreakingFatHow2017" role="doc-biblioref">69</a></sup></span>. It is not unique to mycobacteria as many bacteria, viruses, eukaryotic parasites, and fungi are known to induce LDs in infected hosts. Prior reports suggest that LDs are trafficked toward the mycobacteria-containing vacuole in a cytoskeleton-dependent manner<span class="citation" data-cites="mattosModulationLipidDroplets2011"><sup><a href="../references.html#ref-mattosModulationLipidDroplets2011" role="doc-biblioref">70</a></sup></span>. Further, Barisch et al.&nbsp;showed that <em>Mtb</em> hydrolyzes TG from LDs to fuel its metabolism as a primary source of energy<span class="citation" data-cites="barischBreakingFatHow2017"><sup><a href="../references.html#ref-barischBreakingFatHow2017" role="doc-biblioref">69</a></sup></span>. Thus, LDs are believed to play a crucial role in the host-pathogen interaction during <em>Mtb</em> infection. Recent work by Bedard et al.&nbsp;showed that individual <em>Mtb</em> pathogenicity factors, such as 1-tuberculosinyladenosine, are sufficient to induce the accumulation of lipid droplets<span class="citation" data-cites="bedardTerpeneNucleosideTuberculosis2023a"><sup><a href="../references.html#ref-bedardTerpeneNucleosideTuberculosis2023a" role="doc-biblioref">41</a></sup></span>.</p>
<p>Further research is required to fully understand the mechanisms involved in the formation and utilization of LDs by Mtb, which could lead to developing new therapeutic interventions for TB. Many points in this pathway may serve as targets of antitubercular therapy, including blocking the formation of these organelles, halting the trafficking of LDs to the <em>Mtb</em>-containing vacuole, inhibiting the <em>Mtb</em> phospholipases that hydrolyze TG, or disrupting the <em>Mtb</em> fatty acid β-oxidation pathway. Much research is needed to determine which, if any, of these lipid droplet-targeted therapies may have the most significant effect.</p>
</section>
<section id="cytokine-production-in-the-granuloma" class="level3" data-number="2.3.6">
<h3 data-number="2.3.6" class="anchored" data-anchor-id="cytokine-production-in-the-granuloma"><span class="header-section-number">2.3.6</span> Cytokine production in the granuloma</h3>
<p>The cytokines within the granuloma microenvironment hold immense sway in the direction a TB infection can go. Inflammatory cytokines such as Type II interferon (IFN-γ) can potently stimulate the antimicrobial capacity of macrophages, stimulating lysosomal activity, antigen cross-presentation, and heightened production of other inflammatory cytokines such as IL-1β, which further initiate a broad antimicrobial response<span class="citation" data-cites="flynnImmuneCellInteractions2022a"><sup><a href="../references.html#ref-flynnImmuneCellInteractions2022a" role="doc-biblioref">6</a></sup></span>. This immune cross-talk allows a fully immunocompetent host to limit the spread of <em>Mtb</em> within the lung and limit bacterial growth<span class="citation" data-cites="flynnImmuneCellInteractions2022a"><sup><a href="../references.html#ref-flynnImmuneCellInteractions2022a" role="doc-biblioref">6</a></sup></span>. However, <em>Mtb</em> is also adept at subverting these immune processes – reports by Fortes et al.&nbsp;and others demonstrate that <em>Mtb</em> can prevent the production of inflammatory cytokines and instead induce the secretion of anti-inflammatory cytokines such as TGF-β and suppress the secretion of IFN-γ<span class="citation" data-cites="othienoInteractionMycobacteriumTuberculosis1999 fortesDetectionVitroInterferong2005"><sup><a href="../references.html#ref-othienoInteractionMycobacteriumTuberculosis1999" role="doc-biblioref">71</a>,<a href="../references.html#ref-fortesDetectionVitroInterferong2005" role="doc-biblioref">72</a></sup></span>. Consequently, the overarching immunocompetence of the host can result in feedback loops of either <em>Mtb</em> restriction or <em>Mtb</em> success.</p>
<p>With these feedback loops in mind, cytokine therapy is under study as a potential form of host-directed therapy. Berns et al.&nbsp;reviewed the clinical efficiency of exogenous IFN-γ therapy and found repeated benefits to aerosolized or subcutaneous IFN-γ adjunctive treatment in clinical trials<span class="citation" data-cites="bernsTherapeuticPotentialInterferongamma2022"><sup><a href="../references.html#ref-bernsTherapeuticPotentialInterferongamma2022" role="doc-biblioref">73</a></sup></span>. Berns et al.&nbsp;write that IFN-γ strongly stimulates antigen presentation and can overcome <em>Mtb</em>’s inhibition of immune processing, resulting in a coordinated and multifaceted attack on the infecting <em>Mtb</em><span class="citation" data-cites="bernsTherapeuticPotentialInterferongamma2022"><sup><a href="../references.html#ref-bernsTherapeuticPotentialInterferongamma2022" role="doc-biblioref">73</a></sup></span>. In addition, IFN-γ robustly activates macrophages and stimulates chemotactic migration toward the site of infection. Highly activated macrophages release nitric oxide into the granuloma microenvironment, placing extreme oxidative stress on infected cells and bacteria.</p>
<p>However, some studies have suggested that cytokine therapy can inadvertently cause increased pathology by increasing damage to surrounding lung tissue and exacerbating lung infection<span class="citation" data-cites="youngTherapeuticHostdirectedStrategies2020 gaoAdjunctiveTherapyInterferongamma2011"><sup><a href="../references.html#ref-youngTherapeuticHostdirectedStrategies2020" role="doc-biblioref">74</a>,<a href="../references.html#ref-gaoAdjunctiveTherapyInterferongamma2011" role="doc-biblioref">75</a></sup></span>. Thus, cytokine therapies, including IFN-γ, are still controversial and subjects of clinical trials. Nonetheless, IFN-γ is a highly cost-effective adjunctive therapeutic in the Russian Federation<span class="citation" data-cites="bernsTherapeuticPotentialInterferongamma2022"><sup><a href="../references.html#ref-bernsTherapeuticPotentialInterferongamma2022" role="doc-biblioref">73</a></sup></span>. It reduces treatment time and antibiotics, thereby reducing costs and increasing supplies.</p>
</section>
</section>
<section id="mtb-and-lipids-a-recipe-for-pathogenicity" class="level2" data-number="2.4">
<h2 data-number="2.4" class="anchored" data-anchor-id="mtb-and-lipids-a-recipe-for-pathogenicity"><span class="header-section-number">2.4</span> <em>Mtb</em> and Lipids: A recipe for pathogenicity</h2>
<p>Many papers describe the dependence of <em>Mtb</em> on host lipid biology. As Ghazaei beautifully wrote in their 2018 review on lipid metabolism in <em>Mtb</em> infection: “If the metabolism of the pathogen is studied, the use of lipid metabolism has been documented”<span class="citation" data-cites="ghazaeiMycobacteriumTuberculosisLipids2018"><sup><a href="../references.html#ref-ghazaeiMycobacteriumTuberculosisLipids2018" role="doc-biblioref">76</a></sup></span>. In summary, <em>Mtb</em> is an intracellular pathogen with unique lipid dependency, and the full description of this statement would encompass too many topics for this review. However, we will briefly discuss a few examples of <em>Mtb</em>’s unique lipid biology.</p>
<p>A critical phenomenon preceding the progression to active TB disease is the accumulation of “foamy” macrophages in the granuloma<span class="citation" data-cites="guerriniFoamCellsOne2019"><sup><a href="../references.html#ref-guerriniFoamCellsOne2019" role="doc-biblioref">77</a></sup></span>. The accumulation of lipids within these cells gives them their name: these cells have undergone significant dyslipidemia, driving the formation of many lipid droplets within them<span class="citation" data-cites="guerriniFoamCellsOne2019"><sup><a href="../references.html#ref-guerriniFoamCellsOne2019" role="doc-biblioref">77</a></sup></span>. When these cells undergo necroptosis, they release this lipidated material into the granuloma/alveolar space – foamy macrophages are the source of the lipid pneumonia associated with active TB disease. DAG and TAG species have been previously observed to increase upon infection with <em>Mtb</em><span class="citation" data-cites="costaMycobacteriumTuberculosisInduces2023"><sup><a href="../references.html#ref-costaMycobacteriumTuberculosisInduces2023" role="doc-biblioref">78</a></sup></span> and are a significant component of TB-associated lipid droplets<span class="citation" data-cites="guerriniFoamCellsOne2019"><sup><a href="../references.html#ref-guerriniFoamCellsOne2019" role="doc-biblioref">77</a></sup></span>. More than a visual cue of metabolic dysfunction in the cell, lipid droplets are a significant energy and carbon source for <em>Mtb</em><span class="citation" data-cites="barischBreakingFatHow2017"><sup><a href="../references.html#ref-barischBreakingFatHow2017" role="doc-biblioref">69</a></sup></span>. In some agreement with this, <em>Mtb</em> enzyme Rv2252 is a verified diacylglycerol kinase involved in the production of phosphatidyl-<em>myo</em>-inositol mannosides, <em>Mtb</em>-specific lipids<span class="citation" data-cites="owensTuberculosisRv2252Encodes2006a"><sup><a href="../references.html#ref-owensTuberculosisRv2252Encodes2006a" role="doc-biblioref">79</a></sup></span>.</p>
<p>In fact, <em>Mtb</em> depends on host lipids as a primary carbon source during infection. Jain et al.&nbsp;show that <em>Mtb</em> prefers β-oxidation of fatty acids over glycolysis during infection, shifting its metabolism upon entry into the host cell<span class="citation" data-cites="jainLipidomicsRevealsControl2007a"><sup><a href="../references.html#ref-jainLipidomicsRevealsControl2007a" role="doc-biblioref">80</a></sup></span>. These authors found an increase in membrane content of odd-chain lipids in <em>Mtb</em> isolated from infected cells, suggesting that the bacteria selectively shifts to β-oxidation during infection<span class="citation" data-cites="jainLipidomicsRevealsControl2007a"><sup><a href="../references.html#ref-jainLipidomicsRevealsControl2007a" role="doc-biblioref">80</a></sup></span>. Along the same lines, Chandra et al.&nbsp;used inhibitors of fatty acid β-oxidation and found that they severely restrict the intracellular growth of <em>Mtb</em> in tissue culture<span class="citation" data-cites="chandraInhibitionFattyAcid2020a"><sup><a href="../references.html#ref-chandraInhibitionFattyAcid2020a" role="doc-biblioref">81</a></sup></span>, and Yang et al.&nbsp;showed that inhibiting β-oxidation enhances <em>Mtb</em> clearance in a mouse infection model<span class="citation" data-cites="yangInterceptionHostFatty2021a"><sup><a href="../references.html#ref-yangInterceptionHostFatty2021a" role="doc-biblioref">82</a></sup></span>. Beyond β-oxidation, many reports have found links between <em>Mtb</em> and host cholesterol. Mendum et al.&nbsp;used a transposon mutant library to identify genes that enable <em>Mtb</em> fitness during infection<span class="citation" data-cites="mendumLipidMetabolismType2015"><sup><a href="../references.html#ref-mendumLipidMetabolismType2015" role="doc-biblioref">34</a></sup></span>. Among their findings, they identify a preponderance of cholesterol-catabolizing enzymes that are required for bacterial persistence/growth<span class="citation" data-cites="mendumLipidMetabolismType2015"><sup><a href="../references.html#ref-mendumLipidMetabolismType2015" role="doc-biblioref">34</a></sup></span>. These findings are supported by many similar reports dating back decades<span class="citation" data-cites="segalBIOCHEMICALDIFFERENTIATIONMYCOBACTERIUM1956 mckinneyPersistenceMycobacteriumTuberculosis2000 schnappingerTranscriptionalAdaptationMycobacterium2003 timmDifferentialExpressionIron2003 wilburnCholesterolFattyAcids2018 leeIntracellularMycobacteriumTuberculosis2013a"><sup><a href="../references.html#ref-segalBIOCHEMICALDIFFERENTIATIONMYCOBACTERIUM1956" role="doc-biblioref">83</a>–<a href="../references.html#ref-leeIntracellularMycobacteriumTuberculosis2013a" role="doc-biblioref">88</a></sup></span>.</p>
<p>These are only a few of the many examples of the manners in which lipids are essential for <em>Mycobacterium tuberculosis</em> during infection. We must now shift course briefly to introduce sphingolipids, as this enigmatic class of lipids appears to play decisive roles in <em>Mtb</em>’s struggle for control of the macrophage.</p>
</section>
<section id="sphingolipids-overview" class="level2" data-number="2.5">
<h2 data-number="2.5" class="anchored" data-anchor-id="sphingolipids-overview"><span class="header-section-number">2.5</span> Sphingolipids overview</h2>
<section id="sphingolipid-synthesis-and-trafficking" class="level3" data-number="2.5.1">
<h3 data-number="2.5.1" class="anchored" data-anchor-id="sphingolipid-synthesis-and-trafficking"><span class="header-section-number">2.5.1</span> Sphingolipid synthesis and trafficking</h3>
<p>Sphingolipids are a diverse class of membrane lipids distinguished by a shared sphingoid base. Through much concerted effort, these enigmatic lipids are slowly being recognized for their many roles in neuronal health, development, apoptosis, membrane stability, and signaling capacity. We and others have extensively described the mechanisms of sphingolipid synthesis and trafficking. We recommend the following references for more in-depth reviews of these topics: <a href="../Addenda/addenda_SLs_GeneticTools.html" class="quarto-xref"><span>Chapter 7</span></a><span class="citation" data-cites="guzmanGeneticToolsStudying2023"><sup><a href="../references.html#ref-guzmanGeneticToolsStudying2023" role="doc-biblioref">89</a></sup></span>, <a href="../results/results_Mtb_phagocytosis.html" class="quarto-xref"><span>Chapter 3</span></a><span class="citation" data-cites="niekampSphingomyelinBiosynthesisEssential2021"><sup><a href="../references.html#ref-niekampSphingomyelinBiosynthesisEssential2021" role="doc-biblioref">90</a></sup></span>, <a href="../results/results_Mtb_Membrane_Damage_V2.html" class="quarto-xref"><span>Chapter 4</span></a>, Hannun, 2018<span class="citation" data-cites="hannunSphingolipidsTheirMetabolism2018"><sup><a href="../references.html#ref-hannunSphingolipidsTheirMetabolism2018" role="doc-biblioref">91</a></sup></span>, Wattenberg, 2018<span class="citation" data-cites="wattenbergLongShortCeramides2018"><sup><a href="../references.html#ref-wattenbergLongShortCeramides2018" role="doc-biblioref">92</a></sup></span>, Quinville et al., 2021<span class="citation" data-cites="quinvilleComprehensiveReviewSphingolipid2021"><sup><a href="../references.html#ref-quinvilleComprehensiveReviewSphingolipid2021" role="doc-biblioref">93</a></sup></span>, and Gault et al., 2010<span class="citation" data-cites="gaultOverviewSphingolipidMetabolism2010a"><sup><a href="../references.html#ref-gaultOverviewSphingolipidMetabolism2010a" role="doc-biblioref">94</a></sup></span>. For this review, we, too, must dive into the sphingolipid synthesis and salvage pathways to begin discussing how sphingolipid biology may influence a <em>Mycobacterium tuberculosis</em> infection.</p>
<p>As depicted in <a href="#fig-ScientificIntro-Fig2" class="quarto-xref">Figure&nbsp;<span>2.2</span></a>, sphingolipid production begins in the endoplasmic reticulum. The first and rate-limiting step of sphingolipid synthesis is the condensation of the amino acid L-serine with palmitoyl-CoA via the serine palmitoyltransferase complex (SPT) to produce the transient product 3-ketodihydrosphingosine (KDS). SPT is composed of two primary subunits (SPTLC1 and SPTLC2, though SPTLC3 appears partially redundant with SPTLC2) and acts in tight conjunction with two downstream enzymes: 3-ketodihydrosphingosine reductase reduces KDS to dihydrosphingosine and a cohort of [dihydro]ceramide synthases (CerS1-6) append a secondary acyl chain of varying length. Dihydroceramide Δ4-desaturase (DES) reduces dihydroceramide to produce ceramide (Cer), the nexus of sphingolipid metabolism. After all these initial steps of sphingolipid synthesis, it is from Cer that all complex sphingolipids will be made.</p>
<div class="border">
<div id="fig-ScientificIntro-Fig2" class="quarto-figure quarto-figure-center quarto-float anchored" data-group="intro-ScientificGallery">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-ScientificIntro-Fig2-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<a href="../../parts/introduction/introduction_files/Figure 2-SLsynthesisandcatabolism_v2.png" class="lightbox" data-gallery="intro-ScientificGallery" data-glightbox="description: .lightbox-desc-2"><img src="../../parts/introduction/introduction_files/Figure 2-SLsynthesisandcatabolism_v2.png" class="img-fluid figure-img"></a>
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-ScientificIntro-Fig2-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;2.2: <strong>Sphingolipid synthetic and metabolic pathway</strong> Abbreviations: SPT = Serine palmitoyltransferase; KDHSR: 3-Ketodihydrosphingosine reductase; CerS1-6 = Ceramide synthase 1-6; DES = dihydroceramide Δ4-saturase; CK = Ceramide kinase; C1PP = Ceramide-1-phosphate phosphatase; UGCG = UDP-glucose ceramide glucosyltransferase; PC = phosphatidylcholine; SGMS1/2 = Sphingomyelin synthase 1/2; DAG = Diacylglycerol; a/nCDase = Acid/neutral ceramidase; a/nSMase = Acid/neutral sphingomyelinase; S1PL = Sphingosine-1-lyase; SK1/2 = Sphingosine kinase 1/2; SPPase = Sphingosine-1-phosphate phosphatase.
</figcaption>
</figure>
</div>
</div>
<p>Why maintain the redundancy of six individual ceramide synthases? Recent work has shown that CerS enzymes prefer appending fatty acyl chains of distinct lengths (with some overlap), and different tissues express different proportions of each enzyme. CerS selectivity for chain length was excellently reviewed by Ho et al.&nbsp;in 2022<span class="citation" data-cites="hoCeramideAcylChain2022"><sup><a href="../references.html#ref-hoCeramideAcylChain2022" role="doc-biblioref">95</a></sup></span> – here, briefly: CerS1 is most expressed in the brain and skeletal tissues and appends a C18 acyl-CoA; CerS2 appends a C22-24 acyl-CoA and is ubiquitously expressed, though enriched in the liver and kidney; CerS3 appends C26-34 acyl-CoA and is expressed in skin and testes; CerS4 is expressed in skin, leukocytes, heart, and liver and adds a C18-20 acyl-coA; CerS5 and CerS6 both append a C14-16 acyl-CoA chain, but CerS5 is minimally expressed save for the skin, testes, and kidneys while CerS6 is expressed primarily in the intestine and kidneys<span class="citation" data-cites="hoCeramideAcylChain2022"><sup><a href="../references.html#ref-hoCeramideAcylChain2022" role="doc-biblioref">95</a></sup></span>. The many chain length variants of Cer will be differentially modified into many variants of “higher” sphingolipids within the <em>trans</em>-Golgi apparatus, a process which occurs in tight coordination with Cer synthesis. Crucially, the total Cer content in the ER membrane is kept at trace levels by ORMDL proteins, which sense excessive Cer buildup and inhibit the SPT complex if excess Cer accumulates in the ER<span class="citation" data-cites="olsonTamingSphinxMechanisms2016"><sup><a href="../references.html#ref-olsonTamingSphinxMechanisms2016" role="doc-biblioref">96</a></sup></span>. Many have previously shown that ER Cer accumulation triggers an apoptotic cascade, resulting in cell death<span class="citation" data-cites="newtonRevisitingSphingolipidRheostat2015"><sup><a href="../references.html#ref-newtonRevisitingSphingolipidRheostat2015" role="doc-biblioref">97</a></sup></span>.</p>
<p>The Cer transport protein (CERT) mediates the transfer of Cer to the <em>trans</em>-Golgi. Here, a relatively small portion of Cer is modified with glucose, galactose, or lactose to produce a cohort of glyco-ceramides, further modified into products such as globosides, gangliosides, sulfatides, and many so-called glycosphingolipids (GSLs)<span class="citation" data-cites="liuCeramideGlycosylationCatalyzed2013a gaultOverviewSphingolipidMetabolism2010a"><sup><a href="../references.html#ref-gaultOverviewSphingolipidMetabolism2010a" role="doc-biblioref">94</a>,<a href="../references.html#ref-liuCeramideGlycosylationCatalyzed2013a" role="doc-biblioref">98</a></sup></span>. However, the bulk of total Golgi Cer is converted into sphingomyelin (SM) by sphingomyelin synthase 1 (SMS1) by transferring a phosphocholine headgroup from phosphatidylcholine, producing diacylglycerol (DAG) as a side-product<span class="citation" data-cites="gaultOverviewSphingolipidMetabolism2010a"><sup><a href="../references.html#ref-gaultOverviewSphingolipidMetabolism2010a" role="doc-biblioref">94</a></sup></span>. Intriguingly, this secondary role for SMS1 (producing DAG) is a primary mechanism of regulating DAG synthesis in the Golgi<span class="citation" data-cites="villaniSphingomyelinSynthasesRegulate2008"><sup><a href="../references.html#ref-villaniSphingomyelinSynthasesRegulate2008" role="doc-biblioref">99</a></sup></span>. Among others, Cerbon et al.&nbsp;report that DAG produced by SMS1 regulates PKC activity and cell proliferation<span class="citation" data-cites="cerbonDiacylglycerolGeneratedSphingomyelin2003a"><sup><a href="../references.html#ref-cerbonDiacylglycerolGeneratedSphingomyelin2003a" role="doc-biblioref">100</a></sup></span>.</p>
<p>Once synthesized, the vast majority of SM and glycosphingolipids are exported to the plasma membrane via secretory vesicular trafficking. These trafficking patterns are mediated by highly selective proteins that direct the newly synthesized lipids to the appropriate compartments in the cell. In 2007, Koivusalo et al.&nbsp;showed that the chain length of the secondary acyl chain of SM impacts its trafficking throughout the cell<span class="citation" data-cites="koivusaloEndocyticTraffickingSphingomyelin2007"><sup><a href="../references.html#ref-koivusaloEndocyticTraffickingSphingomyelin2007" role="doc-biblioref">101</a></sup></span>. In support of this, in 2012, Contreras et al.&nbsp;identified an SM binding domain in the COPI sorting protein p24. This domain selectively binds one particular SM species, SM(d18:0/18:0), and mediates its transport to the plasma membrane<span class="citation" data-cites="contrerasMolecularRecognitionSingle2012"><sup><a href="../references.html#ref-contrerasMolecularRecognitionSingle2012" role="doc-biblioref">102</a></sup></span>. Genetically transferring this binding domain to p23 confers SM binding capacity. Similarly, the protein FAPP2 transports glucosylceramide within the Golgi for further modifications<span class="citation" data-cites="dangeloGlycosphingolipidSynthesisRequires2007"><sup><a href="../references.html#ref-dangeloGlycosphingolipidSynthesisRequires2007" role="doc-biblioref">103</a></sup></span> and, as its name would suggest, the ceramide 1-phosphate transport protein mediates the transport of ceramide 1-phosphate between the Golgi and the plasma membrane<span class="citation" data-cites="boathRegulationTrafficCeramide2008"><sup><a href="../references.html#ref-boathRegulationTrafficCeramide2008" role="doc-biblioref">104</a></sup></span>.</p>
<p>Most sphingolipids in the cell accumulate as SM or GSLs at the plasma membrane<span class="citation" data-cites="quinnTwoSeparatePools1992"><sup><a href="../references.html#ref-quinnTwoSeparatePools1992" role="doc-biblioref">105</a></sup></span>. The glut of the remaining intracellular pool of sphingolipids is located in the endosomal compartment of the cell<span class="citation" data-cites="quinnTwoSeparatePools1992"><sup><a href="../references.html#ref-quinnTwoSeparatePools1992" role="doc-biblioref">105</a></sup></span>. The endosomal SM primarily comprises lipids re-internalized from the plasma membrane during events such as phagocytosis<span class="citation" data-cites="koivusaloEndocyticTraffickingSphingomyelin2007"><sup><a href="../references.html#ref-koivusaloEndocyticTraffickingSphingomyelin2007" role="doc-biblioref">101</a></sup></span>. The role of these endosomal SM and GSLs will be discussed extensively in <a href="../results/results_Mtb_Membrane_Damage_V2.html" class="quarto-xref"><span>Chapter 4</span></a>. These intracellular sphingolipids are the primary source of the so-called “bioactive sphingolipids,” which are short-lived and induce potent cellular effects.</p>
</section>
<section id="sphingolipid-breakdown-signaling-through-salvage" class="level3" data-number="2.5.2">
<h3 data-number="2.5.2" class="anchored" data-anchor-id="sphingolipid-breakdown-signaling-through-salvage"><span class="header-section-number">2.5.2</span> Sphingolipid breakdown: signaling through salvage</h3>
<p>Freysz and Mandel showed in 1980 that the half-life of SM can be measured in weeks or years, depending on the tissue<span class="citation" data-cites="freyszTurnoverMolecularSpecies1980 freyszMETABOLISMBRAINSPHINGOMYELINS1976"><sup><a href="../references.html#ref-freyszTurnoverMolecularSpecies1980" role="doc-biblioref">106</a>,<a href="../references.html#ref-freyszMETABOLISMBRAINSPHINGOMYELINS1976" role="doc-biblioref">107</a></sup></span> – in contrast, sphingosine 1-phosphate (S1P) has a half-life as low as fifteen minutes in the blood<span class="citation" data-cites="ksiazekSourcesMetabolismRegulation2015"><sup><a href="../references.html#ref-ksiazekSourcesMetabolismRegulation2015" role="doc-biblioref">108</a></sup></span>. The shorter half-lives of sphingolipids such as S1P reflect the potency of their effect as signaling molecules. Perhaps the most well-characterized example of sphingolipid signaling, S1P is a potent chemotactic signal for lymphocytes: T cells express S1PR1 (one of five S1P receptors) and rapidly extravasate from the circulatory system to sites of tissue damage or infection up a gradient of S1P concentration<span class="citation" data-cites="garrisSphingosinePhosphateReceptor2014"><sup><a href="../references.html#ref-garrisSphingosinePhosphateReceptor2014" role="doc-biblioref">109</a></sup></span>. Because lymphocytes must travel up an S1P gradient during chemotaxis, S1P in the plasma and healthy tissue must be kept at exceedingly low concentrations and produced in rapid excess in damaged or infected tissue. Given these potent effects and these short half-lives, one may ask: “Where do signaling sphingolipids come from?”</p>
<p>Of course, the cell can synthesize bioactive signaling lipids such as Cer and S1P via <em>de novo</em> synthesis, trafficking these products through the Golgi, and exporting them through secretory vesicular trafficking. Indeed, Menuz et al.&nbsp;and others have shown that <em>de novo</em> ceramide synthesis is upregulated in response to hypoxia and anoxia<span class="citation" data-cites="menuzProtectionElegansAnoxia2009 noureddineModulationTotalCeramide2008"><sup><a href="../references.html#ref-menuzProtectionElegansAnoxia2009" role="doc-biblioref">110</a>,<a href="../references.html#ref-noureddineModulationTotalCeramide2008" role="doc-biblioref">111</a></sup></span>. However, recent work has shown that the primary source of bioactive sphingolipids is the degradation of SM and GSLs at the plasmas membrane and within the endosomal compartment<span class="citation" data-cites="ksiazekSourcesMetabolismRegulation2015 quinvilleComprehensiveReviewSphingolipid2021"><sup><a href="../references.html#ref-quinvilleComprehensiveReviewSphingolipid2021" role="doc-biblioref">93</a>,<a href="../references.html#ref-ksiazekSourcesMetabolismRegulation2015" role="doc-biblioref">108</a></sup></span>. As depicted in the right side of <a href="#fig-ScientificIntro-Fig2" class="quarto-xref">Figure&nbsp;<span>2.2</span></a>, SM can be sent back through the sphingolipid synthesis cascade to result in localized accumulation of Cer, Sph, and S1P<span class="citation" data-cites="gaultOverviewSphingolipidMetabolism2010a"><sup><a href="../references.html#ref-gaultOverviewSphingolipidMetabolism2010a" role="doc-biblioref">94</a></sup></span>. Several sphingomyelinases (SMases) are known. Neutral SMase is most active at neutral pH and mainly resides in the outer leaflet of the plasma membrane (mainly cleaving extracellular SM). The highly related acid sphingomyelinase (aSMase) is regulated by acidic pH – this enzyme is primarily active within the lysosome. The degradation of lysosomal SM (and the subsequent production of sphingosine) induces targeted autophagy of the lysosome (lysophagy) and, subsequently, programmed cell death<span class="citation" data-cites="hoglingerIntracellularSphingosineReleases2015a"><sup><a href="../references.html#ref-hoglingerIntracellularSphingosineReleases2015a" role="doc-biblioref">112</a></sup></span>. Additionally, cytosolic SMase activity has been shown to play a role in coordinating membrane repair mechanisms<span class="citation" data-cites="niekampCa2ActivatedSphingomyelin2022a ramirez-montielPlasmaMembraneDamage2019"><sup><a href="../references.html#ref-niekampCa2ActivatedSphingomyelin2022a" role="doc-biblioref">113</a>,<a href="../references.html#ref-ramirez-montielPlasmaMembraneDamage2019" role="doc-biblioref">114</a></sup></span>. Similar glycosphingolipid-degrading enzymes can send glycosphingolipids back through the synthesis cascade to produce ceramide<span class="citation" data-cites="gaultOverviewSphingolipidMetabolism2010a"><sup><a href="../references.html#ref-gaultOverviewSphingolipidMetabolism2010a" role="doc-biblioref">94</a></sup></span>.</p>
<p>Enzymes such as sphingomyelinase also allow cells to acquire extracellular sphingolipids and incorporate them as membrane constituents via salvage<span class="citation" data-cites="gaultOverviewSphingolipidMetabolism2010a"><sup><a href="../references.html#ref-gaultOverviewSphingolipidMetabolism2010a" role="doc-biblioref">94</a></sup></span>. We have previously reported that ablating all forward sphingolipid synthesis (via genetic knockout or inhibition of the SPT complex) does not fully deplete a cell of all sphingolipids<span class="citation" data-cites="niekampSphingomyelinBiosynthesisEssential2021"><sup><a href="../references.html#ref-niekampSphingomyelinBiosynthesisEssential2021" role="doc-biblioref">90</a></sup></span> – and in fact, we anecdotally note that cells inhibited in sphingolipid production rapidly die when cultured in serum-free media.</p>
<p>Having described the sphingolipid metabolic network, we can discuss how sphingolipids are involved in disease before returning to their potential roles during <em>Mycobacterium tuberculosis</em> infection.</p>
</section>
<section id="sphingolipids-and-disease" class="level3" data-number="2.5.3">
<h3 data-number="2.5.3" class="anchored" data-anchor-id="sphingolipids-and-disease"><span class="header-section-number">2.5.3</span> Sphingolipids and disease</h3>
<p>Dysregulation of sphingolipid biology is intricately tied to many diseases. We and others have written extensively on this topic (<a href="../Addenda/addenda_SLs_GeneticTools.html" class="quarto-xref"><span>Chapter 7</span></a>)<span class="citation" data-cites="leeFunctionalRolesSphingolipids2023 hlaSphingolipidSignalingMetabolic2012 hannunSphingolipidsTheirMetabolism2018"><sup><a href="../references.html#ref-hannunSphingolipidsTheirMetabolism2018" role="doc-biblioref">91</a>,<a href="../references.html#ref-leeFunctionalRolesSphingolipids2023" role="doc-biblioref">115</a>,<a href="../references.html#ref-hlaSphingolipidSignalingMetabolic2012" role="doc-biblioref">116</a></sup></span>, and this review will only briefly touch on some of the most well-characterized examples of diseases of sphingolipid dysregulation, as the scope of sphingolipid metabolism disorders encompasses every step of the sphingolipid pathway and could easily fill many volumes.</p>
<p>Several of the most studied sphingolipid disorders cause lysosomal storage disorder (LSD). A spectrum of more than 70 individual diseases, LSD is generally a progressive disorder that results in the accumulation of lysosomal contents<span class="citation" data-cites="sunLysosomalStorageDisease2018"><sup><a href="../references.html#ref-sunLysosomalStorageDisease2018" role="doc-biblioref">117</a></sup></span>. The most common LSD is Gaucher disease, a genetic deficiency in the glucocerebrosidase (GBA) enzyme. GBA mediates the cleavage of glucosylceramide into glucose and ceramide, and the severity of the disease aligns with the activity of a patient’s GBA alleles<span class="citation" data-cites="sunLysosomalStorageDisease2018"><sup><a href="../references.html#ref-sunLysosomalStorageDisease2018" role="doc-biblioref">117</a></sup></span>. Gaucher disease is characterized by developmental neurological delays, progressive loss of bone density, and cachexia<span class="citation" data-cites="sunLysosomalStorageDisease2018"><sup><a href="../references.html#ref-sunLysosomalStorageDisease2018" role="doc-biblioref">117</a></sup></span>. Beyond Gaucher disease, GBA mutations are strongly associated with the neurodegenerative Parkinson’s disease<span class="citation" data-cites="doGlucocerebrosidaseItsRelevance2019"><sup><a href="../references.html#ref-doGlucocerebrosidaseItsRelevance2019" role="doc-biblioref">118</a></sup></span>.</p>
<p>Similarly, Fabry disease is the product of mutations in the alpha-galactosidase (GLA) enzyme, which results in the accumulation of another glycosphingolipid, globotriasylceramide (GL3)<span class="citation" data-cites="sunLysosomalStorageDisease2018"><sup><a href="../references.html#ref-sunLysosomalStorageDisease2018" role="doc-biblioref">117</a></sup></span>. Enzyme replacement therapy (ERT) is an effective treatment for many Gaucher and Fabry patients. In ERT, patients receive infusions of exogenous enzyme to complement the deficient endogenous activity<span class="citation" data-cites="sunLysosomalStorageDisease2018 beutlerEnzymeReplacementGaucher2004"><sup><a href="../references.html#ref-sunLysosomalStorageDisease2018" role="doc-biblioref">117</a>,<a href="../references.html#ref-beutlerEnzymeReplacementGaucher2004" role="doc-biblioref">119</a></sup></span>. During the production of these therapies, the recombinant enzyme is mannosylated – this encourages endocytic uptake and, conveniently, the trafficking of the enzyme directly to the site in which it is needed<span class="citation" data-cites="beutlerEnzymeReplacementGaucher2004"><sup><a href="../references.html#ref-beutlerEnzymeReplacementGaucher2004" role="doc-biblioref">119</a></sup></span>. Ongoing efforts are underway to find delivery methods to treat the neurological manifestations of these diseases, as in ERT, the recombinant enzyme does not efficiently cross the blood-brain barrier<span class="citation" data-cites="doGlucocerebrosidaseItsRelevance2019"><sup><a href="../references.html#ref-doGlucocerebrosidaseItsRelevance2019" role="doc-biblioref">118</a></sup></span>.</p>
<p>Beyond lysosomal storage disorders, sphingolipids are known to play intricate roles throughout development, aging, osteoporosis, and many cancers. The interface between host and pathogen is an intriguing and developing research arena. We have previously written on this topic (including several of the works presented in this dissertation: <a href="../Addenda/addenda_SLs_Fungus.html" class="quarto-xref"><span>Chapter 8</span></a><span class="citation" data-cites="guzmanSqueakyYeastGets2020"><sup><a href="../references.html#ref-guzmanSqueakyYeastGets2020" role="doc-biblioref">27</a></sup></span>, <a href="../Addenda/addenda_SLs_GeneticTools.html" class="quarto-xref"><span>Chapter 7</span></a><span class="citation" data-cites="guzmanGeneticToolsStudying2023"><sup><a href="../references.html#ref-guzmanGeneticToolsStudying2023" role="doc-biblioref">89</a></sup></span>), as have others. Utermolen et al.&nbsp;discussed in 2008 the role of aSMase as a target for several bugs, including <em>Neisseria gonorrhoeae</em> and <em>Listeria monocytogenes</em><span class="citation" data-cites="utermohlenFusogenicityMembranesImpact2008"><sup><a href="../references.html#ref-utermohlenFusogenicityMembranesImpact2008" role="doc-biblioref">43</a></sup></span>. These authors find that aSMase appears essential for enabling the many membrane fission/fusion events that must occur as the lysosome matures. We have published similar reports on the necessity of sphingolipid production for efficient phagocytosis of environmental pathogens (<a href="../results/results_Mtb_phagocytosis.html" class="quarto-xref"><span>Chapter 3</span></a>)<span class="citation" data-cites="niekampSphingomyelinBiosynthesisEssential2021 tafesseDisruptionSphingolipidBiosynthesis2015a"><sup><a href="../references.html#ref-niekampSphingomyelinBiosynthesisEssential2021" role="doc-biblioref">90</a>,<a href="../references.html#ref-tafesseDisruptionSphingolipidBiosynthesis2015a" role="doc-biblioref">120</a></sup></span>.</p>
<p>Notably, sphingolipids are largely absent from the prokaryotic lipidome - with the exception of a handful of bacterial phyla, including <em>Bacteroides</em>, <em>Sphingomonas</em>, and <em>Sphingobacterium</em><span class="citation" data-cites="olsenSphingolipidsBacteriaFungi2001 brownBacteroidesDerivedSphingolipidsAre2019 wangFunctionsSphingolipidsPathogenesis2021 baiRoleInteractionBacterial2023"><sup><a href="../references.html#ref-olsenSphingolipidsBacteriaFungi2001" role="doc-biblioref">121</a>–<a href="../references.html#ref-baiRoleInteractionBacterial2023" role="doc-biblioref">124</a></sup></span>. The many roles that these bacterial sphingolipids play in human health are discussed at length by Bai et al, 2023<span class="citation" data-cites="baiRoleInteractionBacterial2023"><sup><a href="../references.html#ref-baiRoleInteractionBacterial2023" role="doc-biblioref">124</a></sup></span> – these roles span from pro- to anti-inflammatory among commensal bacterial strains<span class="citation" data-cites="brownBacteroidesDerivedSphingolipidsAre2019 ohPublisherCorrectionHost2022"><sup><a href="../references.html#ref-brownBacteroidesDerivedSphingolipidsAre2019" role="doc-biblioref">122</a>,<a href="../references.html#ref-ohPublisherCorrectionHost2022" role="doc-biblioref">125</a></sup></span>. Here it must be noted that <em>Mtb</em> is not among the bacterial families which are capable of <em>de novo</em> sphingolipid synthesis – an <em>in vitro</em>, cultured <em>Mtb</em> bacillus is devoid of all sphingolipids; however, numerous reports have shown that <em>Mtb</em> does express a gene, Rv0888, which has demonstrable sphingomyelinase activity<span class="citation" data-cites="griffinHighResolutionPhenotypicProfiling2011"><sup><a href="../references.html#ref-griffinHighResolutionPhenotypicProfiling2011" role="doc-biblioref">126</a></sup></span>, and which allows <em>Mtb</em> to utilize carbon from SM during replication<span class="citation" data-cites="speerSurfaceHydrolysisSphingomyelin2015"><sup><a href="../references.html#ref-speerSurfaceHydrolysisSphingomyelin2015" role="doc-biblioref">127</a></sup></span>.</p>
<p>With this context, we can return to the roles of sphingolipids during <em>Mtb</em> infection.</p>
</section>
</section>
<section id="open-questions-regarding-sphingolipids-in-mtb-infection" class="level2" data-number="2.6">
<h2 data-number="2.6" class="anchored" data-anchor-id="open-questions-regarding-sphingolipids-in-mtb-infection"><span class="header-section-number">2.6</span> Open questions regarding sphingolipids in <em>Mtb</em> infection</h2>
<p>There are many open questions regarding how sphingolipids may influence the progression of a tuberculosis infection. We can categorize these questions into groups: (1) Does <em>Mtb</em> utilize host sphingolipids as a carbon source? (2) Does sphingolipid dysfunction in host cells impact <em>Mtb</em> survival/growth or TB disease progression? And, finally, (3) Can sphingolipid biology be modulated to serve as host-directed therapy? We will briefly summarize the current literature surrounding each of these questions below.</p>
<p>It is known that <em>Mtb</em> utilizes host lipids as a source of carbon and energy: this includes stimulating cells to produce triacylglycerides and sterols in high abundance and storing them in lipid droplets, and subsequently utilizing fatty acids released from these triacylglycerol and sterols by lipases; these fatty acids appear to be used in both fatty acid β-oxidation (energy production) and directly utilized in the synthesis of <em>Mtb</em> lipids<span class="citation" data-cites="wilburnCholesterolFattyAcids2018 leeIntracellularMycobacteriumTuberculosis2013 danielInductionNovelClass2004 danielMycobacteriumTuberculosisUses2011 barischBreakingFatHow2017 srinivasFunctionalCharacterizationPhospholipase2008"><sup><a href="../references.html#ref-barischBreakingFatHow2017" role="doc-biblioref">69</a>,<a href="../references.html#ref-wilburnCholesterolFattyAcids2018" role="doc-biblioref">87</a>,<a href="../references.html#ref-leeIntracellularMycobacteriumTuberculosis2013" role="doc-biblioref">128</a>–<a href="../references.html#ref-srinivasFunctionalCharacterizationPhospholipase2008" role="doc-biblioref">131</a></sup></span> Many fewer studies have investigated the utilization of host sphingolipids – however, as noted above, in 2015, Speer et al.&nbsp;identified the sole enzyme with SMase activity in the <em>Mtb</em> genome, Rv0888, and that the expression of this enzyme is dependent on the presence of SM and enables <em>Mtb</em> growth on SM-supplemented minimal growth media<span class="citation" data-cites="speerSurfaceHydrolysisSphingomyelin2015"><sup><a href="../references.html#ref-speerSurfaceHydrolysisSphingomyelin2015" role="doc-biblioref">127</a></sup></span>. Further, Dang et al.&nbsp;showed that this enzyme is both membrane-bound and secreted and contributes to lung pathology by exacerbating neutrophil-induced inflammation<span class="citation" data-cites="dangExtracellularSphingomyelinaseRv08882018"><sup><a href="../references.html#ref-dangExtracellularSphingomyelinaseRv08882018" role="doc-biblioref">132</a></sup></span>. Much work remains to fully understand whether other sphingolipids may similarly serve as energy sources for <em>Mtb</em> during infection. For instance, the above studies by Speer et al.&nbsp;and Dang et al.&nbsp;do not investigate GSLs or Cer as potential catabolites of Rv0888.</p>
<p>More work has sought to characterize the roles of sphingolipids in the host antimicrobial response to <em>Mtb</em>. In one example, Nadella et al.&nbsp;and others have reported that the potently bioactive sphingolipid sphingosine 1-phosphate (S-1P) is a crucial factor in stimulating the recruitment of T cells and macrophages to the site of <em>Mtb</em> infection and that high localized levels of this sphingolipid product stimulate potent M1 differentiation in macrophages – activating the production of inducible nitric oxide synthase (iNOS)<span class="citation" data-cites="nadellaSphingosine1PhosphateS1PPromotes2020 heoProInflammatoryRoleS1P2019 mohammedSphingolipidsMycobacteriaHost2022"><sup><a href="../references.html#ref-nadellaSphingosine1PhosphateS1PPromotes2020" role="doc-biblioref">133</a>–<a href="../references.html#ref-mohammedSphingolipidsMycobacteriaHost2022" role="doc-biblioref">135</a></sup></span>. Nadella et al.&nbsp;also showed that S-1P treatment enhanced control of <em>Mtb</em> infection in both <em>in vivo</em> and <em>in vitro</em> mouse models<span class="citation" data-cites="nadellaSphingosine1PhosphateS1PPromotes2020"><sup><a href="../references.html#ref-nadellaSphingosine1PhosphateS1PPromotes2020" role="doc-biblioref">133</a></sup></span>. However, other studies have shown that direct S-1P treatment via aerosolization can induce hyperresponsiveness to bronchoconstriction – perhaps precluding its utility as an antitubercular therapeutic<span class="citation" data-cites="maguireSphingosine1phosphateInducesAirway2023"><sup><a href="../references.html#ref-maguireSphingosine1phosphateInducesAirway2023" role="doc-biblioref">136</a></sup></span>. An alternative to direct S-1P would be to increase the activity of sphingosine kinase (SphK), which produces S-1P, or increase the abundance of sphingosine substrate for SphK, as discussed below.</p>
<p>In another example of sphingolipids modulating the severity/progression of infections, McGovern et al.&nbsp;showed that aSMase deficiency confers high susceptibility to infectious pneumonia<span class="citation" data-cites="mcgovernDiseaseManifestationsBurden2017"><sup><a href="../references.html#ref-mcgovernDiseaseManifestationsBurden2017" role="doc-biblioref">137</a></sup></span> and that active TB patients display lower aSMase activity<span class="citation" data-cites="mohammedSphingolipidsMycobacteriaHost2022"><sup><a href="../references.html#ref-mohammedSphingolipidsMycobacteriaHost2022" role="doc-biblioref">135</a></sup></span>. Wu et al.&nbsp;found in 2020 that aSMase deficient mice are highly susceptible to infection by the attenuated Bacillus Calmette-Guerin (BCG) strain of <em>M. bovis</em>. Adoptive transfer of wildtype (aSMase+) macrophages into knockout mice (aSMase-) restores the ability to control BCG infection<span class="citation" data-cites="wuAcidSphingomyelinaseContributes2020"><sup><a href="../references.html#ref-wuAcidSphingomyelinaseContributes2020" role="doc-biblioref">138</a></sup></span>. Vasquez et al.&nbsp;observe that Functional inhibitors of acid sphingomyelinase (FIASMAs), a common category antidepressant including amitriptyline and desipramine, have been shown to result in enhanced mycobacterial growth<span class="citation" data-cites="vazquezProneurotrophinReceptorSortilin2016"><sup><a href="../references.html#ref-vazquezProneurotrophinReceptorSortilin2016" role="doc-biblioref">139</a></sup></span>. These reports on aSMase regulating the antimicrobial response to <em>Mtb</em> are intriguing because several mechanisms appear simultaneously enabled by aSMase activity.</p>
<p>Ceramide produced by aSMase has direct biological effects within the lysosome. In one example, Cer directly regulates proteases such as Cathepsin D (CTSD). While CTSD has been long known to be inhibited via membrane association<span class="citation" data-cites="dimentCathepsinMembraneassociatedMacrophage1988"><sup><a href="../references.html#ref-dimentCathepsinMembraneassociatedMacrophage1988" role="doc-biblioref">140</a></sup></span>, Heinrich et al.&nbsp;showed in 2000 that CTSD activity is directly coupled to aSMase activity, and it has since been shown that direct binding of Cer stimulates autoproteolysis to release a 32 kD catalytically active CTSD protein from the lysosomal membrane fraction<span class="citation" data-cites="heinrichCathepsinTargetedAcid2000 zebrakovskaComplexModulationPeptidolytic2011"><sup><a href="../references.html#ref-heinrichCathepsinTargetedAcid2000" role="doc-biblioref">141</a>,<a href="../references.html#ref-zebrakovskaComplexModulationPeptidolytic2011" role="doc-biblioref">142</a></sup></span>. Others have similarly found that Cer binds to Cathepsin B<span class="citation" data-cites="taniguchiLysosomalCeramideGenerated2015"><sup><a href="../references.html#ref-taniguchiLysosomalCeramideGenerated2015" role="doc-biblioref">143</a></sup></span>, phospholipase A2<span class="citation" data-cites="bharathCeramideInitiatedProteinPhosphatase2015"><sup><a href="../references.html#ref-bharathCeramideInitiatedProteinPhosphatase2015" role="doc-biblioref">144</a></sup></span>, and the kinase suppressor of Ras-1<span class="citation" data-cites="zhangKinaseSuppressorRas12011"><sup><a href="../references.html#ref-zhangKinaseSuppressorRas12011" role="doc-biblioref">145</a></sup></span>. Cer’s activation of these and many other proteins is at least partially related to this lipid’s self-association into Cer-enriched platforms<span class="citation" data-cites="liCrosstalkAcidSphingomyelinase2020 gulbinsCentralRoleAcid2015"><sup><a href="../references.html#ref-liCrosstalkAcidSphingomyelinase2020" role="doc-biblioref">146</a>,<a href="../references.html#ref-gulbinsCentralRoleAcid2015" role="doc-biblioref">147</a></sup></span>. As described above, Cer produced by aSMase induces direct cellular effects and also serves as the primary cellular source for other signaling sphingolipids, such as sphingosine 1-phosphate.</p>
<p>As a product of the above mechanisms, aSMase activity has been tightly linked to the regulation of cell death pathways – namely, the decision between inflammatory necrotic cell death and non-inflammatory apoptotic cell death. Lysosomal SM-derived Cer serves as a second messenger that induces translocation of BAX from the cytosol to the mitochondria, inducing loss of mitochondrial integrity and cytochrome <em>c</em> release<span class="citation" data-cites="jinCeramideGeneratedSphingomyelin2008a"><sup><a href="../references.html#ref-jinCeramideGeneratedSphingomyelin2008a" role="doc-biblioref">148</a></sup></span>. In parallel, it has been long known that mycobacterial infection appears to manipulate this pathway to induce non-inflammatory necrotic cell death<span class="citation" data-cites="rocaTNFInducesPathogenic2019"><sup><a href="../references.html#ref-rocaTNFInducesPathogenic2019" role="doc-biblioref">149</a></sup></span>. The subtlety between routes of cell death that promote <em>Mtb</em> control versus those that enable unrestricted <em>Mtb</em> growth is yet to be fully characterized – though this has been the subject of many studies: Butler et al.&nbsp;review contradicting evidence by several studies, and they report that mycobacterial virulence is not a factor on necrotic versus apoptotic cell death<span class="citation" data-cites="butlerBalanceApoptoticNecrotic2012 parkVirulentClinicalIsolates2005 derrickESAT6ProteinMycobacterium2007 santucciMycobacteriumTuberculosisInduced2000"><sup><a href="../references.html#ref-butlerBalanceApoptoticNecrotic2012" role="doc-biblioref">150</a>–<a href="../references.html#ref-santucciMycobacteriumTuberculosisInduced2000" role="doc-biblioref">153</a></sup></span>. Bringing a long point home: there are many open questions regarding how aSMase activity may be a critical inflection point in the success or failure of an <em>Mtb</em> infection, and much work remains to explore the possibility of modulating this enzyme in a host-directed therapy.</p>
<p>As noted by Mohammed et al.&nbsp;in their 2022 review, the sphingolipid pathway is ripe with HDT possibilities<span class="citation" data-cites="mohammedSphingolipidsMycobacteriaHost2022"><sup><a href="../references.html#ref-mohammedSphingolipidsMycobacteriaHost2022" role="doc-biblioref">135</a></sup></span>. However, the nuances of infection mean that different patients may require dramatically different paradigms of sphingolipid modulation, depending on their latent-vs-active TB state, lipid profile, and immunocompetence. Much work remains to uncover how sphingolipids influence the progression of an <em>Mtb</em> infection. Questions such as these have compelled the work in this dissertation. In <a href="../results/results_Mtb_phagocytosis.html" class="quarto-xref"><span>Chapter 3</span></a>, we will explore our findings that sphingolipids are essential for the initial stage of <em>Mtb</em> infection: entry into the host cell via phagocytosis. In <a href="../results/results_Mtb_Membrane_Damage_V2.html" class="quarto-xref"><span>Chapter 4</span></a>, we will discuss the apparent role of sphingolipid synthesis in repairing endosomal/lysosomal damage induced by <em>Mtb</em> pathogenicity factors.</p>
</section>
<section id="challenges-and-breakthroughs-in-studying-lipids" class="level2" data-number="2.7">
<h2 data-number="2.7" class="anchored" data-anchor-id="challenges-and-breakthroughs-in-studying-lipids"><span class="header-section-number">2.7</span> Challenges and breakthroughs in studying lipids</h2>
<p>With all the evidence described above establishing sphingolipids as strong candidates for host-directed therapy, one must ask: why are there so many open questions about how SM, Cer, and S-1P affect <em>Mtb</em> infection? With the clear ties with cell survival and immune signaling, one would expect a concerted effort to address whether this pathway is amenable to HDT. However, studying lipids can be challenging, with logical pitfalls and technical challenges.</p>
<p>I describe many such challenges in studying sphingolipids during viral infections in detail in <a href="../Addenda/addenda_SLs_GeneticTools.html" class="quarto-xref"><span>Chapter 7</span></a><span class="citation" data-cites="guzmanGeneticToolsStudying2023"><sup><a href="../references.html#ref-guzmanGeneticToolsStudying2023" role="doc-biblioref">89</a></sup></span>. In brief, however, lipids lie at the terminus of the central dogma – they are the product of a long series of chemical reactions mediated by proteins. One cannot use simple genetic tools (knockout or point mutations) to alter a lipid’s structure or trafficking subtly. Each lipid species is a part of a complex metabolic network with astounding potential to be modified and subsumed into other lipid classes or degraded into base components. The comparatively small size of most lipid species precludes changing their structure dramatically, and their hydrophobicity/biochemistry often precludes ectopic treatment. Similarly, their small size means there are few interfaces with which a lipid-binding protein can strongly interact; for example, few lipids can participate in hydrogen bonding. Finally, the biophysics and effects of specific lipids prevent simple complementation via add-back experiments.</p>
<p>Sphingomyelin is an excellent example of a challenging lipid to study directly. Add-back experiments with SM are nearly impossible because this conical lipid strongly prefers planar, rigid, impermeable membrane structures, and treating cells with SM-enriched micelles can only provide a low percentage of SM content. Some studies have even proposed SM/Cholesterol liposomes as slow-release encapsulations for drug/vaccine delivery<span class="citation" data-cites="chavoshianSphingomyelinLiposomesContaining2013 kasagiOptimizationDihydrosphingomyelinCholesterol2023"><sup><a href="../references.html#ref-chavoshianSphingomyelinLiposomesContaining2013" role="doc-biblioref">154</a>,<a href="../references.html#ref-kasagiOptimizationDihydrosphingomyelinCholesterol2023" role="doc-biblioref">155</a></sup></span>. The utility of encapsulating drugs in liposomes of this composition lies in the fact that SM-enriched membranes are notably recalcitrant to fuse with other membranes, allowing these encapsulations to stay in the plasma longer<span class="citation" data-cites="chavoshianSphingomyelinLiposomesContaining2013 kasagiOptimizationDihydrosphingomyelinCholesterol2023"><sup><a href="../references.html#ref-chavoshianSphingomyelinLiposomesContaining2013" role="doc-biblioref">154</a>,<a href="../references.html#ref-kasagiOptimizationDihydrosphingomyelinCholesterol2023" role="doc-biblioref">155</a></sup></span>. In contrast, ceramide can be fed to cells as an ectopic source of sphingolipids<span class="citation" data-cites="shabbitsIntracellularDeliveryCeramide2003a"><sup><a href="../references.html#ref-shabbitsIntracellularDeliveryCeramide2003a" role="doc-biblioref">156</a></sup></span>. However, it is well-documented that excess Cer is a potent inducer of apoptosis<span class="citation" data-cites="kolesnickCeramideApoptosis1999"><sup><a href="../references.html#ref-kolesnickCeramideApoptosis1999" role="doc-biblioref">157</a></sup></span>. The apoptosis-inducing effects of Cer have driven substantial research into using Cer-loaded liposomes as a chemotherapeutic against cancer<span class="citation" data-cites="shabbitsIntracellularDeliveryCeramide2003a"><sup><a href="../references.html#ref-shabbitsIntracellularDeliveryCeramide2003a" role="doc-biblioref">156</a></sup></span>.</p>
<p>And, though this list is not comprehensive, a final challenge in studying lipids is that their metabolic network is a sprawling and complex architecture in which lipids are rapidly interconverted, modified, and catabolized. Blocking the synthesis of a particular lipid will result in accumulating its source inputs and losing any secondary products. For example, inhibiting sphingomyelin production results in ceramide accumulation, phosphatidylcholine accumulation, <em>and</em> a reduction in diacylglycerol production; the cell will partially respond to ceramide accumulation by reducing SPT activity, but it will also result in increased glycosphingolipid production<span class="citation" data-cites="liInhibitionSphingomyelinSynthase2007 jiangSphingolipidsHDLMetabolism2014"><sup><a href="../references.html#ref-liInhibitionSphingomyelinSynthase2007" role="doc-biblioref">158</a>,<a href="../references.html#ref-jiangSphingolipidsHDLMetabolism2014" role="doc-biblioref">159</a></sup></span>. In addition to these direct effects resulting from inhibiting the pathway, there can be secondary effects: blocking SMS activity also induces a significant loss of cellular cholesterol content<span class="citation" data-cites="liInhibitionSphingomyelinSynthase2007"><sup><a href="../references.html#ref-liInhibitionSphingomyelinSynthase2007" role="doc-biblioref">158</a></sup></span>. Inhibiting or knocking out one enzyme is much like removing a node in a spider’s web – the whole network must adjust to the node’s absence.</p>
<p>These examples demonstrate that the reductionist approach has suited many aspects of biological study (observe the effects of gene knockout, then determine if reconstituting restores the <em>status quo</em>). With these challenges in mind, a question arises: “How <em>does</em> one study sphingolipids?” We have previously written extensively on genetic knockout to study the roles of sphingolipids (<a href="../Addenda/addenda_SLs_GeneticTools.html" class="quarto-xref"><span>Chapter 7</span></a>)<span class="citation" data-cites="guzmanGeneticToolsStudying2023"><sup><a href="../references.html#ref-guzmanGeneticToolsStudying2023" role="doc-biblioref">89</a></sup></span>. Here, we will briefly touch on techniques that allow for measuring and visualizing native lipids and techniques that employ synthetic lipid analogs to track the metabolism and interactions of the target lipids.</p>
<p>As with the field of genomics and the advent of next-generation sequencing, the fields of proteomics and lipidomics have seen an explosive maturation in the sensitivity, throughput, and depth of coverage that a mass spectrometer can achieve. The major hurdle has rapidly become: “How do we glean information from these tens/hundreds of thousands of mass spectra?” Tools like LIQUID<span class="citation" data-cites="kyleLIQUIDAnopenSource2017a"><sup><a href="../references.html#ref-kyleLIQUIDAnopenSource2017a" role="doc-biblioref">160</a></sup></span> allow for rapidly identifying many lipid species from mass spectrometry data. Databases such as MycoMass also annotate many lipid species unique to mycobacteria. These improvements in computational tools allow for deeper exploration into the broad changes that occur during a complex event such as an <em>Mtb</em> infection.</p>
<p>However, even highly sensitive mass spectrometers have difficulty identifying and quantifying the presence of highly transient lipid species such as plasma membrane Cer or serum S1P. The speed and quality of sample preparation can have an immense impact on the concentrations measured for these lipids. Greene et al.&nbsp;recently reported a new technique for measuring plasma membrane Cer<span class="citation" data-cites="greeneSimpleHighlySensitive2023"><sup><a href="../references.html#ref-greeneSimpleHighlySensitive2023" role="doc-biblioref">161</a></sup></span>.</p>
<p>Similarly, a panel of sphingolipid-binding proteins serves as valuable tools in visualizing the localization and density of a sphingolipid. For example, the fluorescent fusion proteins lysenin-GFP and Equinatoxin-GFP enable the visualization of sphingomyelin via fluorescence microscopy. Lysenin and Equinatoxin were produced from pore-forming toxins isolated from <em>Eisenia fetida</em><span class="citation" data-cites="yamajiLyseninNovelSphingomyelinspecific1998"><sup><a href="../references.html#ref-yamajiLyseninNovelSphingomyelinspecific1998" role="doc-biblioref">162</a></sup></span> and <em>Actinia equina</em><span class="citation" data-cites="bakracToxinbasedProbeReveals2010"><sup><a href="../references.html#ref-bakracToxinbasedProbeReveals2010" role="doc-biblioref">163</a></sup></span>. Similarly, an anti-ceramide antibody allows one to visualize ceramide in fixed cells and tissue<span class="citation" data-cites="krishnamurthyDevelopmentCharacterizationNovel2007 rotoloAnticeramideAntibodyPrevents2012"><sup><a href="../references.html#ref-krishnamurthyDevelopmentCharacterizationNovel2007" role="doc-biblioref">164</a>,<a href="../references.html#ref-rotoloAnticeramideAntibodyPrevents2012" role="doc-biblioref">165</a></sup></span>.</p>
<p>In parallel to these techniques, which enable the detection and visualization of native sphingolipids, a variety of synthetic sphingolipid analogs allow for in-depth analysis of the trafficking, protein-lipid interactions, and metabolism of select lipid species. Chief among these are the trifunctionalized lipid analogs reported by Höglinger, Haberkant, Farley, and Schultz<span class="citation" data-cites="hoglingerIntracellularSphingosineReleases2015a hoglingerTrifunctionalLipidProbes2017 haberkantBifunctionalSphingosineCellBased2016a haberkantFatFabulousBifunctional2014 schultzChemicalToolsLipid2023 schultzFlashClickMultifunctionalized2022a farleyTrifunctionalSphinganineNew2024"><sup><a href="../references.html#ref-hoglingerIntracellularSphingosineReleases2015a" role="doc-biblioref">112</a>,<a href="../references.html#ref-hoglingerTrifunctionalLipidProbes2017" role="doc-biblioref">166</a>–<a href="../references.html#ref-farleyTrifunctionalSphinganineNew2024" role="doc-biblioref">171</a></sup></span>. These lipid analogs will be discussed in great detail in <a href="../results/results_trifunctionalProteomics.html" class="quarto-xref"><span>Chapter 6</span></a>.</p>
</section>
<section id="conclusion" class="level2" data-number="2.8">
<h2 data-number="2.8" class="anchored" data-anchor-id="conclusion"><span class="header-section-number">2.8</span> Conclusion</h2>
<p>After years of research, it is clear that lipids play a crucial role in the interaction between <em>Mycobacterium tuberculosis</em> and host cells. Recent studies have further highlighted the importance of sphingolipids in directing the course of Mtb infection, and there is much interest in exploring the potential of sphingolipids as targets for host-directed therapy. This area of research has implications for developing new antitubercular therapies and broader implications for understanding how sphingolipids enable mammalian immune activity. As we unravel the complexities of Mtb infection, it is clear that a multidisciplinary approach to understanding the role of lipids in infection will be essential for developing new treatments and improving human health.</p>
</section>
<section id="contributions" class="level2" data-number="2.9">
<h2 data-number="2.9" class="anchored" data-anchor-id="contributions"><span class="header-section-number">2.9</span> Contributions</h2>
<p>GG compiled the concepts discussed in this review and wrote the entirety of the text. FGT oversaw the preparation of this review.</p>


<div class="hidden" aria-hidden="true">
<span class="glightbox-desc lightbox-desc-1">Figure&nbsp;2.1: <strong>The balancing act of <em>Mtb</em> control.</strong> A highly simplified cartoon depicting the anti-/pro-<em>Mtb</em> features of infected macrophages. The terminal fate of internalized <em>Mtb</em> appears related to programming initiated with the sensing and internalization of the bacteria by PRRs. Inflammatory PRRs direct the bacteria toward a maturing endosome, resulting in ROS/RNS production, bacterial death, and secretion of inflammatory cytokines involved in overall infection control. Uptake by anti-inflammatory PRRs results in the bacteria residing in a non-maturing endosome, gaining cytosolic access via membrane disruption, the accumulation of lipid droplets, and finally, anti-inflammatory cytokine production — resulting in tuberculosis disease progression. (Abbreviations: PRR = pathogen recognition receptor; TLR2 = toll-like receptor 2; CR = complement receptor; FCγR = Fc-gamma receptor; MR = mannose receptor; SP-A = surfactant protein A; ROS/RNS = reactive oxygen/nitrogen species; IL-12/18/1β/10/4 = interleukins 12/18/1β/10/4; TGF-β = transformative growth factor-β; IFN-α/β = interferon-α/β).</span>
<span class="glightbox-desc lightbox-desc-2">Figure&nbsp;2.2: <strong>Sphingolipid synthetic and metabolic pathway</strong> Abbreviations: SPT = Serine palmitoyltransferase; KDHSR: 3-Ketodihydrosphingosine reductase; CerS1-6 = Ceramide synthase 1-6; DES = dihydroceramide Δ4-saturase; CK = Ceramide kinase; C1PP = Ceramide-1-phosphate phosphatase; UGCG = UDP-glucose ceramide glucosyltransferase; PC = phosphatidylcholine; SGMS1/2 = Sphingomyelin synthase 1/2; DAG = Diacylglycerol; a/nCDase = Acid/neutral ceramidase; a/nSMase = Acid/neutral sphingomyelinase; S1PL = Sphingosine-1-lyase; SK1/2 = Sphingosine kinase 1/2; SPPase = Sphingosine-1-phosphate phosphatase.</span>
</div>
<div id="refs" class="references csl-bib-body" role="list" style="display: none">
<div id="ref-quevalMacrophageDisputedFortress2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Queval, C.J., Brosch, R., and Simeone, R. (2017). The <span>Macrophage</span>: <span>A Disputed Fortress</span> in the <span>Battle</span> against <span>Mycobacterium</span> tuberculosis. Frontiers in Microbiology <em>8</em>. <a href="https://doi.org/10.3389/fmicb.2017.02284">10.3389/fmicb.2017.02284</a>.</div>
</div>
<div id="ref-tobinHostDirectedTherapiesTuberculosis2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Tobin, D.M. (2015). Host-<span>Directed Therapies</span> for <span>Tuberculosis</span>: <span>Figure</span> 1. Cold Spring Harb Perspect Med <em>5</em>, a021196. <a href="https://doi.org/10.1101/cshperspect.a021196">10.1101/cshperspect.a021196</a>.</div>
</div>
<div id="ref-duttaAdjunctiveHostDirectedTherapy2020a" class="csl-entry" role="listitem">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Dutta, N.K., Bruiners, N., Zimmerman, M.D., Tan, S., Dartois, V., Gennaro, M.L., and Karakousis, P.C. (2020). Adjunctive <span>Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes</span> in <span>Mice</span>. The Journal of Infectious Diseases <em>221</em>, 1079–1087. <a href="https://doi.org/10.1093/infdis/jiz517">10.1093/infdis/jiz517</a>.</div>
</div>
<div id="ref-zhaoGlobalAirborneBacterial2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Zhao, J., Jin, L., Wu, D., Xie, J., Li, J., Fu, X., Cong, Z., Fu, P., Zhang, Y., Luo, X., et al. (2022). Global airborne bacterial community—interactions with <span>Earth</span>’s microbiomes and anthropogenic activities. Proc. Natl. Acad. Sci. U.S.A. <em>119</em>, e2204465119. <a href="https://doi.org/10.1073/pnas.2204465119">10.1073/pnas.2204465119</a>.</div>
</div>
<div id="ref-noceraExosomeSwarmsEliminate2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Nocera, A.L., Mueller, S.K., Stephan, J.R., Hing, L., Seifert, P., Han, X., Lin, D.T., Amiji, M.M., Libermann, T., and Bleier, B.S. (2019). Exosome swarms eliminate airway pathogens and provide passive epithelial immunoprotection through nitric oxide. Journal of Allergy and Clinical Immunology <em>143</em>, 1525–1535.e1. <a href="https://doi.org/10.1016/j.jaci.2018.08.046">10.1016/j.jaci.2018.08.046</a>.</div>
</div>
<div id="ref-flynnImmuneCellInteractions2022a" class="csl-entry" role="listitem">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Flynn, J.L., and Chan, J. (2022). Immune cell interactions in tuberculosis. Cell <em>185</em>, 4682–4702. <a href="https://doi.org/10.1016/j.cell.2022.10.025">10.1016/j.cell.2022.10.025</a>.</div>
</div>
<div id="ref-rosalesPhagocytosisFundamentalProcess2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Rosales, C., and Uribe-Querol, E. (2017). Phagocytosis: <span>A Fundamental Process</span> in <span>Immunity</span>. BioMed Research International <em>2017</em>. <a href="https://doi.org/10.1155/2017/9042851">10.1155/2017/9042851</a>.</div>
</div>
<div id="ref-michaudTaxonspecificAerosolizationBacteria2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Michaud, J.M., Thompson, L.R., Kaul, D., Espinoza, J.L., Richter, R.A., Xu, Z.Z., Lee, C., Pham, K.M., Beall, C.M., Malfatti, F., et al. (2018). Taxon-specific aerosolization of bacteria and viruses in an experimental ocean-atmosphere mesocosm. Nat Commun <em>9</em>, 2017. <a href="https://doi.org/10.1038/s41467-018-04409-z">10.1038/s41467-018-04409-z</a>.</div>
</div>
<div id="ref-pfrommerEnhancedTenacityMycobacterial2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Pfrommer, E., Dreier, C., Gabriel, G., Dallenga, T., Reimer, R., Schepanski, K., Scherließ, R., Schaible, U.E., and Gutsmann, T. (2020). Enhanced tenacity of mycobacterial aerosols from necrotic neutrophils. Sci Rep <em>10</em>, 9159. <a href="https://doi.org/10.1038/s41598-020-65781-9">10.1038/s41598-020-65781-9</a>.</div>
</div>
<div id="ref-o1963experimental" class="csl-entry" role="listitem">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">O’grady, F., and Riley, R. (1963). Experimental airborne tuberculosis. Adv. Tuberc. Res <em>12</em>, 150–190.</div>
</div>
<div id="ref-rileyAERIALDISSEMINATIONOP1995" class="csl-entry" role="listitem">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">Riley, R.L., Mills, C.C., Nyka, W., Weinstock, N., Storey, P.B., Sultan, L.U., Riley, M.C., and Wells, W.F. (1995). <span>AERIAL DISSEMINATION OP PULMONARY TUBERCULOSIS</span>: <span>A TWO-YEAR STUDY OF CONTAGION IN A TUBERCULOSIS WARD1</span>. American Journal of Epidemiology <em>142</em>, 3–14. <a href="https://doi.org/10.1093/oxfordjournals.aje.a117542">10.1093/oxfordjournals.aje.a117542</a>.</div>
</div>
<div id="ref-martinDigitallyBarcodingMycobacterium2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">Martin, C.J., Cadena, A.M., Leung, V.W., Lin, P.L., Maiello, P., Hicks, N., Chase, M.R., Flynn, J.L., and Fortune, S.M. (2017). Digitally <span>Barcoding</span> <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> <span>Reveals</span> <span><span><em>In Vivo</em></span></span> <span>Infection Dynamics</span> in the <span>Macaque Model</span> of <span>Tuberculosis</span>. mBio <em>8</em>, e00312–17. <a href="https://doi.org/10.1128/mBio.00312-17">10.1128/mBio.00312-17</a>.</div>
</div>
<div id="ref-linSterilizationGranulomasCommon2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Lin, P.L., Ford, C.B., Coleman, M.T., Myers, A.J., Gawande, R., Ioerger, T., Sacchettini, J., Fortune, S.M., and Flynn, J.L. (2014). Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med <em>20</em>, 75–79. <a href="https://doi.org/10.1038/nm.3412">10.1038/nm.3412</a>.</div>
</div>
<div id="ref-ehlersGranulomaTuberculosisDynamics2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Ehlers, S., and Schaible, U.E. (2013). The <span>Granuloma</span> in <span>Tuberculosis</span>: <span>Dynamics</span> of a <span>Host</span>–<span>Pathogen Collusion</span>. Front. Immun. <em>3</em>. <a href="https://doi.org/10.3389/fimmu.2012.00411">10.3389/fimmu.2012.00411</a>.</div>
</div>
<div id="ref-kellerGeneticallyDeterminedSusceptibility2006" class="csl-entry" role="listitem">
<div class="csl-left-margin">15. </div><div class="csl-right-inline">Keller, C., Hoffmann, R., Lang, R., Brandau, S., Hermann, C., and Ehlers, S. (2006). Genetically <span>Determined Susceptibility</span> to <span>Tuberculosis</span> in <span>Mice Causally Involves Accelerated</span> and <span>Enhanced Recruitment</span> of <span>Granulocytes</span>. Infect Immun <em>74</em>, 4295–4309. <a href="https://doi.org/10.1128/IAI.00057-06">10.1128/IAI.00057-06</a>.</div>
</div>
<div id="ref-cardonaDynamicReinfectionHypothesis2009" class="csl-entry" role="listitem">
<div class="csl-left-margin">16. </div><div class="csl-right-inline">Cardona, P.-J. (2009). A <span>Dynamic Reinfection Hypothesis</span> of <span>Latent Tuberculosis Infection</span>. Infection <em>37</em>, 80–86. <a href="https://doi.org/10.1007/s15010-008-8087-y">10.1007/s15010-008-8087-y</a>.</div>
</div>
<div id="ref-kimCaseationHumanTuberculosis2010" class="csl-entry" role="listitem">
<div class="csl-left-margin">17. </div><div class="csl-right-inline">Kim, M., Wainwright, H.C., Locketz, M., Bekker, L., Walther, G.B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010). Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Molecular Medicine <em>2</em>, 258–274. <a href="https://doi.org/10.1002/emmm.201000079">10.1002/emmm.201000079</a>.</div>
</div>
<div id="ref-hunterPathologyPostprimaryTuberculosis2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">18. </div><div class="csl-right-inline">Hunter, R.L., Jagannath, C., and Actor, J.K. (2007). Pathology of postprimary tuberculosis in humans and mice: <span>Contradiction</span> of long-held beliefs. Tuberculosis <em>87</em>, 267–278. <a href="https://doi.org/10.1016/j.tube.2006.11.003">10.1016/j.tube.2006.11.003</a>.</div>
</div>
<div id="ref-vankooykDCSIGNEscapeMechanism2003a" class="csl-entry" role="listitem">
<div class="csl-left-margin">19. </div><div class="csl-right-inline">Van Kooyk, Y., and Geijtenbeek, T.B.H. (2003). <span>DC-SIGN</span>: <span>Escape</span> mechanism for pathogens. Nature Reviews Immunology <em>3</em>, 697–709. <a href="https://doi.org/10.1038/nri1182">10.1038/nri1182</a>.</div>
</div>
<div id="ref-hossainPatternRecognitionReceptors2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">20. </div><div class="csl-right-inline">Hossain, Md.M., and Norazmi, M.-N. (2013). Pattern <span>Recognition Receptors</span> and <span>Cytokines</span> in <span>Mycobacterium</span> tuberculosis <span>Infection</span>—<span>The Double-Edged Sword</span>? BioMed Research International <em>2013</em>, 1–18. <a href="https://doi.org/10.1155/2013/179174">10.1155/2013/179174</a>.</div>
</div>
<div id="ref-kleinnijenhuisInnateImmuneRecognition2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">21. </div><div class="csl-right-inline">Kleinnijenhuis, J., Oosting, M., Joosten, L.A.B., Netea, M.G., and Van Crevel, R. (2011). Innate <span>Immune Recognition</span> of <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span>. Clinical and Developmental Immunology <em>2011</em>, 1–12. <a href="https://doi.org/10.1155/2011/405310">10.1155/2011/405310</a>.</div>
</div>
<div id="ref-arishMacrophagePlasticityTherapeutic2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">22. </div><div class="csl-right-inline">Arish, M., and Naz, F. (2022). Macrophage plasticity as a therapeutic target in tuberculosis. Eur J Immunol <em>52</em>, 696–704. <a href="https://doi.org/10.1002/eji.202149624">10.1002/eji.202149624</a>.</div>
</div>
<div id="ref-purdyTakingOutTB2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">23. </div><div class="csl-right-inline">Purdy, G.E. (2011). Taking <span>Out TB</span>–<span>Lysosomal Trafficking</span> and <span>Mycobactericidal Ubiquitin-Derived Peptides</span>. Front. Microbio. <em>2</em>. <a href="https://doi.org/10.3389/fmicb.2011.00007">10.3389/fmicb.2011.00007</a>.</div>
</div>
<div id="ref-flannaganCellBiologyPhagocytosis2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">24. </div><div class="csl-right-inline">Flannagan, R.S., Jaumouillé, V., and Grinstein, S. (2012). The <span>Cell Biology</span> of <span>Phagocytosis</span>. Annual Review of Pathology: Mechanisms of Disease <em>7</em>, 61–98. <a href="https://doi.org/10.1146/annurev-pathol-011811-132445">10.1146/annurev-pathol-011811-132445</a>.</div>
</div>
<div id="ref-harrisonPhagosomesFuseLate2003" class="csl-entry" role="listitem">
<div class="csl-left-margin">25. </div><div class="csl-right-inline">Harrison, R.E., Bucci, C., Vieira, O.V., Schroer, T.A., and Grinstein, S. (2003). Phagosomes <span>Fuse</span> with <span>Late Endosomes</span> and/or <span>Lysosomes</span> by <span>Extension</span> of <span>Membrane Protrusions</span> along <span>Microtubules</span>: <span>Role</span> of <span>Rab7</span> and <span>RILP</span>. Molecular and Cellular Biology <em>23</em>, 6494 LP–6506. <a href="https://doi.org/10.1128/MCB.23.18.6494-6506.2003">10.1128/MCB.23.18.6494-6506.2003</a>.</div>
</div>
<div id="ref-chernomordikProteinLipidInterplayFusion2003" class="csl-entry" role="listitem">
<div class="csl-left-margin">26. </div><div class="csl-right-inline">Chernomordik, L.V., and Kozlov, M.M. (2003). Protein-<span>Lipid Interplay</span> in <span>Fusion</span> and <span>Fission</span> of <span>Biological Membranes</span>. Annual Review of Biochemistry <em>72</em>, 175–207. <a href="https://doi.org/10.1146/annurev.biochem.72.121801.161504">10.1146/annurev.biochem.72.121801.161504</a>.</div>
</div>
<div id="ref-guzmanSqueakyYeastGets2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">27. </div><div class="csl-right-inline">Guzman, G., Niekamp, P., and Tafesse, F.G. (2020). The <span>Squeaky Yeast Gets Greased</span>: <span>The Roles</span> of <span>Host Lipids</span> in the <span>Clearance</span> of <span>Pathogenic Fungi</span>. Journal of Fungi <em>6</em>, 19. <a href="https://doi.org/10.3390/jof6010019">10.3390/jof6010019</a>.</div>
</div>
<div id="ref-tanMycobacteriumTuberculosisResponds2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">28. </div><div class="csl-right-inline">Tan, S., Sukumar, N., Abramovitch, R.B., Parish, T., and Russell, D.G. (2013). Mycobacterium tuberculosis <span>Responds</span> to <span>Chloride</span> and <span class="nocase">pH</span> as <span>Synergistic Cues</span> to the <span>Immune Status</span> of its <span>Host Cell</span>. PLoS Pathogens <em>9</em>. <a href="https://doi.org/10.1371/journal.ppat.1003282">10.1371/journal.ppat.1003282</a>.</div>
</div>
<div id="ref-carranzaSeveralRoutesSame2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">29. </div><div class="csl-right-inline">Carranza, C., and Chavez-Galan, L. (2019). Several <span>Routes</span> to the <span>Same Destination</span>: <span>Inhibition</span> of <span>Phagosome-Lysosome Fusion</span> by <span>Mycobacterium</span> tuberculosis. The American Journal of the Medical Sciences <em>357</em>, 184–194. <a href="https://doi.org/10.1016/j.amjms.2018.12.003">10.1016/j.amjms.2018.12.003</a>.</div>
</div>
<div id="ref-poirierMycobacteriumTuberculosisModulators2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">30. </div><div class="csl-right-inline">Poirier, V., and Av-Gay, Y. (2012). Mycobacterium tuberculosis modulators of the macrophage’s cellular events. Microbes and Infection <em>14</em>, 1211–1219. <a href="https://doi.org/10.1016/j.micinf.2012.07.001">10.1016/j.micinf.2012.07.001</a>.</div>
</div>
<div id="ref-upadhyayTuberculosisArtMacrophage2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">31. </div><div class="csl-right-inline">Upadhyay, S., Mittal, E., and Philips, J.A. (2018). Tuberculosis and the art of macrophage manipulation. Pathogens and Disease <em>76</em>. <a href="https://doi.org/10.1093/femspd/fty037">10.1093/femspd/fty037</a>.</div>
</div>
<div id="ref-jaberClassIIIPI3K2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">32. </div><div class="csl-right-inline">Jaber, N., and Zong, W. (2013). Class <span>III PI3K Vps34</span>: Essential roles in autophagy, endocytosis, and heart and liver function. Annals of the New York Academy of Sciences <em>1280</em>, 48–51. <a href="https://doi.org/10.1111/nyas.12026">10.1111/nyas.12026</a>.</div>
</div>
<div id="ref-schnettgerRab20DependentMembraneTrafficking2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">33. </div><div class="csl-right-inline">Schnettger, L., Rodgers, A., Repnik, U., Lai, R.P., Pei, G., Verdoes, M., Wilkinson, R.J., Young, D.B., and Gutierrez, M.G. (2017). A <span>Rab20-Dependent Membrane Trafficking Pathway Controls M</span>.&nbsp;Tuberculosis <span>Replication</span> by <span>Regulating Phagosome Spaciousness</span> and <span>Integrity</span>. Cell Host and Microbe <em>21</em>, 619–628.e5. <a href="https://doi.org/10.1016/j.chom.2017.04.004">10.1016/j.chom.2017.04.004</a>.</div>
</div>
<div id="ref-mendumLipidMetabolismType2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">34. </div><div class="csl-right-inline">Mendum, T.A., Wu, H., Kierzek, A.M., and Stewart, G.R. (2015). Lipid metabolism and <span>Type VII</span> secretion systems dominate the genome scale virulence profile of <span>Mycobacterium</span> tuberculosis in human dendritic cells. BMC Genomics <em>16</em>, 372. <a href="https://doi.org/10.1186/s12864-015-1569-2">10.1186/s12864-015-1569-2</a>.</div>
</div>
<div id="ref-quigleyCellWallLipid2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">35. </div><div class="csl-right-inline">Quigley, J., Hughitt, V.K., Velikovsky, C.A., Mariuzza, R.A., El-Sayed, N.M., and Briken, V. (2017). The <span>Cell Wall Lipid PDIM Contributes</span> to <span>Phagosomal Escape</span> and <span>Host Cell Exit</span> of <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span>. mBio <em>8</em>, e00148–17. <a href="https://doi.org/10.1128/mBio.00148-17">10.1128/mBio.00148-17</a>.</div>
</div>
<div id="ref-osmanMycobacteriumMarinumPhthiocerol2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">36. </div><div class="csl-right-inline">Osman, M.M., Pagán, A.J., Shanahan, J.K., and Ramakrishnan, L. (2020). Mycobacterium marinum phthiocerol dimycocerosates enhance macrophage phagosomal permeabilization and membrane damage. PLoS ONE <em>15</em>, e0233252. <a href="https://doi.org/10.1371/journal.pone.0233252">10.1371/journal.pone.0233252</a>.</div>
</div>
<div id="ref-bedardTerpeneNucleosideTuberculosis2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">37. </div><div class="csl-right-inline">Bedard, M., Van Der Niet, S., Bernard, E.M., Babunovic, G., Cheng, T.-Y., Aylan, B., Grootemaat, A.E., Raman, S., Botella, L., Ishikawa, E., et al. (2023). A terpene nucleoside from <span>M</span>. Tuberculosis induces lysosomal lipid storage in foamy macrophages. Journal of Clinical Investigation <em>133</em>, e161944. <a href="https://doi.org/10.1172/JCI161944">10.1172/JCI161944</a>.</div>
</div>
<div id="ref-pengMechanismESAT6Membrane2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">38. </div><div class="csl-right-inline">Peng, X., and Sun, J. (2016). Mechanism of <span>ESAT-6</span> membrane interaction and its roles in pathogenesis of <span>Mycobacterium</span> tuberculosis. Toxicon <em>116</em>, 29–34. <a href="https://doi.org/10.1016/j.toxicon.2015.10.003">10.1016/j.toxicon.2015.10.003</a>.</div>
</div>
<div id="ref-simeonePhagosomalRuptureMycobacterium2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">39. </div><div class="csl-right-inline">Simeone, R., Bobard, A., Lippmann, J., Bitter, W., Majlessi, L., Brosch, R., and Enninga, J. (2012). Phagosomal <span>Rupture</span> by <span>Mycobacterium</span> tuberculosis <span>Results</span> in <span>Toxicity</span> and <span>Host Cell Death</span>. PLoS Pathogens <em>8</em>, e1002507. <a href="https://doi.org/10.1371/journal.ppat.1002507">10.1371/journal.ppat.1002507</a>.</div>
</div>
<div id="ref-buterMycobacteriumTuberculosisReleases2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">40. </div><div class="csl-right-inline">Buter, J., Cheng, T.-Y., Ghanem, M., Grootemaat, A.E., Raman, S., Feng, X., Plantijn, A.R., Ennis, T., Wang, J., Cotton, R.N., et al. (2019). Mycobacterium tuberculosis releases an antacid that remodels phagosomes. Nat Chem Biol <em>15</em>, 889–899. <a href="https://doi.org/10.1038/s41589-019-0336-0">10.1038/s41589-019-0336-0</a>.</div>
</div>
<div id="ref-bedardTerpeneNucleosideTuberculosis2023a" class="csl-entry" role="listitem">
<div class="csl-left-margin">41. </div><div class="csl-right-inline">Bedard, M., van der Niet, S., Bernard, E.M., Babunovic, G., Cheng, T.-Y., Aylan, B., Grootemaat, A.E., Raman, S., Botella, L., Ishikawa, E., et al. (2023). A terpene nucleoside from <span>M</span>. Tuberculosis induces lysosomal lipid storage in foamy macrophages. Journal of Clinical Investigation <em>133</em>. <a href="https://doi.org/10.1172/jci161944">10.1172/jci161944</a>.</div>
</div>
<div id="ref-russellInsOutsMycobacterium2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">42. </div><div class="csl-right-inline">Russell, D.G. (2016). The ins and outs of the <span>Mycobacterium</span> tuberculosis-containing vacuole. Cellular Microbiology <em>18</em>, 1065–1069. <a href="https://doi.org/10.1111/cmi.12623">10.1111/cmi.12623</a>.</div>
</div>
<div id="ref-utermohlenFusogenicityMembranesImpact2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">43. </div><div class="csl-right-inline">Utermöhlen, O., Herz, J., Schramm, M., and Krönke, M. (2008). Fusogenicity of membranes: <span>The</span> impact of acid sphingomyelinase on innate immune responses. Immunobiology <em>213</em>, 307–314. <a href="https://doi.org/10.1016/j.imbio.2007.10.016">10.1016/j.imbio.2007.10.016</a>.</div>
</div>
<div id="ref-houbenESXMediatedTranslocation2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">44. </div><div class="csl-right-inline">Houben, D., Demangel, C., Van Ingen, J., Perez, J., Baldeón, L., Abdallah, A.M., Caleechurn, L., Bottai, D., Van Zon, M., De Punder, K., et al. (2012). <span>ESX</span>‐1‐mediated translocation to the cytosol controls virulence of mycobacteria. Cellular Microbiology <em>14</em>, 1287–1298. <a href="https://doi.org/10.1111/j.1462-5822.2012.01799.x">10.1111/j.1462-5822.2012.01799.x</a>.</div>
</div>
<div id="ref-barischMembraneDamageRepair2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">45. </div><div class="csl-right-inline">Barisch, C., Holthuis, J.C.M., and Cosentino, K. (2023). Membrane damage and repair: A thin line between life and death. Biological Chemistry <em>404</em>, 467–490. <a href="https://doi.org/10.1515/hsz-2022-0321">10.1515/hsz-2022-0321</a>.</div>
</div>
<div id="ref-sachdevaInterplayHostLysosomes2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">46. </div><div class="csl-right-inline">Sachdeva, K., and Sundaramurthy, V. (2020). The <span>Interplay</span> of <span>Host Lysosomes</span> and <span>Intracellular Pathogens</span>. Front. Cell. Infect. Microbiol. <em>10</em>, 595502. <a href="https://doi.org/10.3389/fcimb.2020.595502">10.3389/fcimb.2020.595502</a>.</div>
</div>
<div id="ref-santucciIntracellularPathogensMembrane2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">47. </div><div class="csl-right-inline">Santucci, P. (2021). Intracellular pathogens, membrane damage and cytosolic access. Cellular Microbiology <em>23</em>. <a href="https://doi.org/10.1111/cmi.13296">10.1111/cmi.13296</a>.</div>
</div>
<div id="ref-simeoneESXTypeVII2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">48. </div><div class="csl-right-inline">Simeone, R., Bottai, D., Frigui, W., Majlessi, L., and Brosch, R. (2015). <span>ESX</span>/type <span>VII</span> secretion systems of mycobacteria: <span>Insights</span> into evolution, pathogenicity and protection. Tuberculosis <em>95</em>, S150–S154. <a href="https://doi.org/10.1016/j.tube.2015.02.019">10.1016/j.tube.2015.02.019</a>.</div>
</div>
<div id="ref-osmanTerminusMycobacteriumESX12022" class="csl-entry" role="listitem">
<div class="csl-left-margin">49. </div><div class="csl-right-inline">Osman, M.M., Shanahan, J.K., Chu, F., Takaki, K.K., Pinckert, M.L., Pagán, A.J., Brosch, R., Conrad, W.H., and Ramakrishnan, L. (2022). The <span>C</span> terminus of the mycobacterium <span>ESX-1</span> secretion system substrate <span>ESAT-6</span> is required for phagosomal membrane damage and virulence. Proc. Natl. Acad. Sci. U.S.A. <em>119</em>, e2122161119. <a href="https://doi.org/10.1073/pnas.2122161119">10.1073/pnas.2122161119</a>.</div>
</div>
<div id="ref-smithEvidencePoreFormation2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">50. </div><div class="csl-right-inline">Smith, J., Manoranjan, J., Pan, M., Bohsali, A., Xu, J., Liu, J., McDonald, K.L., Szyk, A., LaRonde-LeBlanc, N., and Gao, L.-Y. (2008). Evidence for <span>Pore Formation</span> in <span>Host Cell Membranes</span> by <span>ESX-1-Secreted ESAT-6</span> and <span>Its Role</span> in <span><span><em>Mycobacterium</em></span></span><span><span><em> Marinum</em></span></span> <span>Escape</span> from the <span>Vacuole</span>. Infect Immun <em>76</em>, 5478–5487. <a href="https://doi.org/10.1128/IAI.00614-08">10.1128/IAI.00614-08</a>.</div>
</div>
<div id="ref-dejongeESAT6MycobacteriumTuberculosis2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">51. </div><div class="csl-right-inline">De Jonge, M.I., Pehau-Arnaudet, G., Fretz, M.M., Romain, F., Bottai, D., Brodin, P., Honoré, N., Marchal, G., Jiskoot, W., England, P., et al. (2007). <span>ESAT-6</span> from <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> <span>Dissociates</span> from <span>Its Putative Chaperone CFP-10</span> under <span>Acidic Conditions</span> and <span>Exhibits Membrane-Lysing Activity</span>. J Bacteriol <em>189</em>, 6028–6034. <a href="https://doi.org/10.1128/JB.00469-07">10.1128/JB.00469-07</a>.</div>
</div>
<div id="ref-hsuPrimaryMechanismAttenuation2003" class="csl-entry" role="listitem">
<div class="csl-left-margin">52. </div><div class="csl-right-inline">Hsu, T., Hingley-Wilson, S.M., Chen, B., Chen, M., Dai, A.Z., Morin, P.M., Marks, C.B., Padiyar, J., Goulding, C., Gingery, M., et al. (2003). The primary mechanism of attenuation of bacillus <span>Calmette</span>–<span>Guérin</span> is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl. Acad. Sci. U.S.A. <em>100</em>, 12420–12425. <a href="https://doi.org/10.1073/pnas.1635213100">10.1073/pnas.1635213100</a>.</div>
</div>
<div id="ref-radulovicCholesterolTransferEndoplasmic2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">53. </div><div class="csl-right-inline">Radulovic, M., Wenzel, E.M., Gilani, S., Holland, L.K., Lystad, A.H., Phuyal, S., Olkkonen, V.M., Brech, A., Jäättelä, M., Maeda, K., et al. (2022). Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair. The EMBO Journal <em>41</em>, e112677. <a href="https://doi.org/10.15252/embj.2022112677">10.15252/embj.2022112677</a>.</div>
</div>
<div id="ref-papadopoulosDetectionClearanceDamaged2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">54. </div><div class="csl-right-inline">Papadopoulos, C., and Meyer, H. (2017). Detection and <span>Clearance</span> of <span>Damaged Lysosomes</span> by the <span>Endo-Lysosomal Damage Response</span> and <span>Lysophagy</span>. Current Biology <em>27</em>, R1330–R1341. <a href="https://doi.org/10.1016/j.cub.2017.11.012">10.1016/j.cub.2017.11.012</a>.</div>
</div>
<div id="ref-dereticAutophagyInnateImmunity2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">55. </div><div class="csl-right-inline">Deretic, V. (2012). Autophagy as an innate immunity paradigm: Expanding the scope and repertoire of pattern recognition receptors. Current Opinion in Immunology <em>24</em>, 21–31. <a href="https://doi.org/10.1016/j.coi.2011.10.006">10.1016/j.coi.2011.10.006</a>.</div>
</div>
<div id="ref-henneESCRTPathway2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">56. </div><div class="csl-right-inline">Henne, W.M., Buchkovich, N.J., and Emr, S.D. (2011). The <span>ESCRT Pathway</span>. Developmental Cell <em>21</em>, 77–91. <a href="https://doi.org/10.1016/j.devcel.2011.05.015">10.1016/j.devcel.2011.05.015</a>.</div>
</div>
<div id="ref-maejimaAutophagySequestersDamaged2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">57. </div><div class="csl-right-inline">Maejima, I., Takahashi, A., Omori, H., Kimura, T., Takabatake, Y., Saitoh, T., Yamamoto, A., Hamasaki, M., Noda, T., Isaka, Y., et al. (2013). Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J <em>32</em>, 2336–2347. <a href="https://doi.org/10.1038/emboj.2013.171">10.1038/emboj.2013.171</a>.</div>
</div>
<div id="ref-khandiaComprehensiveReviewAutophagy2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">58. </div><div class="csl-right-inline">Khandia, R., Dadar, M., Munjal, A., Dhama, K., Karthik, K., Tiwari, R., Yatoo, Mohd.I., Iqbal, H.M.N., Singh, K.P., Joshi, S.K., et al. (2019). A <span>Comprehensive Review</span> of <span>Autophagy</span> and <span>Its Various Roles</span> in <span>Infectious</span>, <span>Non-Infectious</span>, and <span>Lifestyle Diseases</span>: <span>Current Knowledge</span> and <span>Prospects</span> for <span>Disease Prevention</span>, <span>Novel Drug Design</span>, and <span>Therapy</span>. Cells <em>8</em>, 674. <a href="https://doi.org/10.3390/cells8070674">10.3390/cells8070674</a>.</div>
</div>
<div id="ref-schutterLocalFattyAcid2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">59. </div><div class="csl-right-inline">Schütter, M., Giavalisco, P., Brodesser, S., and Graef, M. (2020). Local <span>Fatty Acid Channeling</span> into <span>Phospholipid Synthesis Drives Phagophore Expansion</span> during <span>Autophagy</span>. Cell <em>180</em>, 135–149.e14. <a href="https://doi.org/10.1016/j.cell.2019.12.005">10.1016/j.cell.2019.12.005</a>.</div>
</div>
<div id="ref-golovkineAutophagyRestrictsMycobacterium2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">60. </div><div class="csl-right-inline">Golovkine, G.R., Roberts, A.W., Morrison, H.M., Rivera-Lugo, R., McCall, R.M., Nilsson, H., Garelis, N.E., Repasy, T., Cronce, M., Budzik, J., et al. (2023). Autophagy restricts <span>Mycobacterium</span> tuberculosis during acute infection in mice. Nat Microbiol <em>8</em>, 819–832. <a href="https://doi.org/10.1038/s41564-023-01354-6">10.1038/s41564-023-01354-6</a>.</div>
</div>
<div id="ref-siregarAutophagyresistantMycobacteriumTuberculosis2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">61. </div><div class="csl-right-inline">Siregar, T.A.P., Prombutara, P., Kanjanasirirat, P., Kunkaew, N., Tubsuwan, A., Boonmee, A., Palaga, T., Khumpanied, T., Borwornpinyo, S., Chaiprasert, A., et al. (2022). The autophagy-resistant <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> <span>Beijing</span> strain upregulates <span>KatG</span> to evade starvation-induced autophagic restriction. Pathogens and Disease <em>80</em>, ftac004. <a href="https://doi.org/10.1093/femspd/ftac004">10.1093/femspd/ftac004</a>.</div>
</div>
<div id="ref-typasAutophagyCounteractsMycobacterium2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">62. </div><div class="csl-right-inline">Typas, D. (2023). Autophagy counteracts <span>Mycobacterium</span> tuberculosis infection at early stages. Nat Struct Mol Biol <em>30</em>, 720–720. <a href="https://doi.org/10.1038/s41594-023-01024-5">10.1038/s41594-023-01024-5</a>.</div>
</div>
<div id="ref-sainiSuppressionAutophagyAntigen2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">63. </div><div class="csl-right-inline">Saini, N.K., Baena, A., Ng, T.W., Venkataswamy, M.M., Kennedy, S.C., Kunnath-Velayudhan, S., Carreño, L.J., Xu, J., Chan, J., Larsen, M.H., et al. (2016). Suppression of autophagy and antigen presentation by <span>Mycobacterium</span> tuberculosis <span>PE</span>_<span>PGRS47</span>. Nat Microbiol <em>1</em>, 16133. <a href="https://doi.org/10.1038/nmicrobiol.2016.133">10.1038/nmicrobiol.2016.133</a>.</div>
</div>
<div id="ref-divangahiMycobacteriumTuberculosisEvades2009" class="csl-entry" role="listitem">
<div class="csl-left-margin">64. </div><div class="csl-right-inline">Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T.T., Lee, D.M., Fortune, S., Behar, S.M., and Remold, H.G. (2009). Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol <em>10</em>, 899–906. <a href="https://doi.org/10.1038/ni.1758">10.1038/ni.1758</a>.</div>
</div>
<div id="ref-mittalMycobacteriumTuberculosisType2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">65. </div><div class="csl-right-inline">Mittal, E., Skowyra, M.L., Uwase, G., Tinaztepe, E., Mehra, A., Köster, S., Hanson, P.I., and Philips, J.A. (2018). Mycobacterium tuberculosis <span>Type VII Secretion System Effectors Differentially Impact</span> the <span>ESCRT Endomembrane Damage Response</span>. mBio <em>9</em>, e01765–18. <a href="https://doi.org/10.1128/mBio.01765-18">10.1128/mBio.01765-18</a>.</div>
</div>
<div id="ref-duanMycobacteriumTuberculosisEIS2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">66. </div><div class="csl-right-inline">Duan, L., Yi, M., Chen, J., Li, S., and Chen, W. (2016). Mycobacterium tuberculosis <span>EIS</span> gene inhibits macrophage autophagy through up-regulation of <span>IL-10</span> by increasing the acetylation of histone <span>H3</span>. Biochemical and Biophysical Research Communications <em>473</em>, 1229–1234. <a href="https://doi.org/10.1016/j.bbrc.2016.04.045">10.1016/j.bbrc.2016.04.045</a>.</div>
</div>
<div id="ref-strongIdentificationAutophagyInhibitingFactors2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">67. </div><div class="csl-right-inline">Strong, E.J., Jurcic Smith, K.L., Saini, N.K., Ng, T.W., Porcelli, S.A., and Lee, S. (2020). Identification of <span>Autophagy-Inhibiting Factors</span> of <span>Mycobacterium</span> tuberculosis by <span class="nocase">High-Throughput Loss-of-Function Screening</span>. Infect Immun <em>88</em>, e00269–20. <a href="https://doi.org/10.1128/IAI.00269-20">10.1128/IAI.00269-20</a>.</div>
</div>
<div id="ref-olzmannDynamicsFunctionsLipid2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">68. </div><div class="csl-right-inline">Olzmann, J.A., and Carvalho, P. (2019). Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol <em>20</em>, 137–155. <a href="https://doi.org/10.1038/s41580-018-0085-z">10.1038/s41580-018-0085-z</a>.</div>
</div>
<div id="ref-barischBreakingFatHow2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">69. </div><div class="csl-right-inline">Barisch, C., and Soldati, T. (2017). Breaking fat! <span>How</span> mycobacteria and other intracellular pathogens manipulate host lipid droplets. Biochimie <em>141</em>, 54–61. <a href="https://doi.org/10.1016/j.biochi.2017.06.001">10.1016/j.biochi.2017.06.001</a>.</div>
</div>
<div id="ref-mattosModulationLipidDroplets2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">70. </div><div class="csl-right-inline">Mattos, K.A., Lara, F.A., Oliveira, V.G.C., Rodrigues, L.S., D’Avila, H., Melo, R.C.N., Manso, P.P.A., Sarno, E.N., Bozza, P.T., and Pessolani, M.C.V. (2011). Modulation of lipid droplets by <span>Mycobacterium</span> leprae in <span>Schwann</span> cells: A putative mechanism for host lipid acquisition and bacterial survival in phagosomes: <span>M</span>. Leprae-driven lipid droplets in <span>Schwann</span> cells. Cellular Microbiology <em>13</em>, 259–273. <a href="https://doi.org/10.1111/j.1462-5822.2010.01533.x">10.1111/j.1462-5822.2010.01533.x</a>.</div>
</div>
<div id="ref-othienoInteractionMycobacteriumTuberculosis1999" class="csl-entry" role="listitem">
<div class="csl-left-margin">71. </div><div class="csl-right-inline">Othieno, C., Hirsch, C.S., Hamilton, B.D., Wilkinson, K., Ellner, J.J., and Toossi, Z. (1999). Interaction of <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> -<span>Induced Transforming Growth Factor</span> Β1 and <span>Interleukin-10</span>. Infect Immun <em>67</em>, 5730–5735. <a href="https://doi.org/10.1128/IAI.67.11.5730-5735.1999">10.1128/IAI.67.11.5730-5735.1999</a>.</div>
</div>
<div id="ref-fortesDetectionVitroInterferong2005" class="csl-entry" role="listitem">
<div class="csl-left-margin">72. </div><div class="csl-right-inline">Fortes, A., Pereira, K., Antas, P.R.Z., Franken, C.L.M.C., Dalcolmo, M., Ribeiro-Carvalho, M.M., Cunha, K.S., Geluk, A., Kritski, A., Kolk, A., et al. (2005). Detection of <span><span><em>in Vitro</em></span></span> interferon-γ and serum tumour necrosis factor-α in multidrug-resistant tuberculosis patients. Clinical and Experimental Immunology <em>141</em>, 541–548. <a href="https://doi.org/10.1111/j.1365-2249.2005.02872.x">10.1111/j.1365-2249.2005.02872.x</a>.</div>
</div>
<div id="ref-bernsTherapeuticPotentialInterferongamma2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">73. </div><div class="csl-right-inline">Berns, S.A., Isakova, J.A., and Pekhtereva, P. (2022). The <span>Therapeutic</span> potential of interferon-gamma in tuberculosis. ADMET DMPK. <a href="https://doi.org/10.5599/admet.1078">10.5599/admet.1078</a>.</div>
</div>
<div id="ref-youngTherapeuticHostdirectedStrategies2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">74. </div><div class="csl-right-inline">Young, C., Walzl, G., and Du Plessis, N. (2020). Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunology <em>13</em>, 190–204. <a href="https://doi.org/10.1038/s41385-019-0226-5">10.1038/s41385-019-0226-5</a>.</div>
</div>
<div id="ref-gaoAdjunctiveTherapyInterferongamma2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">75. </div><div class="csl-right-inline">Gao, X.-F., Yang, Z.-W., and Li, J. (2011). Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: A systematic review. International Journal of Infectious Diseases <em>15</em>, e594–e600. <a href="https://doi.org/10.1016/j.ijid.2011.05.002">10.1016/j.ijid.2011.05.002</a>.</div>
</div>
<div id="ref-ghazaeiMycobacteriumTuberculosisLipids2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">76. </div><div class="csl-right-inline">Ghazaei, C. (2018). Mycobacterium tuberculosis and lipids: <span>Insights</span> into molecular mechanisms from persistence to virulence. J Res Med Sci <em>23</em>, 63. <a href="https://doi.org/10.4103/jrms.JRMS_904_17">10.4103/jrms.JRMS_904_17</a>.</div>
</div>
<div id="ref-guerriniFoamCellsOne2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">77. </div><div class="csl-right-inline">Guerrini, V., and Gennaro, M.L. (2019). Foam <span>Cells</span>: <span>One Size Doesn</span>’t <span>Fit All</span>. Trends in Immunology <em>40</em>, 1163–1179. <a href="https://doi.org/10.1016/j.it.2019.10.002">10.1016/j.it.2019.10.002</a>.</div>
</div>
<div id="ref-costaMycobacteriumTuberculosisInduces2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">78. </div><div class="csl-right-inline">Costa, M.F.D.S., Pereira‐Dutra, F., Deboosere, N., Jouny, S., Song, O., Iack, G., Souza, A.L., Roma, E.H., Delorme, V., Bozza, P.T., et al. (2023). <span><em>Mycobacterium Tuberculosis</em></span> induces delayed lipid droplet accumulation in dendritic cells depending on bacterial viability and virulence. Molecular Microbiology <em>119</em>, 224–236. <a href="https://doi.org/10.1111/mmi.15023">10.1111/mmi.15023</a>.</div>
</div>
<div id="ref-owensTuberculosisRv2252Encodes2006a" class="csl-entry" role="listitem">
<div class="csl-left-margin">79. </div><div class="csl-right-inline">Owens, R.M., Hsu, F.F., VanderVen, B.C., Purdy, G.E., Hesteande, E., Giannakas, P., Sacchettini, J.C., McKinney, J.D., Hill, P.J., Belisle, J.T., et al. (2006). M. Tuberculosis <span>Rv2252</span> encodes a diacylglycerol kinase involved in the biosynthesis of phosphatidylinositol mannosides (<span>PIMs</span>). Mol Microbiol <em>60</em>, 1152–1163. <a href="https://doi.org/10.1111/j.1365-2958.2006.05174.x">10.1111/j.1365-2958.2006.05174.x</a>.</div>
</div>
<div id="ref-jainLipidomicsRevealsControl2007a" class="csl-entry" role="listitem">
<div class="csl-left-margin">80. </div><div class="csl-right-inline">Jain, M., Petzold, C.J., Schelle, M.W., Leavell, M.D., Mougous, J.D., Bertozzi, C.R., Leary, J.A., and Cox, J.S. (2007). Lipidomics reveals control of <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> virulence lipids via metabolic coupling. Proceedings of the National Academy of Sciences <em>104</em>, 5133–5138. <a href="https://doi.org/10.1073/pnas.0610634104">10.1073/pnas.0610634104</a>.</div>
</div>
<div id="ref-chandraInhibitionFattyAcid2020a" class="csl-entry" role="listitem">
<div class="csl-left-margin">81. </div><div class="csl-right-inline">Chandra, P., He, L., Zimmerman, M., Yang, G., Köster, S., Ouimet, M., Wang, H., Moore, K.J., Dartois, V., Schilling, J.D., et al. (2020). Inhibition of <span>Fatty Acid Oxidation Promotes Macrophage Control</span> of <span>Mycobacterium</span> tuberculosis. mBio <em>11</em>, e01139–20. <a href="https://doi.org/10.1128/mBio.01139-20">10.1128/mBio.01139-20</a>.</div>
</div>
<div id="ref-yangInterceptionHostFatty2021a" class="csl-entry" role="listitem">
<div class="csl-left-margin">82. </div><div class="csl-right-inline">Yang, H., Wang, F., Guo, X., Liu, F., Liu, Z., Wu, X., Zhao, M., Ma, M., Liu, H., Qin, L., et al. (2021). Interception of host fatty acid metabolism by mycobacteria under hypoxia to suppress anti-<span>TB</span> immunity. Cell Discov <em>7</em>, 90. <a href="https://doi.org/10.1038/s41421-021-00301-1">10.1038/s41421-021-00301-1</a>.</div>
</div>
<div id="ref-segalBIOCHEMICALDIFFERENTIATIONMYCOBACTERIUM1956" class="csl-entry" role="listitem">
<div class="csl-left-margin">83. </div><div class="csl-right-inline">Segal, W., and Bloch, H. (1956). <span>BIOCHEMICAL DIFFERENTIATION OF</span> <span><span><em>MYCOBACTERIUM TUBERCULOSIS</em></span></span> <span>GROWN</span> <span><span><em>IN VIVO</em></span></span> <span>AND</span> <span><span><em>IN VITRO</em></span></span>. J Bacteriol <em>72</em>, 132–141. <a href="https://doi.org/10.1128/jb.72.2.132-141.1956">10.1128/jb.72.2.132-141.1956</a>.</div>
</div>
<div id="ref-mckinneyPersistenceMycobacteriumTuberculosis2000" class="csl-entry" role="listitem">
<div class="csl-left-margin">84. </div><div class="csl-right-inline">McKinney, J.D., Zu Bentrup, K.H., Muñoz-Elías, E.J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J.C., Jacobs, W.R., and Russell, D.G. (2000). Persistence of <span>Mycobacterium</span> tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature <em>406</em>, 735–738. <a href="https://doi.org/10.1038/35021074">10.1038/35021074</a>.</div>
</div>
<div id="ref-schnappingerTranscriptionalAdaptationMycobacterium2003" class="csl-entry" role="listitem">
<div class="csl-left-margin">85. </div><div class="csl-right-inline">Schnappinger, D., Ehrt, S., Voskuil, M.I., Liu, Y., Mangan, J.A., Monahan, I.M., Dolganov, G., Efron, B., Butcher, P.D., Nathan, C., et al. (2003). Transcriptional <span>Adaptation</span> of <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> within <span>Macrophages</span>. The Journal of Experimental Medicine <em>198</em>, 693–704. <a href="https://doi.org/10.1084/jem.20030846">10.1084/jem.20030846</a>.</div>
</div>
<div id="ref-timmDifferentialExpressionIron2003" class="csl-entry" role="listitem">
<div class="csl-left-margin">86. </div><div class="csl-right-inline">Timm, J., Post, F.A., Bekker, L.-G., Walther, G.B., Wainwright, H.C., Manganelli, R., Chan, W.-T., Tsenova, L., Gold, B., Smith, I., et al. (2003). Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl. Acad. Sci. U.S.A. <em>100</em>, 14321–14326. <a href="https://doi.org/10.1073/pnas.2436197100">10.1073/pnas.2436197100</a>.</div>
</div>
<div id="ref-wilburnCholesterolFattyAcids2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">87. </div><div class="csl-right-inline">Wilburn, K.M., Fieweger, R.A., and VanderVen, B.C. (2018). Cholesterol and fatty acids grease the wheels of <span>Mycobacterium</span> tuberculosis pathogenesis. Pathogens and Disease <em>76</em>, 1–14. <a href="https://doi.org/10.1093/femspd/fty021">10.1093/femspd/fty021</a>.</div>
</div>
<div id="ref-leeIntracellularMycobacteriumTuberculosis2013a" class="csl-entry" role="listitem">
<div class="csl-left-margin">88. </div><div class="csl-right-inline">Lee, W., VanderVen, B.C., Fahey, R.J., and Russell, D.G. (2013). Intracellular <span>Mycobacterium</span> tuberculosis <span class="nocase">Exploits Host-derived Fatty Acids</span> to <span>Limit Metabolic Stress</span>. Journal of Biological Chemistry <em>288</em>, 6788–6800. <a href="https://doi.org/10.1074/jbc.M112.445056">10.1074/jbc.M112.445056</a>.</div>
</div>
<div id="ref-guzmanGeneticToolsStudying2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">89. </div><div class="csl-right-inline">Guzman, G., Creek, C., Farley, S., and Tafesse, F.G. (2023). Genetic <span>Tools</span> for <span>Studying</span> the <span>Roles</span> of <span>Sphingolipids</span> in <span>Viral Infections</span>. In Methods in <span>Molecular Biology</span> (Humana Press Inc.), pp. 1–16. <a href="https://doi.org/10.1007/978-1-0716-2895-9_1">10.1007/978-1-0716-2895-9_1</a>.</div>
</div>
<div id="ref-niekampSphingomyelinBiosynthesisEssential2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">90. </div><div class="csl-right-inline">Niekamp, P., Guzman, G., Leier, H.C., Rashidfarrokhi, A., Richina, V., Pott, F., Barisch, C., Holthuis, J.C.M.M., and Tafesse, F.G. (2021). Sphingomyelin <span>Biosynthesis Is Essential</span> for <span>Phagocytic Signaling</span> during <span>Mycobacterium</span> tuberculosis <span>Host Cell Entry</span>. mBio <em>12</em>, 1–19. <a href="https://doi.org/10.1128/mBio.03141-20">10.1128/mBio.03141-20</a>.</div>
</div>
<div id="ref-hannunSphingolipidsTheirMetabolism2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">91. </div><div class="csl-right-inline">Hannun, Y.A., and Obeid, L.M. (2018). Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol <em>19</em>, 175–191. <a href="https://doi.org/10.1038/nrm.2017.107">10.1038/nrm.2017.107</a>.</div>
</div>
<div id="ref-wattenbergLongShortCeramides2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">92. </div><div class="csl-right-inline">Wattenberg, B.W. (2018). The long and the short of ceramides. Journal of Biological Chemistry <em>293</em>, 9922–9923. <a href="https://doi.org/10.1074/jbc.H118.003522">10.1074/jbc.H118.003522</a>.</div>
</div>
<div id="ref-quinvilleComprehensiveReviewSphingolipid2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">93. </div><div class="csl-right-inline">Quinville, B.M., Deschenes, N.M., Ryckman, A.E., and Walia, J.S. (2021). A <span>Comprehensive Review</span>: <span>Sphingolipid Metabolism</span> and <span>Implications</span> of <span>Disruption</span> in <span>Sphingolipid Homeostasis</span>. IJMS <em>22</em>, 5793. <a href="https://doi.org/10.3390/ijms22115793">10.3390/ijms22115793</a>.</div>
</div>
<div id="ref-gaultOverviewSphingolipidMetabolism2010a" class="csl-entry" role="listitem">
<div class="csl-left-margin">94. </div><div class="csl-right-inline">Gault, C.R., Obeid, L.M., and Hannun, Y.A. (2010). An <span>Overview</span> of <span>Sphingolipid Metabolism</span>: <span>From Synthesis</span> to <span>Breakdown</span>. In Adv <span>Exp Med Biol</span>, pp. 1–23. <a href="https://doi.org/10.1007/978-1-4419-6741-1_1">10.1007/978-1-4419-6741-1_1</a>.</div>
</div>
<div id="ref-hoCeramideAcylChain2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">95. </div><div class="csl-right-inline">Ho, Q.W.C., Zheng, X., and Ali, Y. (2022). Ceramide <span>Acyl Chain Length</span> and <span>Its Relevance</span> to <span>Intracellular Lipid Regulation</span>. IJMS <em>23</em>, 9697. <a href="https://doi.org/10.3390/ijms23179697">10.3390/ijms23179697</a>.</div>
</div>
<div id="ref-olsonTamingSphinxMechanisms2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">96. </div><div class="csl-right-inline">Olson, D.K., Fröhlich, F., Farese, R.V., and Walther, T.C. (2016). Taming the sphinx: <span>Mechanisms</span> of cellular sphingolipid homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids <em>1861</em>, 784–792. <a href="https://doi.org/10.1016/j.bbalip.2015.12.021">10.1016/j.bbalip.2015.12.021</a>.</div>
</div>
<div id="ref-newtonRevisitingSphingolipidRheostat2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">97. </div><div class="csl-right-inline">Newton, J., Lima, S., Maceyka, M., and Spiegel, S. (2015). Revisiting the sphingolipid rheostat: <span>Evolving</span> concepts in cancer therapy. Experimental Cell Research <em>333</em>, 195–200. <a href="https://doi.org/10.1016/j.yexcr.2015.02.025">10.1016/j.yexcr.2015.02.025</a>.</div>
</div>
<div id="ref-liuCeramideGlycosylationCatalyzed2013a" class="csl-entry" role="listitem">
<div class="csl-left-margin">98. </div><div class="csl-right-inline">Liu, Y.-Y., Hill, R.A., and Li, Y.-T. (2013). Ceramide <span>Glycosylation Catalyzed</span> by <span>Glucosylceramide Synthase</span> and <span>Cancer Drug Resistance</span>. In Advances in <span>Cancer Research</span> (Elsevier), pp. 59–89. <a href="https://doi.org/10.1016/B978-0-12-394274-6.00003-0">10.1016/B978-0-12-394274-6.00003-0</a>.</div>
</div>
<div id="ref-villaniSphingomyelinSynthasesRegulate2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">99. </div><div class="csl-right-inline">Villani, M., Subathra, M., Im, Y.-B., Choi, Y., Signorelli, P., Del Poeta, M., and Luberto, C. (2008). Sphingomyelin synthases regulate production of diacylglycerol at the <span>Golgi</span>. Biochemical Journal <em>414</em>, 31–41. <a href="https://doi.org/10.1042/BJ20071240">10.1042/BJ20071240</a>.</div>
</div>
<div id="ref-cerbonDiacylglycerolGeneratedSphingomyelin2003a" class="csl-entry" role="listitem">
<div class="csl-left-margin">100. </div><div class="csl-right-inline">Cerbón, J., and Del Carmen López-Sánchez, R. (2003). Diacylglycerol generated during sphingomyelin synthesis is involved in protein kinase <span>C</span> activation and cell proliferation in <span>Madin-Darby</span> canine kidney cells. Biochemical Journal <em>373</em>, 917–924. <a href="https://doi.org/10.1042/bj20021732">10.1042/bj20021732</a>.</div>
</div>
<div id="ref-koivusaloEndocyticTraffickingSphingomyelin2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">101. </div><div class="csl-right-inline">Koivusalo, M., Jansen, M., Somerharju, P., and Ikonen, E. (2007). Endocytic <span>Trafficking</span> of <span>Sphingomyelin Depends</span> on <span>Its Acyl Chain Length</span>. MBoC <em>18</em>, 5113–5123. <a href="https://doi.org/10.1091/mbc.e07-04-0330">10.1091/mbc.e07-04-0330</a>.</div>
</div>
<div id="ref-contrerasMolecularRecognitionSingle2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">102. </div><div class="csl-right-inline">Contreras, F.X., Ernst, A.M., Haberkant, P., Björkholm, P., Lindahl, E., Gönen, B., Tischer, C., Elofsson, A., Von Heijne, G., Thiele, C., et al. (2012). Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain. Nature <em>481</em>, 525–529. <a href="https://doi.org/10.1038/nature10742">10.1038/nature10742</a>.</div>
</div>
<div id="ref-dangeloGlycosphingolipidSynthesisRequires2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">103. </div><div class="csl-right-inline">D’Angelo, G., Polishchuk, E., Tullio, G.D., Santoro, M., Campli, A.D., Godi, A., West, G., Bielawski, J., Chuang, C.-C., van der Spoel, A.C., et al. (2007). Glycosphingolipid synthesis requires <span>FAPP2</span> transfer of glucosylceramide. Nature <em>449</em>, 62–67. <a href="https://doi.org/10.1038/nature06097">10.1038/nature06097</a>.</div>
</div>
<div id="ref-boathRegulationTrafficCeramide2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">104. </div><div class="csl-right-inline">Boath, A., Graf, C., Lidome, E., Ullrich, T., Nussbaumer, P., and Bornancin, F. (2008). Regulation and <span>Traffic</span> of <span>Ceramide</span> 1-<span>Phosphate Produced</span> by <span>Ceramide Kinase</span>. Journal of Biological Chemistry <em>283</em>, 8517–8526. <a href="https://doi.org/10.1074/jbc.M707107200">10.1074/jbc.M707107200</a>.</div>
</div>
<div id="ref-quinnTwoSeparatePools1992" class="csl-entry" role="listitem">
<div class="csl-left-margin">105. </div><div class="csl-right-inline">Quinn, P., and Allan, D. (1992). Two separate pools of sphingomyelin in <span>BHK</span> cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism <em>1124</em>, 95–100. <a href="https://doi.org/10.1016/0005-2760(92)90131-E">10.1016/0005-2760(92)90131-E</a>.</div>
</div>
<div id="ref-freyszTurnoverMolecularSpecies1980" class="csl-entry" role="listitem">
<div class="csl-left-margin">106. </div><div class="csl-right-inline">Freysz, L., and Mandel, P. (1980). Turnover of <span>Molecular Species</span> of <span>Sphingomyelin</span> in <span>Microsomes</span> and <span>Myelin</span> of <span>Rat Brain</span>. Journal of Neurochemistry <em>34</em>, 305–308. <a href="https://doi.org/10.1111/j.1471-4159.1980.tb06597.x">10.1111/j.1471-4159.1980.tb06597.x</a>.</div>
</div>
<div id="ref-freyszMETABOLISMBRAINSPHINGOMYELINS1976" class="csl-entry" role="listitem">
<div class="csl-left-margin">107. </div><div class="csl-right-inline">Freysz, L., Lastennet, A., and Mandel, P. (1976). <span>METABOLISM OF BRAIN SPHINGOMYELINS</span>: <span>HALF</span>‐<span>LIVES OF SPHINGOSINE</span>, <span>FATTY ACIDS AND PHOSPHATE FROM TWO TYPES OF RAT BRAIN SPHINGOMYELIN</span>. Journal of Neurochemistry <em>27</em>, 355–359. <a href="https://doi.org/10.1111/j.1471-4159.1976.tb12253.x">10.1111/j.1471-4159.1976.tb12253.x</a>.</div>
</div>
<div id="ref-ksiazekSourcesMetabolismRegulation2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">108. </div><div class="csl-right-inline">Książek, M., Chacińska, M., Chabowski, A., and Baranowski, M. (2015). Sources, metabolism, and regulation of circulating sphingosine-1-phosphate. Journal of Lipid Research <em>56</em>, 1271–1281. <a href="https://doi.org/10.1194/jlr.R059543">10.1194/jlr.R059543</a>.</div>
</div>
<div id="ref-garrisSphingosinePhosphateReceptor2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">109. </div><div class="csl-right-inline">Garris, C.S., Blaho, V.A., Hla, T., and Han, M.H. (2014). Sphingosine‐1‐phosphate receptor 1 signalling in <span>T</span> cells: Trafficking and beyond. Immunology <em>142</em>, 347–353. <a href="https://doi.org/10.1111/imm.12272">10.1111/imm.12272</a>.</div>
</div>
<div id="ref-menuzProtectionElegansAnoxia2009" class="csl-entry" role="listitem">
<div class="csl-left-margin">110. </div><div class="csl-right-inline">Menuz, V., Howell, K.S., Gentina, S., Epstein, S., Riezman, I., Fornallaz-Mulhauser, M., Hengartner, M.O., Gomez, M., Riezman, H., and Martinou, J.-C. (2009). Protection of <span><span><em>C</em></span></span><span><span><em>. Elegans</em></span></span> from <span>Anoxia</span> by <span>HYL-2 Ceramide Synthase</span>. Science <em>324</em>, 381–384. <a href="https://doi.org/10.1126/science.1168532">10.1126/science.1168532</a>.</div>
</div>
<div id="ref-noureddineModulationTotalCeramide2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">111. </div><div class="csl-right-inline">Noureddine, L., Azzam, R., Nemer, G., Bielawski, J., Nasser, M., Bitar, F., and Dbaibo, G.S. (2008). Modulation of total ceramide and constituent ceramide species in the acutely and chronically hypoxic mouse heart at different ages. Prostaglandins &amp; Other Lipid Mediators <em>86</em>, 49–55. <a href="https://doi.org/10.1016/j.prostaglandins.2008.02.003">10.1016/j.prostaglandins.2008.02.003</a>.</div>
</div>
<div id="ref-hoglingerIntracellularSphingosineReleases2015a" class="csl-entry" role="listitem">
<div class="csl-left-margin">112. </div><div class="csl-right-inline">Höglinger, D., Haberkant, P., Aguilera-Romero, A., Riezman, H., Porter, F.D., Platt, F.M., Galione, A., and Schultz, C. (2015). Intracellular sphingosine releases calcium from lysosomes. eLife <em>4</em>. <a href="https://doi.org/10.7554/eLife.10616">10.7554/eLife.10616</a>.</div>
</div>
<div id="ref-niekampCa2ActivatedSphingomyelin2022a" class="csl-entry" role="listitem">
<div class="csl-left-margin">113. </div><div class="csl-right-inline">Niekamp, P., Scharte, F., Sokoya, T., Vittadello, L., Kim, Y., Deng, Y., Südhoff, E., Hilderink, A., Imlau, M., Clarke, C.J., et al. (2022). Ca2+-activated sphingomyelin scrambling and turnover mediate <span class="nocase">ESCRT-independent</span> lysosomal repair. Nature Communications <em>13</em>. <a href="https://doi.org/10.1038/s41467-022-29481-4">10.1038/s41467-022-29481-4</a>.</div>
</div>
<div id="ref-ramirez-montielPlasmaMembraneDamage2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">114. </div><div class="csl-right-inline">Ramírez-Montiel, F., Mendoza-Macías, C., Andrade-Guillén, S., Rangel-Serrano, Á., Páramo-Pérez, I., Rivera-Cuéllar, P.E., España-Sánchez, B.L., Luna-Bárcenas, G., Anaya-Velázquez, F., Franco, B., et al. (2019). Plasma membrane damage repair is mediated by an acid sphingomyelinase in <span>Entamoeba</span> histolytica. PLoS Pathog <em>15</em>, e1008016. <a href="https://doi.org/10.1371/journal.ppat.1008016">10.1371/journal.ppat.1008016</a>.</div>
</div>
<div id="ref-leeFunctionalRolesSphingolipids2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">115. </div><div class="csl-right-inline">Lee, M., Lee, S.Y., and Bae, Y.-S. (2023). Functional roles of sphingolipids in immunity and their implication in disease. Exp Mol Med <em>55</em>, 1110–1130. <a href="https://doi.org/10.1038/s12276-023-01018-9">10.1038/s12276-023-01018-9</a>.</div>
</div>
<div id="ref-hlaSphingolipidSignalingMetabolic2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">116. </div><div class="csl-right-inline">Hla, T., and Dannenberg, A.J. (2012). Sphingolipid <span>Signaling</span> in <span>Metabolic Disorders</span>. Cell Metabolism <em>16</em>, 420–434. <a href="https://doi.org/10.1016/j.cmet.2012.06.017">10.1016/j.cmet.2012.06.017</a>.</div>
</div>
<div id="ref-sunLysosomalStorageDisease2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">117. </div><div class="csl-right-inline">Sun, A. (2018). Lysosomal storage disease overview. Ann. Transl. Med <em>6</em>, 476.–476. <a href="https://doi.org/10.21037/atm.2018.11.39">10.21037/atm.2018.11.39</a>.</div>
</div>
<div id="ref-doGlucocerebrosidaseItsRelevance2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">118. </div><div class="csl-right-inline">Do, J., McKinney, C., Sharma, P., and Sidransky, E. (2019). Glucocerebrosidase and its relevance to <span>Parkinson</span> disease. Mol Neurodegeneration <em>14</em>, 36. <a href="https://doi.org/10.1186/s13024-019-0336-2">10.1186/s13024-019-0336-2</a>.</div>
</div>
<div id="ref-beutlerEnzymeReplacementGaucher2004" class="csl-entry" role="listitem">
<div class="csl-left-margin">119. </div><div class="csl-right-inline">Beutler, E. (2004). Enzyme <span>Replacement</span> in <span>Gaucher Disease</span>. PLoS Med <em>1</em>, e21. <a href="https://doi.org/10.1371/journal.pmed.0010021">10.1371/journal.pmed.0010021</a>.</div>
</div>
<div id="ref-tafesseDisruptionSphingolipidBiosynthesis2015a" class="csl-entry" role="listitem">
<div class="csl-left-margin">120. </div><div class="csl-right-inline">Tafesse, F.G., Rashidfarrokhi, A., Schmidt, F.I., Freinkman, E., Dougan, S., Dougan, M., Esteban, A., Maruyama, T., Strijbis, K., and Ploegh, H.L. (2015). Disruption of <span>Sphingolipid Biosynthesis Blocks Phagocytosis</span> of <span>Candida</span> albicans. PLoS pathogens <em>11</em>, e1005188. <a href="https://doi.org/10.1371/journal.ppat.1005188">10.1371/journal.ppat.1005188</a>.</div>
</div>
<div id="ref-olsenSphingolipidsBacteriaFungi2001" class="csl-entry" role="listitem">
<div class="csl-left-margin">121. </div><div class="csl-right-inline">Olsen, I., and Jantzen, E. (2001). Sphingolipids in <span>Bacteria</span> and <span>Fungi</span>. Anaerobe <em>7</em>, 103–112. <a href="https://doi.org/10.1006/anae.2001.0376">10.1006/anae.2001.0376</a>.</div>
</div>
<div id="ref-brownBacteroidesDerivedSphingolipidsAre2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">122. </div><div class="csl-right-inline">Brown, E.M., Ke, X., Hitchcock, D., Jeanfavre, S., Avila-Pacheco, J., Nakata, T., Arthur, T.D., Fornelos, N., Heim, C., Franzosa, E.A., et al. (2019). Bacteroides-<span>Derived Sphingolipids Are Critical</span> for <span>Maintaining Intestinal Homeostasis</span> and <span>Symbiosis</span>. Cell Host &amp; Microbe <em>25</em>, 668–680.e7. <a href="https://doi.org/10.1016/j.chom.2019.04.002">10.1016/j.chom.2019.04.002</a>.</div>
</div>
<div id="ref-wangFunctionsSphingolipidsPathogenesis2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">123. </div><div class="csl-right-inline">Wang, J., Chen, Y.-L., Li, Y.-K., Chen, D.-K., He, J.-F., and Yao, N. (2021). Functions of <span>Sphingolipids</span> in <span>Pathogenesis During Host</span>–<span>Pathogen Interactions</span>. Front. Microbiol. <em>12</em>, 701041. <a href="https://doi.org/10.3389/fmicb.2021.701041">10.3389/fmicb.2021.701041</a>.</div>
</div>
<div id="ref-baiRoleInteractionBacterial2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">124. </div><div class="csl-right-inline">Bai, X., Ya, R., Tang, X., and Cai, M. (2023). Role and interaction of bacterial sphingolipids in human health. Front. Microbiol. <em>14</em>, 1289819. <a href="https://doi.org/10.3389/fmicb.2023.1289819">10.3389/fmicb.2023.1289819</a>.</div>
</div>
<div id="ref-ohPublisherCorrectionHost2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">125. </div><div class="csl-right-inline">Oh, S.F., Praveena, T., Song, H., Yoo, J.-S., Jung, D.-J., Erturk-Hasdemir, D., Hwang, Y.S., Lee, C.C., Le Nours, J., Kim, H., et al. (2022). Publisher <span>Correction</span>: <span>Host</span> immunomodulatory lipids created by symbionts from dietary amino acids. Nature <em>601</em>, E32–E32. <a href="https://doi.org/10.1038/s41586-021-04276-7">10.1038/s41586-021-04276-7</a>.</div>
</div>
<div id="ref-griffinHighResolutionPhenotypicProfiling2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">126. </div><div class="csl-right-inline">Griffin, J.E., Gawronski, J.D., DeJesus, M.A., Ioerger, T.R., Akerley, B.J., and Sassetti, C.M. (2011). High-<span>Resolution Phenotypic Profiling Defines Genes Essential</span> for <span>Mycobacterial Growth</span> and <span>Cholesterol Catabolism</span>. PLoS Pathog <em>7</em>, e1002251. <a href="https://doi.org/10.1371/journal.ppat.1002251">10.1371/journal.ppat.1002251</a>.</div>
</div>
<div id="ref-speerSurfaceHydrolysisSphingomyelin2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">127. </div><div class="csl-right-inline">Speer, A., Sun, J., Danilchanka, O., Meikle, V., Rowland, J.L., Walter, K., Buck, B.R., Pavlenok, M., Hölscher, C., Ehrt, S., et al. (2015). Surface hydrolysis of sphingomyelin by the outer membrane protein <span>Rv0888</span> supports replication of <span>M</span> ycobacterium tuberculosis in macrophages. Molecular Microbiology <em>97</em>, 881–897. <a href="https://doi.org/10.1111/mmi.13073">10.1111/mmi.13073</a>.</div>
</div>
<div id="ref-leeIntracellularMycobacteriumTuberculosis2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">128. </div><div class="csl-right-inline">Lee, W., VanderVen, B.C., Fahey, R.J., and Russell, D.G. (2013). Intracellular <span>Mycobacterium</span> tuberculosis <span class="nocase">Exploits Host-derived Fatty Acids</span> to <span>Limit Metabolic Stress</span>. Journal of Biological Chemistry <em>288</em>, 6788–6800. <a href="https://doi.org/10.1074/jbc.M112.445056">10.1074/jbc.M112.445056</a>.</div>
</div>
<div id="ref-danielInductionNovelClass2004" class="csl-entry" role="listitem">
<div class="csl-left-margin">129. </div><div class="csl-right-inline">Daniel, J., Deb, C., Dubey, V.S., Sirakova, T.D., Abomoelak, B., Morbidoni, H.R., and Kolattukudy, P.E. (2004). Induction of a <span>Novel Class</span> of <span>Diacylglycerol Acyltransferases</span> and <span>Triacylglycerol Accumulation</span> in <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> as <span>It Goes</span> into a <span>Dormancy-Like State</span> in <span>Culture</span>. J Bacteriol <em>186</em>, 5017–5030. <a href="https://doi.org/10.1128/JB.186.15.5017-5030.2004">10.1128/JB.186.15.5017-5030.2004</a>.</div>
</div>
<div id="ref-danielMycobacteriumTuberculosisUses2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">130. </div><div class="csl-right-inline">Daniel, J., Maamar, H., Deb, C., Sirakova, T.D., and Kolattukudy, P.E. (2011). Mycobacterium tuberculosis <span>Uses Host Triacylglycerol</span> to <span>Accumulate Lipid Droplets</span> and <span>Acquires</span> a <span>Dormancy-Like Phenotype</span> in <span>Lipid-Loaded Macrophages</span>. PLoS Pathogens <em>7</em>, e1002093. <a href="https://doi.org/10.1371/journal.ppat.1002093">10.1371/journal.ppat.1002093</a>.</div>
</div>
<div id="ref-srinivasFunctionalCharacterizationPhospholipase2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">131. </div><div class="csl-right-inline">Srinivas, M., Rajakumari, S., Narayana, Y., Joshi, B., Katoch, V.M., Rajasekharan, R., and Balaji, K.N. (2008). Functional characterization of the phospholipase <span>C</span> activity of <span>Rv3487c</span> and its localization on the cell wall of <span>Mycobacterium</span> tuberculosis. J Biosci <em>33</em>, 221–230. <a href="https://doi.org/10.1007/s12038-008-0039-2">10.1007/s12038-008-0039-2</a>.</div>
</div>
<div id="ref-dangExtracellularSphingomyelinaseRv08882018" class="csl-entry" role="listitem">
<div class="csl-left-margin">132. </div><div class="csl-right-inline">Dang, G., Cui, Y., Wang, L., Li, T., Cui, Z., Song, N., Chen, L., Pang, H., and Liu, S. (2018). Extracellular <span>Sphingomyelinase Rv0888</span> of <span>Mycobacterium</span> tuberculosis <span>Contributes</span> to <span>Pathological Lung Injury</span> of <span>Mycobacterium</span> smegmatis in <span>Mice</span> via <span>Inducing Formation</span> of <span>Neutrophil Extracellular Traps</span>. Front. Immunol. <em>9</em>, 677. <a href="https://doi.org/10.3389/fimmu.2018.00677">10.3389/fimmu.2018.00677</a>.</div>
</div>
<div id="ref-nadellaSphingosine1PhosphateS1PPromotes2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">133. </div><div class="csl-right-inline">Nadella, V., Sharma, L., Kumar, P., Gupta, P., Gupta, U.D., Tripathi, S., Pothani, S., Qadri, S.S.Y.H., and Prakash, H. (2020). Sphingosine-1-<span>Phosphate</span> (<span>S-1P</span>) <span>Promotes Differentiation</span> of <span>Naive Macrophages</span> and <span>Enhances Protective Immunity Against Mycobacterium</span> tuberculosis. Front. Immunol. <em>10</em>, 3085. <a href="https://doi.org/10.3389/fimmu.2019.03085">10.3389/fimmu.2019.03085</a>.</div>
</div>
<div id="ref-heoProInflammatoryRoleS1P2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">134. </div><div class="csl-right-inline">Heo, J.-Y., and Im, D.-S. (2019). Pro-<span>Inflammatory Role</span> of <span>S1P</span> <span><sub>3</sub></span> in <span>Macrophages</span>. Biomolecules &amp; Therapeutics <em>27</em>, 373–380. <a href="https://doi.org/10.4062/biomolther.2018.215">10.4062/biomolther.2018.215</a>.</div>
</div>
<div id="ref-mohammedSphingolipidsMycobacteriaHost2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">135. </div><div class="csl-right-inline">Mohammed, S.A., Saini, R.V., Jha, A.K., Hadda, V., Singh, A.K., and Prakash, H. (2022). Sphingolipids, mycobacteria and host: <span>Unraveling</span> the tug of war. Front. Immunol. <em>13</em>, 1003384. <a href="https://doi.org/10.3389/fimmu.2022.1003384">10.3389/fimmu.2022.1003384</a>.</div>
</div>
<div id="ref-maguireSphingosine1phosphateInducesAirway2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">136. </div><div class="csl-right-inline">Maguire, T.J.A., Yung, S., Ortiz-Zapater, E., Kayode, O.S., Till, S., Corrigan, C., Siew, L.Q.C., Knock, G.A., and Woszczek, G. (2023). Sphingosine-1-phosphate induces airway smooth muscle hyperresponsiveness and proliferation. Journal of Allergy and Clinical Immunology <em>152</em>, 1131–1140.e6. <a href="https://doi.org/10.1016/j.jaci.2023.05.028">10.1016/j.jaci.2023.05.028</a>.</div>
</div>
<div id="ref-mcgovernDiseaseManifestationsBurden2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">137. </div><div class="csl-right-inline">McGovern, M.M., Avetisyan, R., Sanson, B.-J., and Lidove, O. (2017). Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (<span>ASMD</span>). Orphanet J Rare Dis <em>12</em>, 41. <a href="https://doi.org/10.1186/s13023-017-0572-x">10.1186/s13023-017-0572-x</a>.</div>
</div>
<div id="ref-wuAcidSphingomyelinaseContributes2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">138. </div><div class="csl-right-inline">Wu, Y., Li, C., Peng, H., Swaidan, A., Riehle, A., Pollmeier, B., Zhang, Y., Gulbins, E., and Grassmé, H. (2020). Acid <span>Sphingomyelinase Contributes</span> to the <span>Control</span> of <span>Mycobacterial Infection</span> via a <span>Signaling Cascade Leading</span> from <span>Reactive Oxygen Species</span> to <span>Cathepsin D</span>. Cells <em>9</em>, 2406. <a href="https://doi.org/10.3390/cells9112406">10.3390/cells9112406</a>.</div>
</div>
<div id="ref-vazquezProneurotrophinReceptorSortilin2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">139. </div><div class="csl-right-inline">Vázquez, C.L., Rodgers, A., Herbst, S., Coade, S., Gronow, A., Guzman, C.A., Wilson, M.S., Kanzaki, M., Nykjaer, A., and Gutierrez, M.G. (2016). The proneurotrophin receptor sortilin is required for <span>Mycobacterium</span> tuberculosis control by macrophages. Sci Rep <em>6</em>, 29332. <a href="https://doi.org/10.1038/srep29332">10.1038/srep29332</a>.</div>
</div>
<div id="ref-dimentCathepsinMembraneassociatedMacrophage1988" class="csl-entry" role="listitem">
<div class="csl-left-margin">140. </div><div class="csl-right-inline">Diment, S., Leech, M.S., and Stahl, P.D. (1988). Cathepsin <span>D</span> is membrane-associated in macrophage endosomes. J Biol Chem <em>263</em>, 6901–6907.</div>
</div>
<div id="ref-heinrichCathepsinTargetedAcid2000" class="csl-entry" role="listitem">
<div class="csl-left-margin">141. </div><div class="csl-right-inline">Heinrich, M., Wickel, M., Schneider-Brachert, W., Sandberg, C., Gahr, J., Schwandner, R., Weber, T., Brunner, J., Krönke, M., and Schütze, S. (2000). Cathepsin <span>D</span> targeted by acid sphingomyelinase-derived ceramide. EMBO J <em>19</em>, 315–315. <a href="https://doi.org/10.1038/sj.emboj.7592140">10.1038/sj.emboj.7592140</a>.</div>
</div>
<div id="ref-zebrakovskaComplexModulationPeptidolytic2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">142. </div><div class="csl-right-inline">Žebrakovská, I., Máša, M., Srp, J., Horn, M., Vávrová, K., and Mareš, M. (2011). Complex modulation of peptidolytic activity of cathepsin <span>D</span> by sphingolipids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids <em>1811</em>, 1097–1104. <a href="https://doi.org/10.1016/j.bbalip.2011.09.005">10.1016/j.bbalip.2011.09.005</a>.</div>
</div>
<div id="ref-taniguchiLysosomalCeramideGenerated2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">143. </div><div class="csl-right-inline">Taniguchi, M., Ogiso, H., Takeuchi, T., Kitatani, K., Umehara, H., and Okazaki, T. (2015). Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin <span class="nocase">B-mediated</span> degradation of <span class="nocase">X-linked</span> inhibitor of apoptosis protein in natural killer/<span>T</span> lymphoma cell apoptosis. Cell Death Dis <em>6</em>, e1717–e1717. <a href="https://doi.org/10.1038/cddis.2015.82">10.1038/cddis.2015.82</a>.</div>
</div>
<div id="ref-bharathCeramideInitiatedProteinPhosphatase2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">144. </div><div class="csl-right-inline">Bharath, L.P., Ruan, T., Li, Y., Ravindran, A., Wan, X., Nhan, J.K., Walker, M.L., Deeter, L., Goodrich, R., Johnson, E., et al. (2015). Ceramide-<span>Initiated Protein Phosphatase 2A Activation Contributes</span> to <span>Arterial Dysfunction In Vivo</span>. Diabetes <em>64</em>, 3914–3926. <a href="https://doi.org/10.2337/db15-0244">10.2337/db15-0244</a>.</div>
</div>
<div id="ref-zhangKinaseSuppressorRas12011" class="csl-entry" role="listitem">
<div class="csl-left-margin">145. </div><div class="csl-right-inline">Zhang, Y., Li, X., Carpinteiro, A., Goettel, J.A., Soddemann, M., and Gulbins, E. (2011). Kinase suppressor of <span>Ras-1</span> protects against pulmonary <span>Pseudomonas</span> aeruginosa infections. Nat Med <em>17</em>, 341–346. <a href="https://doi.org/10.1038/nm.2296">10.1038/nm.2296</a>.</div>
</div>
<div id="ref-liCrosstalkAcidSphingomyelinase2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">146. </div><div class="csl-right-inline">Li, C., Guo, S., Pang, W., and Zhao, Z. (2020). Crosstalk <span>Between Acid Sphingomyelinase</span> and <span>Inflammasome Signaling</span> and <span>Their Emerging Roles</span> in <span>Tissue Injury</span> and <span>Fibrosis</span>. Front. Cell Dev. Biol. <em>7</em>, 378. <a href="https://doi.org/10.3389/fcell.2019.00378">10.3389/fcell.2019.00378</a>.</div>
</div>
<div id="ref-gulbinsCentralRoleAcid2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">147. </div><div class="csl-right-inline">Gulbins, E., Walter, S., Becker, K.A., Halmer, R., Liu, Y., Reichel, M., Edwards, M.J., Müller, C.P., Fassbender, K., and Kornhuber, J. (2015). A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression. Journal of Neurochemistry <em>134</em>, 183–192. <a href="https://doi.org/10.1111/jnc.13145">10.1111/jnc.13145</a>.</div>
</div>
<div id="ref-jinCeramideGeneratedSphingomyelin2008a" class="csl-entry" role="listitem">
<div class="csl-left-margin">148. </div><div class="csl-right-inline">Jin, J., Hou, Q., Mullen, T.D., Zeidan, Y.H., Bielawski, J., Kraveka, J.M., Bielawska, A., Obeid, L.M., Hannun, Y.A., and Hsu, Y.T. (2008). Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced bax redistribution to mitochondria in <span>NT-2</span> cells. Journal of Biological Chemistry <em>283</em>, 26509–26517. <a href="https://doi.org/10.1074/jbc.M801597200">10.1074/jbc.M801597200</a>.</div>
</div>
<div id="ref-rocaTNFInducesPathogenic2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">149. </div><div class="csl-right-inline">Roca, F.J., Whitworth, L.J., Redmond, S., Jones, A.A., and Ramakrishnan, L. (2019). <span>TNF Induces Pathogenic Programmed Macrophage Necrosis</span> in <span>Tuberculosis</span> through a <span>Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit</span>. Cell <em>178</em>, 1344–1361.e11. <a href="https://doi.org/10.1016/j.cell.2019.08.004">10.1016/j.cell.2019.08.004</a>.</div>
</div>
<div id="ref-butlerBalanceApoptoticNecrotic2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">150. </div><div class="csl-right-inline">Butler, R.E., Brodin, P., Jang, J., Jang, M.-S., Robertson, B.D., Gicquel, B., and Stewart, G.R. (2012). The <span>Balance</span> of <span>Apoptotic</span> and <span>Necrotic Cell Death</span> in <span>Mycobacterium</span> tuberculosis <span>Infected Macrophages Is Not Dependent</span> on <span>Bacterial Virulence</span>. PLoS ONE <em>7</em>, e47573. <a href="https://doi.org/10.1371/journal.pone.0047573">10.1371/journal.pone.0047573</a>.</div>
</div>
<div id="ref-parkVirulentClinicalIsolates2005" class="csl-entry" role="listitem">
<div class="csl-left-margin">151. </div><div class="csl-right-inline">Park, J.S., Tamayo, M.H., Gonzalez-Juarrero, M., Orme, I.M., and Ordway, D.J. (2005). Virulent clinical isolates of <span><span><em>Mycobacterium</em></span></span><span><span><em> Tuberculosis</em></span></span> grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. Journal of Leukocyte Biology <em>79</em>, 80–86. <a href="https://doi.org/10.1189/jlb.0505250">10.1189/jlb.0505250</a>.</div>
</div>
<div id="ref-derrickESAT6ProteinMycobacterium2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">152. </div><div class="csl-right-inline">Derrick, S.C., and Morris, S.L. (2007). The <span>ESAT6</span> protein of <span>Mycobacterium</span> tuberculosis induces apoptosis of macrophages by activating caspase expression. Cell Microbiol <em>9</em>, 1547–1555. <a href="https://doi.org/10.1111/j.1462-5822.2007.00892.x">10.1111/j.1462-5822.2007.00892.x</a>.</div>
</div>
<div id="ref-santucciMycobacteriumTuberculosisInduced2000" class="csl-entry" role="listitem">
<div class="csl-left-margin">153. </div><div class="csl-right-inline">Santucci, M.B., Amicosante, M., Cicconi, R., Montesano, C., Casarini, M., Giosuè, S., Bisetti, A., Colizzi, V., and Fraziano, M. (2000). <span><em>Mycobacterium Tuberculosis</em></span> –<span>Induced Apoptosis</span> in <span>Monocytes</span>/<span>Macrophages</span>: <span>Early Membrane Modifications</span> and <span>Intracellular Mycobacterial Viability</span>. J INFECT DIS <em>181</em>, 1506–1509. <a href="https://doi.org/10.1086/315371">10.1086/315371</a>.</div>
</div>
<div id="ref-chavoshianSphingomyelinLiposomesContaining2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">154. </div><div class="csl-right-inline">Chavoshian, O., Biari, N., Badiee, A., Khamesipour, A., Abbasi, A., Saberi, Z., Jalali, S.A., and Jaafari, M.R. (2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804844">Sphingomyelin <span>Liposomes Containing Soluble Leishmania</span> major antigens <span>Induced Strong Th2 Immune Response</span> in <span>BALB</span>/c <span>Mice</span></a>. Iran J Basic Med Sci <em>16</em>, 965–972.</div>
</div>
<div id="ref-kasagiOptimizationDihydrosphingomyelinCholesterol2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">155. </div><div class="csl-right-inline">Kasagi, N., Doi, I., Nakabayashi, J., Saito, K., Tadakuma, A., Muraki, N., Hori, R., Kimura, T., Okada, K., Yamada, N., et al. (2023). Optimization of dihydrosphingomyelin/cholesterol mol ratio in topotecan-loaded liposomes to enhance drug retention and plasma half-life by understanding physicochemical and thermodynamic properties of the lipid membrane. Journal of Molecular Structure <em>1283</em>, 135333. <a href="https://doi.org/10.1016/j.molstruc.2023.135333">10.1016/j.molstruc.2023.135333</a>.</div>
</div>
<div id="ref-shabbitsIntracellularDeliveryCeramide2003a" class="csl-entry" role="listitem">
<div class="csl-left-margin">156. </div><div class="csl-right-inline">Shabbits, J.A., and Mayer, L.D. (2003). Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes <em>1612</em>, 98–106. <a href="https://doi.org/10.1016/S0005-2736(03)00108-1">10.1016/S0005-2736(03)00108-1</a>.</div>
</div>
<div id="ref-kolesnickCeramideApoptosis1999" class="csl-entry" role="listitem">
<div class="csl-left-margin">157. </div><div class="csl-right-inline">Kolesnick, R., and Hannun, Y.A. (1999). Ceramide and apoptosis. Trends in Biochemical Sciences <em>24</em>, 224–225. <a href="https://doi.org/10.1016/S0968-0004(99)01408-5">10.1016/S0968-0004(99)01408-5</a>.</div>
</div>
<div id="ref-liInhibitionSphingomyelinSynthase2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">158. </div><div class="csl-right-inline">Li, Z., Hailemariam, T.K., Zhou, H., Li, Y., Duckworth, D.C., Peake, D.A., Zhang, Y., Kuo, M.-S., Cao, G., and Jiang, X.-C. (2007). Inhibition of sphingomyelin synthase (<span>SMS</span>) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids <em>1771</em>, 1186–1194. <a href="https://doi.org/10.1016/j.bbalip.2007.05.007">10.1016/j.bbalip.2007.05.007</a>.</div>
</div>
<div id="ref-jiangSphingolipidsHDLMetabolism2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">159. </div><div class="csl-right-inline">Jiang, X.-C., Li, Z., and Yazdanyar, A. (2014). Sphingolipids and <span>HDL Metabolism</span>. In The <span>HDL Handbook</span> (Elsevier), pp. 133–158. <a href="https://doi.org/10.1016/B978-0-12-407867-3.00006-8">10.1016/B978-0-12-407867-3.00006-8</a>.</div>
</div>
<div id="ref-kyleLIQUIDAnopenSource2017a" class="csl-entry" role="listitem">
<div class="csl-left-margin">160. </div><div class="csl-right-inline">Kyle, J.E., Crowell, K.L., Casey, C.P., Fujimoto, G.M., Kim, S., Dautel, S.E., Smith, R.D., Payne, S.H., and Metz, T.O. (2017). <span>LIQUID</span>: An-open source software for identifying lipids in <span>LC-MS</span>/<span class="nocase">MS-based</span> lipidomics data. Bioinformatics <em>33</em>, 1744–1746. <a href="https://doi.org/10.1093/bioinformatics/btx046">10.1093/bioinformatics/btx046</a>.</div>
</div>
<div id="ref-greeneSimpleHighlySensitive2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">161. </div><div class="csl-right-inline">Greene, M., Hernandez-Corbacho, M.J., Ostermeyer-Fay, A.G., Hannun, Y.A., and Canals, D. (2023). A simple, highly sensitive, and facile method to quantify ceramide at the plasma membrane. Journal of Lipid Research <em>64</em>, 100322. <a href="https://doi.org/10.1016/j.jlr.2022.100322">10.1016/j.jlr.2022.100322</a>.</div>
</div>
<div id="ref-yamajiLyseninNovelSphingomyelinspecific1998" class="csl-entry" role="listitem">
<div class="csl-left-margin">162. </div><div class="csl-right-inline">Yamaji, A., Sekizawa, Y., Emoto, K., Sakuraba, H., Inoue, K., Kobayashi, H., and Umeda, M. (1998). Lysenin, a <span class="nocase">Novel Sphingomyelin-specific Binding Protein</span>. Journal of Biological Chemistry <em>273</em>, 5300–5306. <a href="https://doi.org/10.1074/jbc.273.9.5300">10.1074/jbc.273.9.5300</a>.</div>
</div>
<div id="ref-bakracToxinbasedProbeReveals2010" class="csl-entry" role="listitem">
<div class="csl-left-margin">163. </div><div class="csl-right-inline">Bakrač, B., Kladnik, A., Maček, P., McHaffie, G., Werner, A., Lakey, J.H., and Anderluh, G. (2010). A <span class="nocase">Toxin-based Probe Reveals Cytoplasmic Exposure</span> of <span>Golgi Sphingomyelin</span>. Journal of Biological Chemistry <em>285</em>, 22186–22195. <a href="https://doi.org/10.1074/jbc.M110.105122">10.1074/jbc.M110.105122</a>.</div>
</div>
<div id="ref-krishnamurthyDevelopmentCharacterizationNovel2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">164. </div><div class="csl-right-inline">Krishnamurthy, K., Dasgupta, S., and Bieberich, E. (2007). Development and characterization of a novel anti-ceramide antibody. Journal of Lipid Research <em>48</em>, 968–975. <a href="https://doi.org/10.1194/jlr.D600043-JLR200">10.1194/jlr.D600043-JLR200</a>.</div>
</div>
<div id="ref-rotoloAnticeramideAntibodyPrevents2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">165. </div><div class="csl-right-inline">Rotolo, J., Stancevic, B., Zhang, J., Hua, G., Fuller, J., Yin, X., Haimovitz-Friedman, A., Kim, K., Qian, M., Cardó-Vila, M., et al. (2012). Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J. Clin. Invest. <em>122</em>, 1786–1790. <a href="https://doi.org/10.1172/JCI59920">10.1172/JCI59920</a>.</div>
</div>
<div id="ref-hoglingerTrifunctionalLipidProbes2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">166. </div><div class="csl-right-inline">Höglinger, D., Nadler, A., Haberkant, P., Kirkpatrick, J., Schifferer, M., Stein, F., Hauke, S., Porter, F.D., and Schultz, C. (2017). Trifunctional lipid probes for comprehensive studies of single lipid species in living cells. Proceedings of the National Academy of Sciences <em>114</em>, 1566–1571. <a href="https://doi.org/10.1073/pnas.1611096114">10.1073/pnas.1611096114</a>.</div>
</div>
<div id="ref-haberkantBifunctionalSphingosineCellBased2016a" class="csl-entry" role="listitem">
<div class="csl-left-margin">167. </div><div class="csl-right-inline">Haberkant, P., Stein, F., Höglinger, D., Gerl, M.J., Brügger, B., Van Veldhoven, P.P., Krijgsveld, J., Gavin, A.-C.C., and Schultz, C. (2016). Bifunctional <span>Sphingosine</span> for <span>Cell-Based Analysis</span> of <span>Protein-Sphingolipid Interactions</span>. ACS Chemical Biology <em>11</em>, 222–230. <a href="https://doi.org/10.1021/acschembio.5b00810">10.1021/acschembio.5b00810</a>.</div>
</div>
<div id="ref-haberkantFatFabulousBifunctional2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">168. </div><div class="csl-right-inline">Haberkant, P., and Holthuis, J.C.M. (2014). Fat &amp; fabulous: <span>Bifunctional</span> lipids in the spotlight. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids <em>1841</em>, 1022–1030. <a href="https://doi.org/10.1016/j.bbalip.2014.01.003">10.1016/j.bbalip.2014.01.003</a>.</div>
</div>
<div id="ref-schultzChemicalToolsLipid2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">169. </div><div class="csl-right-inline">Schultz, C. (2023). Chemical <span>Tools</span> for <span>Lipid Cell Biology</span>. Acc. Chem. Res. <em>56</em>, 1168–1177. <a href="https://doi.org/10.1021/acs.accounts.2c00851">10.1021/acs.accounts.2c00851</a>.</div>
</div>
<div id="ref-schultzFlashClickMultifunctionalized2022a" class="csl-entry" role="listitem">
<div class="csl-left-margin">170. </div><div class="csl-right-inline">Schultz, C., Farley, S.E., and Tafesse, F.G. (2022). <span>“<span>Flash</span> &amp; <span>Click</span>”</span>: <span>Multifunctionalized Lipid Derivatives</span> as <span>Tools To Study Viral Infections</span>. J. Am. Chem. Soc. <em>144</em>, 13987–13995. <a href="https://doi.org/10.1021/jacs.2c02705">10.1021/jacs.2c02705</a>.</div>
</div>
<div id="ref-farleyTrifunctionalSphinganineNew2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">171. </div><div class="csl-right-inline">Farley, S., Stein, F., Haberkant, P., Tafesse, F.G., and Schultz, C. (2024). Trifunctional <span>Sphinganine</span>: <span>A New Tool</span> to <span>Dissect Sphingolipid Function</span>. ACS Chem. Biol. <a href="https://doi.org/10.1021/acschembio.3c00554">10.1021/acschembio.3c00554</a>.</div>
</div>
</div>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const disableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'prefetch';
    }
  }
  const enableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'stylesheet';
    }
  }
  const manageTransitions = (selector, allowTransitions) => {
    const els = window.document.querySelectorAll(selector);
    for (let i=0; i < els.length; i++) {
      const el = els[i];
      if (allowTransitions) {
        el.classList.remove('notransition');
      } else {
        el.classList.add('notransition');
      }
    }
  }
  const toggleGiscusIfUsed = (isAlternate, darkModeDefault) => {
    const baseTheme = document.querySelector('#giscus-base-theme')?.value ?? 'light';
    const alternateTheme = document.querySelector('#giscus-alt-theme')?.value ?? 'dark';
    let newTheme = '';
    if(darkModeDefault) {
      newTheme = isAlternate ? baseTheme : alternateTheme;
    } else {
      newTheme = isAlternate ? alternateTheme : baseTheme;
    }
    const changeGiscusTheme = () => {
      // From: https://github.com/giscus/giscus/issues/336
      const sendMessage = (message) => {
        const iframe = document.querySelector('iframe.giscus-frame');
        if (!iframe) return;
        iframe.contentWindow.postMessage({ giscus: message }, 'https://giscus.app');
      }
      sendMessage({
        setConfig: {
          theme: newTheme
        }
      });
    }
    const isGiscussLoaded = window.document.querySelector('iframe.giscus-frame') !== null;
    if (isGiscussLoaded) {
      changeGiscusTheme();
    }
  }
  const toggleColorMode = (alternate) => {
    // Switch the stylesheets
    const alternateStylesheets = window.document.querySelectorAll('link.quarto-color-scheme.quarto-color-alternate');
    manageTransitions('#quarto-margin-sidebar .nav-link', false);
    if (alternate) {
      enableStylesheet(alternateStylesheets);
      for (const sheetNode of alternateStylesheets) {
        if (sheetNode.id === "quarto-bootstrap") {
          toggleBodyColorMode(sheetNode);
        }
      }
    } else {
      disableStylesheet(alternateStylesheets);
      toggleBodyColorPrimary();
    }
    manageTransitions('#quarto-margin-sidebar .nav-link', true);
    // Switch the toggles
    const toggles = window.document.querySelectorAll('.quarto-color-scheme-toggle');
    for (let i=0; i < toggles.length; i++) {
      const toggle = toggles[i];
      if (toggle) {
        if (alternate) {
          toggle.classList.add("alternate");     
        } else {
          toggle.classList.remove("alternate");
        }
      }
    }
    // Hack to workaround the fact that safari doesn't
    // properly recolor the scrollbar when toggling (#1455)
    if (navigator.userAgent.indexOf('Safari') > 0 && navigator.userAgent.indexOf('Chrome') == -1) {
      manageTransitions("body", false);
      window.scrollTo(0, 1);
      setTimeout(() => {
        window.scrollTo(0, 0);
        manageTransitions("body", true);
      }, 40);  
    }
  }
  const isFileUrl = () => { 
    return window.location.protocol === 'file:';
  }
  const hasAlternateSentinel = () => {  
    let styleSentinel = getColorSchemeSentinel();
    if (styleSentinel !== null) {
      return styleSentinel === "alternate";
    } else {
      return false;
    }
  }
  const setStyleSentinel = (alternate) => {
    const value = alternate ? "alternate" : "default";
    if (!isFileUrl()) {
      window.localStorage.setItem("quarto-color-scheme", value);
    } else {
      localAlternateSentinel = value;
    }
  }
  const getColorSchemeSentinel = () => {
    if (!isFileUrl()) {
      const storageValue = window.localStorage.getItem("quarto-color-scheme");
      return storageValue != null ? storageValue : localAlternateSentinel;
    } else {
      return localAlternateSentinel;
    }
  }
  const darkModeDefault = false;
  let localAlternateSentinel = darkModeDefault ? 'alternate' : 'default';
  // Dark / light mode switch
  window.quartoToggleColorScheme = () => {
    // Read the current dark / light value 
    let toAlternate = !hasAlternateSentinel();
    toggleColorMode(toAlternate);
    setStyleSentinel(toAlternate);
    toggleGiscusIfUsed(toAlternate, darkModeDefault);
  };
  // Ensure there is a toggle, if there isn't float one in the top right
  if (window.document.querySelector('.quarto-color-scheme-toggle') === null) {
    const a = window.document.createElement('a');
    a.classList.add('top-right');
    a.classList.add('quarto-color-scheme-toggle');
    a.href = "";
    a.onclick = function() { try { window.quartoToggleColorScheme(); } catch {} return false; };
    const i = window.document.createElement("i");
    i.classList.add('bi');
    a.appendChild(i);
    window.document.body.appendChild(a);
  }
  // Switch to dark mode if need be
  if (hasAlternateSentinel()) {
    toggleColorMode(true);
  } else {
    toggleColorMode(false);
  }
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      // TODO in 1.5, we should make sure this works without a callout special case
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="../../parts/introduction/intro_Layperson.html" class="pagination-link  aria-label=" &lt;span="" part="" 1&lt;="" span&gt;"="">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Introduction Part 1</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="../../parts/results.html" class="pagination-link" aria-label="Main Results">
        <span class="nav-page-text">Main Results</span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
    <div class="nav-footer-left">
<p>Copyright 2024, Gaelen Guzman</p>
</div>   
    <div class="nav-footer-center">
      &nbsp;
    </div>
    <div class="nav-footer-right">
      &nbsp;
    </div>
  </div>
</footer>
<script>var lightboxQuarto = GLightbox({"loop":true,"selector":".lightbox","openEffect":"fade","closeEffect":"fade","descPosition":"bottom"});
window.onload = () => {
  lightboxQuarto.on('slide_before_load', (data) => {
    const { slideIndex, slideNode, slideConfig, player, trigger } = data;
    const href = trigger.getAttribute('href');
    if (href !== null) {
      const imgEl = window.document.querySelector(`a[href="${href}"] img`);
      if (imgEl !== null) {
        const srcAttr = imgEl.getAttribute("src");
        if (srcAttr && srcAttr.startsWith("data:")) {
          slideConfig.href = srcAttr;
        }
      }
    } 
  });

  lightboxQuarto.on('slide_after_load', (data) => {
    const { slideIndex, slideNode, slideConfig, player, trigger } = data;
    if (window.Quarto?.typesetMath) {
      window.Quarto.typesetMath(slideNode);
    }
  });

};
          </script>




</body></html>